strName,strCAS,strMF,Source,Type,numValue,RfDConsistent,dateAssessed,strHyperlink,strDateAssessed,strReference,POD type,numPOD,strUnitsPOD,BMR Type,strCriticalEffect,Adjusted,Route to Route,Animal to Human,strDR,numUF,numUFa,numUFh,numUFs,numUFl,numUFd,numUFother,UFsConsistent,strUFother,strRelatedCompound,Species,Strain,Sex,Route,intHoursPerDay,intDaysPerWeek,strDuration,Duration type,Organ,tblOrgan_strSex,strMOA,idEffect,Effect,tblEffect_strSex,DR Type,strEffectPOD,CV Type,strDoseUnits,strResponseUnits,strDoseConvertedUnits,strDoseHEqUnits,strComment,intDoseOrder,numDose,numDoseConverted,numDoseHEq,intAnimals,intAnimalsEffected,numMeanResponse,numSDResponse
"1,1,1,2-Tetrachloroethane",630206,C2H2Cl4,IRIS,RfD (mg/kg/day),0.03,0.99,12/1/1996,http://www.epa.gov/iris/subst/0265.htm,12/1/1996,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of 1,1,1,2- tetrachloroethane in F344/N rats and B6C3F1 mice (gavage studies). NTP-81-53; NIH Publ.No. 83-1793; NTP Technical Report Series No. 237. NTIS, Springfield, VA.",LOAEL,89.3,mg/kg/day,NA,"Mineralization of the kidneys in males, hepatic clear cell change in females",Yes,None,None,Yes,3000,10,10,,10,3,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,103,Weeks,liver,F,None,551,nonneoplastic histopathology,F,Dichotomous,hepatic clear cell change,,mg/kg/day,,mg/kg/day (ADJ),,,,0,0,,48,0,,
"1,1,2,2-Tetrachloroethane",79345,C2H2Cl4,IRIS,RfD (mg/kg/day),0.02,0.75,9/30/2010,http://www.epa.gov/iris/subst/0193.htm,9/30/2010,"NTP. (National Toxicology Program). (2004) NTP technical report on the toxicity studies of 1,1,2,2_tetrachloroethane administered in microcapsules in feed to F344/N rats and B6C3F1 mice.  U.S. DHHS, Public Health Service, National Institute of Health. Toxicity Report Series, Number 49.",BMDL,15,mg/kg/day,1SD,Increased relative liver weight in rats (a subchronic oral RfD of 0.05 mg/kg/day was derived from the same POD),No,None,None,Yes,1000,10,10,3,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral - other,,,14,Weeks,liver,Both,MOA Evaluation,1351,organ weight,F,Continuous,increased relative liver weight,SE,mg/kg/day,Relative liver wt (mg organ wt/g body wt),,,The 2 highest dose groups were dropped for BMD modeling.,,0,,,10,,35.79,0.56
"1,1,2-Trichloroethane",79005,C2H3Cl3,IRIS,RfD (mg/kg/day),0.004,0.98,2/1/1995,http://www.epa.gov/iris/subst/0198.htm,2/1/1995,"Sanders, V.M., K.L. White, Jr., G.M. Shopp, Jr. and A.E. Munson. 1985. Humoral and cell-mediated immune status of mice exposed to 1,1,2- trichloroethane. Drug Chem. Toxicol. 8(5): 357-372. White, K.L., Jr., V.M. Sanders, V.W. Barnes, G.M. Shopp, Jr. and A.E. Munson. 1985. Toxicology of 1,1,2-trichloroethane in the mouse. Drug Chem. Toxicol. 8(5): 333-355.",NOAEL,3.9,mg/kg/day,NA,Clinical serum chemistry,No,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,,M/F,Oral drinking water,,,90,Days,liver,Both,None,2141,clinical chemistry,F,Continuous,Clinical serum chemistry (SGPT),SE,mg/L,IU/L,mg/kg/day,,"Data obtained from Table 11 of White et al, 1985.",,0,0,,24,,36.9,2.2
"1,1,2-Trichloroethane",79005,C2H3Cl3,IRIS,RfD (mg/kg/day),0.004,0.98,2/1/1995,http://www.epa.gov/iris/subst/0198.htm,2/1/1995,"Sanders, V.M., K.L. White, Jr., G.M. Shopp, Jr. and A.E. Munson. 1985. Humoral and cell-mediated immune status of mice exposed to 1,1,2- trichloroethane. Drug Chem. Toxicol. 8(5): 357-372. White, K.L., Jr., V.M. Sanders, V.W. Barnes, G.M. Shopp, Jr. and A.E. Munson. 1985. Toxicology of 1,1,2-trichloroethane in the mouse. Drug Chem. Toxicol. 8(5): 333-355.",NOAEL,3.9,mg/kg/day,NA,Clinical serum chemistry,No,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,,M/F,Oral drinking water,,,90,Days,liver,Both,None,2140,clinical chemistry,M,Continuous,Clinical serum chemistry (SGPT),SE,mg/L,IU/L,mg/kg/day,,"Data obtained from Table 10 of White et al, 1985; animal number for treated groups was 14-16",,0,0,,24,,62.3,8.4
"1,1,2-Trichloroethane",79005,C2H3Cl3,IRIS,RfD (mg/kg/day),0.004,0.98,2/1/1995,http://www.epa.gov/iris/subst/0198.htm,2/1/1995,"Sanders, V.M., K.L. White, Jr., G.M. Shopp, Jr. and A.E. Munson. 1985. Humoral and cell-mediated immune status of mice exposed to 1,1,2- trichloroethane. Drug Chem. Toxicol. 8(5): 357-372. White, K.L., Jr., V.M. Sanders, V.W. Barnes, G.M. Shopp, Jr. and A.E. Munson. 1985. Toxicology of 1,1,2-trichloroethane in the mouse. Drug Chem. Toxicol. 8(5): 333-355.",NOAEL,3.9,mg/kg/day,NA,Clinical serum chemistry,No,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,,M/F,Oral drinking water,,,90,Days,liver,Both,None,2139,clinical chemistry,F,Continuous,Clinical serum chemistry (SGOT),SE,mg/L,IU/L,mg/kg/day,,"Data obtained from Table 11 of White et al, 1985.",,0,0,,24,,83,5
"1,1,2-Trichloroethane",79005,C2H3Cl3,IRIS,RfD (mg/kg/day),0.004,0.98,2/1/1995,http://www.epa.gov/iris/subst/0198.htm,2/1/1995,"Sanders, V.M., K.L. White, Jr., G.M. Shopp, Jr. and A.E. Munson. 1985. Humoral and cell-mediated immune status of mice exposed to 1,1,2- trichloroethane. Drug Chem. Toxicol. 8(5): 357-372. White, K.L., Jr., V.M. Sanders, V.W. Barnes, G.M. Shopp, Jr. and A.E. Munson. 1985. Toxicology of 1,1,2-trichloroethane in the mouse. Drug Chem. Toxicol. 8(5): 333-355.",NOAEL,3.9,mg/kg/day,NA,Clinical serum chemistry,No,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,,M/F,Oral drinking water,,,90,Days,liver,Both,None,1355,clinical chemistry,M,Continuous,Clinical serum chemistry (SGOT),SE,,IU/L,,,"Data obtained from Table 10 of White et al, 1985; animal number for treated groups was 14-16",,0,0,,24,,116.5,14
"1,1,2-Trichloropropane",598776,C3H5Cl3,IRIS,RfD (mg/kg/day),0.005,1,9/26/1988,http://www.epa.gov/iris/subst/0372.htm,9/26/1988,"Villeneuve, D.C., I. Chu, V.E. Secours, M.G. Cotie, G.L. Plaa and V.E. Valli. 1985. Results of a 90-day toxicity study on 1,2,3- and 1,1,2-trichloropropane administered via the drinking water. Sci. Total Environ. 47: 421-426.",NOEL,15,mg/kg/day,NA,"Mild lesions in liver, kidney, and thyroid",No,None,None,No,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral drinking water,,,90,Days,liver,Both,None,1068,nonneoplastic histopathology,Both,Dichotomous,Mild lesions in liver,,,,,,Histopathological lesions included anisokaryosis and fatty vacuolization.   Incidence data were not available in primary report.,,,,,,,,
"1,1-Dichloroethylene",75354,C2H2Cl2,ATSDR,Chronic Oral MRL (mg/kg/day),0.009,1,,http://www.atsdr.cdc.gov/ToxProfiles/tp39.pdf,May-94,"Quast JF, Humiston CG, Wade CE, et al. 1983. A chronic toxicity and oncogenicity study in rats and subchronic toxicity study in dogs on ingested vinylidene chloride. Fundam Appl Toxicol 3(1):55-62.",LOAEL,9,mg/kg/day,NA,hepatic effects,Yes,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral drinking water,,,2,Years,liver,Both,MOA Evaluation,4087,nonneoplastic histopathology,Both,Dichotomous,hepatocellular swelling with midzonal fatty changes,,,,,,Based on same study and endpoint as IRIS RfD (see IRIS RfD record),,,,,,,,
"1,1-Dichloroethylene",75354,C2H2Cl2,IRIS,RfD (mg/kg/day),0.05,0.92,8/13/2002,http://www.epa.gov/iris/subst/0039.htm,8/13/2002,"Quast, JF; Humiston, CG; Wade, CE; et al. (1983) A chronic toxicity and oncogenicity study in rats and subchronic toxicity study in dogs on ingested vinylidene chloride. Fundam Appl Toxicol 3:55-62.",BMDL,4.6,mg/kg/day,10% ER,Liver toxicity (fatty change),No,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral drinking water,,,2,Years,liver,Both,MOA Evaluation,1362,nonneoplastic histopathology,F,Dichotomous,Liver toxicity (fatty change),,ppm water,,mg/kg/day,,,,0,0,,80,10,,
"1,2,3-Trichloropropane",96184,C3H5Cl3,IRIS,RfD (mg/kg/day),0.004,0.92,9/30/2009,http://www.epa.gov/iris/subst/0200.htm,9/30/2009,"NTP. (1993) Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS No. 96-18-4) in F344/N/N rats and B6C3F1 mice (gavage studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR 384. NIH Publication No. 94-2839. Research Triangle Park, NC: National Institute of Environmental Health Sciences.",BMDL,1.1,mg/kg/day,10% ER,Increased absolute liver weight in male rats,Yes,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,2,Years,liver,Both,MOA Data,1368,organ weight,M,Continuous,Increased absolute liver weight in male rats,SE,mg/kg-day,weight (g),mg/kg-day (ADJ),,"Due to high mortality in high-dose groups, remaining animals were terminated early.  Organ weights were only collected at the 15-month interim sacrifice (data presented below).",,0,0,,10,,14.27,0.37
"1,2,4-Tribromobenzene",615543,C6H3Br3,IRIS,RfD (mg/kg/day),0.005,1,6/1/1993,http://www.epa.gov/iris/subst/0196.htm,6/1/1993,"Carlson, G.P. and R.G. Tardiff. 1977. Effect of 1,4-dibromobenzene and 1,2,4-tribromobenzene on xenobiotic metabolism. Toxicol. Appl. Pharmacol. 42: 189-196.",NOAEL,5,mg/kg/day,NA,"Increased liver-to- body weight ratio and hepatic microsomal enzyme induction",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,M,Oral gavage,,7,90,Days,liver,Both,MOA Determination,575,organ weight,Both,Continuous,Increased liver-to- body weight ratio,SE,mg/kg/day,(liver wt/body wt) X 100,,,Dose response data were obtained from Table 2 of primary report.  Methods section states that data are for 5-6 rats.,,0,,,6,,3.49,0.08
"1,2,4-Tribromobenzene",615543,C6H3Br3,IRIS,RfD (mg/kg/day),0.005,1,6/1/1993,http://www.epa.gov/iris/subst/0196.htm,6/1/1993,"Carlson, G.P. and R.G. Tardiff. 1977. Effect of 1,4-dibromobenzene and 1,2,4-tribromobenzene on xenobiotic metabolism. Toxicol. Appl. Pharmacol. 42: 189-196.",NOAEL,5,mg/kg/day,NA,"Increased liver-to- body weight ratio and hepatic microsomal enzyme induction",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,M,Oral gavage,,7,90,Days,liver,Both,MOA Determination,576,enzyme activity,Both,Continuous,Increased hepatic microsomal enzyme induction,,,,,,,,,,,,,,
"1,2,4-Trichlorobenzene",120821,C6H3Cl3,ATSDR,Chronic Oral MRL (mg/kg/day),0.1,1.33,,http://www.atsdr.cdc.gov/ToxProfiles/tp199.pdf,10-Sep,"Moore MR. 1994a. Final report (6 copies), 104-week dietary carcinogenicity study with 1,2,4-trichlorobenzene in rats, with cover letter dated 6/15/94. Chemical Manufacturers Association. Submitted to the U.S. Environmental Protection Agency under TSCA Section 4. EPA Document No. OPPTS-44612. OTS0558832.",BMDL,13.33,mg/kg/day,10% ER,hepatocellular hypertrophy in male rats,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,MOA Evaluation,3568,nonneoplastic histopathology,M,Dichotomous,hepatocellular hypertrophy,,mg/kg-day,,,,,,0,,,50,2,,
"1,2-Dibromoethane",106934,C2H4Br2,IRIS,RfD (mg/kg/day),0.009,,7/29/2004,http://www.epa.gov/iris/subst/0361.htm,7/29/2004,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",LOAEL,27,mg/kg/day,NA,"Testicular atrophy, liver peliosis, and adrenal corticaldegeneration",Yes,None,None,Yes,3000,10,10,,10,10,,FALSE,"The Cumulative UF is reduced from 10,000 to recommended maximum uncertainty factor of 3000 for the purposes of calculating the final RfD due to recognized overlap in UFs.",,Rat,Osborne-Mendel,M/F,Oral gavage,,5,49-61,Weeks,liver,Both,MOA Evaluation,324,gross pathology,F,Dichotomous,liver peliosis,,mg/kg-day (TWA),,mg/kg-day (ADJ),,"Intubation in the high-dose group were suspended from week 16-30, after which they received the lower dose for the remainder of the study (30-61 weeks)",,0,0,,40,0,,
"1,2-Dibromoethane",106934,C2H4Br2,IRIS,RfD (mg/kg/day),0.009,,7/29/2004,http://www.epa.gov/iris/subst/0361.htm,7/29/2004,"National Cancer Institute (NCI). (1978) Bioassay of 1,2-dibromoethane for possible carcinogenicity. Bethesda, MD: National Cancer Institute. NTIS no. PB 288428.",LOAEL,27,mg/kg/day,NA,"Testicular atrophy, liver peliosis, and adrenal corticaldegeneration",Yes,None,None,Yes,3000,10,10,,10,10,,FALSE,"The Cumulative UF is reduced from 10,000 to recommended maximum uncertainty factor of 3000 for the purposes of calculating the final RfD due to recognized overlap in UFs.",,Rat,Osborne-Mendel,M/F,Oral gavage,,5,49-61,Weeks,liver,Both,MOA Evaluation,323,gross pathology,M,Dichotomous,liver peliosis,,mg/kg-day (TWA),,mg/kg-day (ADJ),,"Intubation in the high-dose group were suspended from week 16-30, after which they received the lower dose for the remainder of the study (30-49 weeks)",,0,0,,40,0,,
"1,2-Dichloropropane",78875,C3H6Cl2,ATSDR,Chronic Oral MRL (mg/kg/day),0.09,0.99,,,Sep-89,"NTP (National Toxicology Program). 1986. Toxicology and carcinogenesis studies of 1,2-dichloropropane (propylene dichloride) in F344/N rats andB6C3Fl mice (gavage studies). Technical Report-No. 263.",LOAEL,89,mg/kg/day,NA,hepatic necrosis,Yes,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,103,Weeks,liver,Both,,4089,nonneoplastic histopathology,F,Dichotomous,hepatic necrosis (focal and centrilobular combined),,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,50,2,,
"1,3-Benzenediamine",108452,C6H8N2,IRIS,RfD (mg/kg/day),0.006,1,8/1/1991,http://www.epa.gov/iris/subst/0087.htm,8/1/1991,"ofer, H., R. Hruby, E Hruby, et al. 1982. Ninety-day toxicity study with m- phenylenediamine on rats. Oestrr. Forschungszent. Seibersdorf (Ber.) OEFZS Ber. No. 4155. p. 1-46.",NOAEL,6,mg/kg/day,NA,"Increased relative and absolute liver weights and degenerative liver lesions",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,M/F,Oral drinking water,,,90,Days,liver,Both,None,410,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
"1,4-Dibromobenzene",106376,C6H4Br2,IRIS,RfD (mg/kg/day),0.01,1,3/1/1988,http://www.epa.gov/iris/subst/0148.htm,3/1/1988,"Carlson, G.P. and R.G. Tardiff. 1977. Effect of 1,4-dibromobenzene and 1,2,4-tribromobenzene on xenobiotic metabolism. Toxicol. Appl. Pharmacol. 42: 189-196.",NOAEL,10,mg/kg/day,NA,"Liver/body weight ratio and hepatic microsomal enzyme induction",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,MOA Evaluation,292,enzyme activity,Both,Continuous,hepatic microsomal enzyme induction (azoreductase),SE,mg/kg/day,ng/min/mg of protein,,,Dose response data are from Table 3 in primary report.  Methods section reports that animal number is 5-6 per group.,,0,,,6,,38.9,4.1
"1,4-Dibromobenzene",106376,C6H4Br2,IRIS,RfD (mg/kg/day),0.01,1,3/1/1988,http://www.epa.gov/iris/subst/0148.htm,3/1/1988,"Carlson, G.P. and R.G. Tardiff. 1977. Effect of 1,4-dibromobenzene and 1,2,4-tribromobenzene on xenobiotic metabolism. Toxicol. Appl. Pharmacol. 42: 189-196.",NOAEL,10,mg/kg/day,NA,"Liver/body weight ratio and hepatic microsomal enzyme induction",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,MOA Evaluation,2533,enzyme activity,Both,Continuous,hepatic microsomal enzyme induction (EFN detoxification),SE,mg/kg/day,ug of p-nitrophenol/50 mg of liver/30 min,,,Dose response data are from Table 3 in primary report.  Methods section reports that animal number is 5-6 per group. Significant increase observed at 10 mg/kg-day was not accompanied by liver weight changes and was not considered in the IRIS summary to represent a significant treatment-related effect.,,0,,,6,,4,0.1
"1,4-Dibromobenzene",106376,C6H4Br2,IRIS,RfD (mg/kg/day),0.01,1,3/1/1988,http://www.epa.gov/iris/subst/0148.htm,3/1/1988,"Carlson, G.P. and R.G. Tardiff. 1977. Effect of 1,4-dibromobenzene and 1,2,4-tribromobenzene on xenobiotic metabolism. Toxicol. Appl. Pharmacol. 42: 189-196.",NOAEL,10,mg/kg/day,NA,"Liver/body weight ratio and hepatic microsomal enzyme induction",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,MOA Evaluation,291,organ weight,Both,Continuous,liver/body weight ratio,SE,mg/kg/day,(liver wt/body wt) x 100,,,Dose response data are from Table 1 in primary report.  Methods section reports that animal number is 5-6 per group.,,0,,,6,,3.01,0.06
"1,4-Dioxane",123911,C4H8O2,ATSDR,Chronic Oral MRL (mg/kg/day),0.1,0.96,,http://www.atsdr.cdc.gov/ToxProfiles/tp187.pdf,12-Apr,"Kociba RJ, McCollister SB, Park C, et al. 1974. 1,4-Dioxane. I. Results of a 2-year ingestion study in rats. Toxicol Appl Pharmacol 30:275-286.",NOAEL,9.6,mg/kg/day,NA,liver effects,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sherman,M/F,Oral drinking water,,,716,Days,liver,M,MOA Evaluation,4416,nonneoplastic histopathology,M,Dichotomous,hepatocellular degeneration and necrosis and evidence of hepatic regeneration as indicated by hepatocellular hyperplastic nodule formation,,,,,,no nonneoplastic incidence data provided in primary report,,,,,,,,
"1,4-Dioxane",123911,C4H8O2,IRIS,RfD (mg/kg/day),0.03,1.07,8/11/2010,http://www.epa.gov/iris/subst/0326.htm,8/11/2010,"Kociba RJ; McCollister SB; Park C; Torkelson TR; Gehring PJ (1974). 1,4-dioxane I Results of a 2-year ingestion study in rats. Toxicol Appl Pharmacol, 30: 275-286.",NOAEL,9.6,mg/kg/day,NA,Liver and kidney toxicity,No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Sherman,M/F,Oral drinking water,,,716,Days,liver,M,MOA Evaluation,476,nonneoplastic histopathology,M,Dichotomous,Liver toxicity,,,,,,no quantitative incidence data for hepatocellular degeneration and necrosis were provided in original report,,,,,,,,
1-Methoxy-2-Propanol,107982,C4H10O2,HEAST,RfD (mg/kg/day),0.7,1.35,,http://epa-heast.ornl.gov/heast.php?chemical=Propylene Glycol Monomethyl Ether,1984,"Rowe V.K., D.D. McCollister, H.C. Spencer et al. 1954. Toxicology of mono-, di-, and tri-Propylene Glycol Methyl Ethers. Arch Ind Hyg Occup Med. 9: 509-525.",NOEL,947,mg/kg/day,NA,histopathology of the liver and kidney,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Albino,M,Oral gavage,,5,35,Days,liver,Both,None,3403,nonneoplastic histopathology,Both,,histopathology of the liver,,,,,,slight congestion and cloudy swelling - incidence not reported in by Rowe et al (1954).,,,,,,,,
1-Naphthyl-N-Methylcarbamate,63252,C12H11NO2,IRIS,RfD (mg/kg/day),0.1,0.96,3/1/1988,http://www.epa.gov/iris/subst/0019.htm,3/1/1988,"Carpenter, C.P., C.W. Weil, P.E. Polin, et al. 1961. Mammalian toxicity of 1-naphthayl-N-methylcarbamate (Sevin insecticide). J. Agric. Food Chem. 9: 30-39.",NOAEL,9.6,mg/kg/day,NA,Kidney and liver toxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,CF-N,M/F,Oral diet,,,2,Years,liver,Both,None,603,nonneoplastic histopathology,Both,Dichotomous,Liver toxicity,,,,,,Histopathological changes (cloudy swelling of hepatic cords); incidence data was not presented in the primary report.,,,,,,,,
"2,3,4,6-Tetrachlorophenol",58902,C6H2Cl4O,IRIS,RfD (mg/kg/day),0.03,0.83,1/1/1992,http://www.epa.gov/iris/subst/0108.htm,1/1/1992,"U.S. EPA. 1986. 2,3,4,6-Tetrachlorophenol. 90-Day subchronic oral toxicity study in rats. Office of Solid Waste, Washington, DC.",NOAEL,25,mg/kg/day,NA,Increased liver weights and centrilobular hypertrophy,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,612,organ weight,M,Continuous,Increased liver weight,SD,mg/kg/day,g,,,Data are from Table 11 of primary report.,,0,,,18,,16.83,2.31
"2,3,4,6-Tetrachlorophenol",58902,C6H2Cl4O,IRIS,RfD (mg/kg/day),0.03,0.83,1/1/1992,http://www.epa.gov/iris/subst/0108.htm,1/1/1992,"U.S. EPA. 1986. 2,3,4,6-Tetrachlorophenol. 90-Day subchronic oral toxicity study in rats. Office of Solid Waste, Washington, DC.",NOAEL,25,mg/kg/day,NA,Increased liver weights and centrilobular hypertrophy,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,2529,nonneoplastic histopathology,M,Dichotomous,centrilobular hypertrophy,,mg/kg/day,,,,,,0,,,18,0,,
"2,3-Dichloropropanol",616239,C3H6Cl2O,IRIS,RfD (mg/kg/day),0.003,,11/1/1990,http://www.epa.gov/iris/subst/0465.htm,11/1/1990,"U.S. EPA. 1989. Rat oral subchronic study with 2,3-dichloropropanol. Study conducted by Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.",NOAEL,10,mg/kg/day,NA,"Myocardial degeneration, hepatotoxicity, and nephrotoxicity",No,None,None,No,3000,10,10,,,,30,TRUE,"30 for the lack of chronic toxicity data, data in a second species and reproductive/ developmental studies.",,Rat,Unspecified,M/F,Oral gavage,,,91-92,Days,liver,Both,None,616,nonneoplastic histopathology,Both,Dichotomous,hepatotoxicity,,,,,,"hypertrophy, karyomegaly, and bile duct proliferations",,,,,,,,
"2,3-Dichloropropanol",616239,C3H6Cl2O,IRIS,RfD (mg/kg/day),0.003,,11/1/1990,http://www.epa.gov/iris/subst/0465.htm,11/1/1990,"U.S. EPA. 1989. Rat oral subchronic study with 2,3-dichloropropanol. Study conducted by Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.",NOAEL,10,mg/kg/day,NA,"Myocardial degeneration, hepatotoxicity, and nephrotoxicity",No,None,None,No,3000,10,10,,,,30,TRUE,"30 for the lack of chronic toxicity data, data in a second species and reproductive/ developmental studies.",,Rat,Unspecified,M/F,Oral gavage,,,91-92,Days,liver,Both,None,616,nonneoplastic histopathology,Both,Continuous,,,,,,,,,,,,,,,
"2,4,5-Trichlorophenol",95954,C6H3Cl3O,IRIS,RfD (mg/kg/day),0.1,1,3/1/1988,http://www.epa.gov/iris/subst/0121.htm,3/1/1988,"McCollister, D.D., D.T. Lockwood and V.K. Rowe. 1961. Toxicologic information on 2,4,5-trichlorophenol. Toxicol. Appl. Pharmacol. 3: 63-70.",NOEL,100,mg/kg/day,NA,Liver and kidney pathology,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,98,Days,liver,Both,None,1414,nonneoplastic histopathology,Both,Dichotomous,liver pathology,,,,,,slight degenerative changes in the liver; incidence data were not presented in primary report,,,,,,,,
"2,4,6-Trinitrotoluene",118967,C7H5N3O6,IRIS,RfD (mg/kg/day),0.0005,,2/1/1993,http://www.epa.gov/iris/subst/0269.htm,2/1/1993,"U.S. Department of Defense (DOD). 1983. AD-A157 002. Available from Defense Technical Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.",LOAEL,0.5,mg/kg/day,NA,Liver effects,No,None,None,No,1000,,,,,,,FALSE,"The UF of 1000 allows for uncertainties in laboratory animal-to-man dose extrapolation, interindividual sensitivity, subchronic-to-chronic extrapolation, and LOAEL-to-NOAEL extrapolation.",,Dog,Beagle,M/F,Oral - other,,,25,Weeks,liver,Both,None,425,nonneoplastic histopathology,Both,Dichotomous,Liver effects,,,,,,Hepatic swelling and hepatocytomegaly (trace to mild),,,,,,,,
"2,4-Dichlorophenoxyacetic Acid",94757,C8H6Cl2O3,IRIS,RfD (mg/kg/day),0.01,1,5/5/1988,http://www.epa.gov/iris/subst/0150.htm,5/5/1988,"Dow Chemical Co. 1983. Acc. No. 251473. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1,mg/kg/day,NA,"Hematologic, hepatic and renal toxicity",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,91,Days,liver,Both,None,1433,clinical chemistry,Both,Continuous,hepatic toxicity,,,,,,"reductions in liver enzymes LDH, SGOT, SGPT, and alkaline phosphatase",,,,,,,,
"2,4-Dinitrotoluene",121142,C7H6N2O4,IRIS,RfD (mg/kg/day),0.002,1,2/1/1993,http://www.epa.gov/iris/subst/0524.htm,2/1/1993,"Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.",NOAEL,0.2,mg/kg/day,NA,"Neurotoxicity, Heinz bodies and biliary tract hyperplasia",No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,2,Years,liver,Both,None,431,nonneoplastic histopathology,Both,Dichotomous,biliary tract hyperplasia,,,,,,"2,4-DNT was administered daily in gelatin capsules",,,,,,,,
"2,4-Dinitrotoluene",121142,C7H6N2O4,IRIS,RfD (mg/kg/day),0.002,1,2/1/1993,http://www.epa.gov/iris/subst/0524.htm,2/1/1993,"Ellis, H.V., C.B. Hong, C.C. Lee, J.C. Dacre and J.P. Glennon. 1985. Subchronic and chronic toxicity studies of 2,4-dinitrotoluene. Part I. Beagle dogs. J. Am. College Toxicol. 4(4): 233-242.",NOAEL,0.2,mg/kg/day,NA,"Neurotoxicity, Heinz bodies and biliary tract hyperplasia",No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,2,Years,liver,Both,None,431,nonneoplastic histopathology,Both,Dichotomous,biliary tract hyperplasia,,,,,,"2,4-DNT was administered daily in gelatin capsules.  Primary report states that ""most dogs given 10 mg/kg/day and some dogs given 1.5 mg/kg/day in the chronic study had hyperplasia of the biliary tract."" Incidence data were not reported.",,,,,,,,
"2,6-Dimethylphenol",576261,C8H10O,IRIS,RfD (mg/kg/day),0.0006,1,9/7/1988,http://www.epa.gov/iris/subst/0230.htm,9/7/1988,"Veldre, I.A. and H.J. Janes. 1979. Toxicological studies of shale oils, some of their components and commercial products. Environ. Health Perspect. 30: 141-146.",NOEL,0.6,mg/kg/day,NA,"Body weight changes and histopathological changes of internal organs (liver, spleen and kidneys)",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,Unspecified,Oral gavage,,,8,Months,liver,Both,None,621,nonneoplastic histopathology,Both,Dichotomous,Histopathological changes; liver,,,,,,Incidence data not reported in Veldre and Janes (1979),,,,,,,,
2-Butoxyethanol,111762,C6H14O2,IRIS,RfD (mg/kg/day),0.1,,3/31/2010,http://www.epa.gov/iris/subst/0500.htm,3/31/2010,"NTP (National Toxicology Program) (2000, 196293) NTP technical report on the toxicology and carcinogenesis studies of 2 butoxyethanol (CAS No. 111 76 2) in F344/N rats and B6C3F1 mice (inhalation studies). http://ntp.niehs.nih.gov/?objectid=070AC403-B110-CA79-3A23AF79DE7B752A; http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr484.pdf",BMDL,1.4,mg/kg/day,10% ER,Hemosiderin deposition in the liver,Yes,PBPK,PBPK,Yes,10,,10,,,,,,,,Rat,Fischer 344,M/F,Inhalation,6,5,2,Years,liver,Both,MOA Determination,437,nonneoplastic histopathology,M,Dichotomous,Hemosiderin deposition in the liver,,ppm air,,mg/m3,,,,0,0,,50,23,,
2-Butoxyethanol,111762,C6H14O2,IRIS,RfD (mg/kg/day),0.1,,3/31/2010,http://www.epa.gov/iris/subst/0500.htm,3/31/2010,"NTP (National Toxicology Program) (2000, 196293) NTP technical report on the toxicology and carcinogenesis studies of 2 butoxyethanol (CAS No. 111 76 2) in F344/N rats and B6C3F1 mice (inhalation studies). http://ntp.niehs.nih.gov/?objectid=070AC403-B110-CA79-3A23AF79DE7B752A; http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr484.pdf",BMDL,1.4,mg/kg/day,10% ER,Hemosiderin deposition in the liver,Yes,PBPK,PBPK,Yes,10,,10,,,,,,,,Rat,Fischer 344,M/F,Inhalation,6,5,2,Years,liver,Both,MOA Determination,439,nonneoplastic histopathology,F,Dichotomous,Hemosiderin deposition in the liver,,ppm,,mg/m3,,,,0,0,,48,15,,
2-Butoxyethanol,111762,C6H14O2,IRIS,RfD (mg/kg/day),0.1,,3/31/2010,http://www.epa.gov/iris/subst/0500.htm,3/31/2010,"NTP (National Toxicology Program) (2000, 196293) NTP technical report on the toxicology and carcinogenesis studies of 2 butoxyethanol (CAS No. 111 76 2) in F344/N rats and B6C3F1 mice (inhalation studies). http://ntp.niehs.nih.gov/?objectid=070AC403-B110-CA79-3A23AF79DE7B752A; http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr484.pdf",BMDL,1.4,mg/kg/day,10% ER,Hemosiderin deposition in the liver,Yes,PBPK,PBPK,Yes,10,,10,,,,,,,,Mouse,B6C3F1,M/F,Inhalation,6,5,2,Years,liver,Both,MOA Determination,440,nonneoplastic histopathology,M,Dichotomous,Hemosiderin deposition in the liver,,ppm air,,mg/m3,,,,0,0,,50,0,,
2-Butoxyethanol,111762,C6H14O2,IRIS,RfD (mg/kg/day),0.1,,3/31/2010,http://www.epa.gov/iris/subst/0500.htm,3/31/2010,"NTP (National Toxicology Program) (2000, 196293) NTP technical report on the toxicology and carcinogenesis studies of 2 butoxyethanol (CAS No. 111 76 2) in F344/N rats and B6C3F1 mice (inhalation studies). http://ntp.niehs.nih.gov/?objectid=070AC403-B110-CA79-3A23AF79DE7B752A; http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr484.pdf",BMDL,1.4,mg/kg/day,10% ER,Hemosiderin deposition in the liver,Yes,PBPK,PBPK,Yes,10,,10,,,,,,,,Mouse,B6C3F1,M/F,Inhalation,6,5,2,Years,liver,Both,MOA Determination,441,nonneoplastic histopathology,F,Dichotomous,Hemosiderin deposition in the liver,,ppm,,mg/m3,,,,0,0,,50,0,,
2-Chloronaphthalene,91587,C10H7Cl,IRIS,RfD (mg/kg/day),0.08,1.04,10/1/1990,http://www.epa.gov/iris/subst/0463.htm,10/1/1990,"U.S. EPA. 1989. Subchronic study in mice with beta-Chloronaphthalene. HLA Study No. 2399-124. Prepared by Hazleton Laboratories America, Inc. for the U.S. EPA, Office of Solid Waste, Washington DC.",NOAEL,250,mg/kg/day,NA,"Dyspnea, abnormal appearance, liver enlargement",No,None,None,No,3000,10,10,10,,3,,TRUE,,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,MOA Data,1456,organ weight,Both,Dichotomous,liver enlargement,,,,,,increased absolute and relative liver weights,,,,,,,,
2-Chloronaphthalene,91587,C10H7Cl,IRIS,RfD (mg/kg/day),0.08,1.04,10/1/1990,http://www.epa.gov/iris/subst/0463.htm,10/1/1990,"U.S. EPA. 1989. Subchronic study in mice with beta-Chloronaphthalene. HLA Study No. 2399-124. Prepared by Hazleton Laboratories America, Inc. for the U.S. EPA, Office of Solid Waste, Washington DC.",NOAEL,250,mg/kg/day,NA,"Dyspnea, abnormal appearance, liver enlargement",No,None,None,No,3000,10,10,10,,3,,TRUE,,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,MOA Data,2121,nonneoplastic histopathology,Both,Dichotomous,liver enlargement,,,,,,centrilobular hepatocellular enlargement,,,,,,,,
"3,4-Dimethylphenol",95658,C8H10O,IRIS,RfD (mg/kg/day),0.001,1.4,1/1/1989,http://www.epa.gov/iris/subst/0231.htm,1/1/1989,"Veldre. I.A. and H.J. Janes. 1979. Toxicological studies of shale oils, some of their components and commercial products. Environ. Health Perspect. 30: 141-146.",NOEL,1.4,mg/kg/day,NA,"Changes in blood pressure and body weight; histopathological changes in liver, kidney and spleen",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,Unspecified,Oral gavage,,,8,Months,liver,Both,None,1482,nonneoplastic histopathology,Both,Dichotomous,histopathological changes in liver,,,,,,Dose-response data were not reported in Veldre and Janes (1979).,,,,,,,,
"3-Amino-2,5-Dichlorobenzoic Acid",133904,C7H5Cl2NO2,IRIS,RfD (mg/kg/day),0.015,1,3/1/1988,http://www.epa.gov/iris/subst/0023.htm,3/1/1988,"Union Carbide Agricultural Products Company, Inc. 1978. MRID No. 00040392, 00040398. Available from EPA. Write for FOI, EPA, Washington DC 20460.",LEL,15,mg/kg/day,NA,Hepatocyte degeneration,No,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,18,Months,liver,Both,None,987,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
"4,4-Methylene bis(2-chloroaniline)",101144,,ATSDR,Chronic Oral MRL (mg/kg/day),0.003,1.11,,http://www.atsdr.cdc.gov/ToxProfiles/tp45.pdf,May-94,"Stula et al. 1977.  Urinary bladder tumors in dogs from 4,4'-methylene-bis(2-chloroaniline) (MOCA). J Environ Pathol Toxicol 1:31-50.",LOAEL,10,mg/kg/day,NA,"hepatic - increased GPT, nodular hepatic hyperplasia",No,None,None,No,3000,10,10,,10,3,,TRUE,,,Dog,Beagle,F,Oral - other,,5,9-Mar,Years,liver,Both,MOA Data,4111,nonneoplastic histopathology,Both,Dichotomous,liver nodular hepatic hyperplasia,,mg/kg-day,,,,One of the 3 treated dogs without nodular hyperplasia died after 3 years on study; this dog was included in the incidence shown here.  Dosing was 3 days/wk for 6 weeks and then 5 days/wk for the remaining time on study.,,0,,,6,0,,
"4,4-Methylene bis(2-chloroaniline)",101144,,ATSDR,Chronic Oral MRL (mg/kg/day),0.003,1.11,,http://www.atsdr.cdc.gov/ToxProfiles/tp45.pdf,May-94,"Stula et al. 1977.  Urinary bladder tumors in dogs from 4,4'-methylene-bis(2-chloroaniline) (MOCA). J Environ Pathol Toxicol 1:31-50.",LOAEL,10,mg/kg/day,NA,"hepatic - increased GPT, nodular hepatic hyperplasia",No,None,None,No,3000,10,10,,10,3,,TRUE,,,Dog,Beagle,F,Oral - other,,5,9-Mar,Years,liver,Both,MOA Data,4432,clinical chemistry,Both,Continuous,Hepatic -Increased GPT,,,,,,"GPT reported for individual dogs in Table 2, page 36  primary reference; group means and SDs not reported.",,,,,,,,
4-methyl-2-Pentanone,108101,C6H12O,HEAST,RfD (mg/kg/day),0.08,1.04,,http://epa-heast.ornl.gov/heast.php?chemical=Methyl Isobutyl Ketone,,"Microbiological Associates. 1986.  Subchronic toxicity of Methyl Isobutyl Keton in Sprague Dawley Rats.  Final Report.  Perforemd for Research Triangle Institute, Research Triangle Park, NC.  Study No. 5221.04.  July 15 1986.",NOAEL,250,mg/kg/day,NA,"CNS depression (lethargy), increased absolute and relative liver weight in females, and increased absolute and relative kidney weight in females",NA,None,None,No,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,13,Weeks,liver,Both,None,4078,organ weight,F,Continuous,increased absolute liver weight,SD,mg/kg/day,g,,,Dose response data are from Table 17 in primary report,,0,,,19,,7.679,0.551
Acenaphthene,83329,C12H10,IRIS,RfD (mg/kg/day),0.06,0.97,4/1/1994,http://www.epa.gov/iris/subst/0442.htm,4/1/1994,"U.S. EPA. 1989. Mouse oral subchronic study with acenaphthene. Study conducted by Hazelton Laboratories, Inc., for the Office of Solid Waste, Washington, DC.",NOAEL,175,mg/kg/day,NA,Hepatotoxicity,No,None,None,No,3000,10,10,10,,3,,TRUE,,,Mouse,CD-1,M/F,Oral gavage,,7,90,Days,liver,Both,None,1256,nonneoplastic histopathology,M,Dichotomous,Hepatotoxicity; hepatocellular hypertrophy,,mg/kg-day,,,,Minimal or slight,,0,,,20,2,,
Acenaphthene,83329,C12H10,IRIS,RfD (mg/kg/day),0.06,0.97,4/1/1994,http://www.epa.gov/iris/subst/0442.htm,4/1/1994,"U.S. EPA. 1989. Mouse oral subchronic study with acenaphthene. Study conducted by Hazelton Laboratories, Inc., for the Office of Solid Waste, Washington, DC.",NOAEL,175,mg/kg/day,NA,Hepatotoxicity,No,None,None,No,3000,10,10,10,,3,,TRUE,,,Mouse,CD-1,M/F,Oral gavage,,7,90,Days,liver,Both,None,4051,nonneoplastic histopathology,F,Dichotomous,Hepatotoxicity; hepatocellular hypertrophy,,mg/kg-day,,,,Minimal or slight,,0,,,20,0,,
Acequinocyl,57960197,,OPP,Chronic RfD (mg/kg/day),0.027,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-0449-0008,11/30/2011,"MRID 45531911, 1994",NOAEL,2.7,mg/kg/day,NA,"clinical chemistry and microscopic non-neoplastic lesions (brown pigmented cells and perivascular inflammatory cells inliver).",No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,Unspecified,M/F,Oral diet,,,18,Months,liver,Both,MOA Evaluation,3678,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Acetamiprid,135410207,,OPP,Chronic RfD (mg/kg/day),0.07,1.01,,http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-099050_20-Nov-01_a.pdf,11/20/2001,"Hatch, R.C. (1999).  Two year dietary toxicity and oncogenicity study in rats.  MPI Research, Inc., Mattawan, MI, Study No. 449-015, September 18, 1999.  MRID 44988429 & 45245304. Unpublished.",NOAEL,7.1,mg/kg/day,NA,reduced body weight and body weight gain (females) and hepatocellular vacuolation (males).,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,CRL/CD,M/F,Oral diet,,,24,Months,liver,M,None,3680,nonneoplastic histopathology,M,Dichotomous,hepatocellular vacuolation,,ppm,,mg/kg/day,,Dose-response data are from Table 5 in the Data Evaluation Record.,,0,0,,12,2,,
Acetochlor,34256821,C14H20ClNO2,IRIS,RfD (mg/kg/day),0.02,1,9/1/1993,http://www.epa.gov/iris/subst/0521.htm,9/1/1993,"ICI, Inc. 1988a. MRID No. 41565118; HED Doc No. 008478. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,2,mg/kg/day,NA,"Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and  decreased blood glucose levels; histopathological changes in kidneys and  testes of males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,52,Weeks,liver,Both,None,201,clinical chemistry,Both,Continuous,increases in alanine aminotransferase (ALT),,mg/kg/day,,,,,,0,,,,,,
Acetochlor,34256821,C14H20ClNO2,IRIS,RfD (mg/kg/day),0.02,1,9/1/1993,http://www.epa.gov/iris/subst/0521.htm,9/1/1993,"ICI, Inc. 1988a. MRID No. 41565118; HED Doc No. 008478. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,2,mg/kg/day,NA,"Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and  decreased blood glucose levels; histopathological changes in kidneys and  testes of males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,52,Weeks,liver,Both,None,203,clinical chemistry,Both,Continuous,increased ornithine carbamyl transferase,,mg/kg/day,,,,,,0,,,,,,
Acetochlor,34256821,C14H20ClNO2,IRIS,RfD (mg/kg/day),0.02,1,9/1/1993,http://www.epa.gov/iris/subst/0521.htm,9/1/1993,"ICI, Inc. 1988a. MRID No. 41565118; HED Doc No. 008478. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,2,mg/kg/day,NA,"Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and  decreased blood glucose levels; histopathological changes in kidneys and  testes of males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,52,Weeks,liver,Both,None,201,clinical chemistry,Both,Dichotomous,,,mg/kg/day,,,,,,,,,,,,
Acetochlor,34256821,C14H20ClNO2,IRIS,RfD (mg/kg/day),0.02,1,9/1/1993,http://www.epa.gov/iris/subst/0521.htm,9/1/1993,"ICI, Inc. 1988a. MRID No. 41565118; HED Doc No. 008478. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,2,mg/kg/day,NA,"Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and  decreased blood glucose levels; histopathological changes in kidneys and  testes of males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,52,Weeks,liver,Both,None,1070,clinical chemistry,Both,Continuous,increased triglyceride levels,,,,,,,,,,,,,,
Acetochlor,34256821,C14H20ClNO2,IRIS,RfD (mg/kg/day),0.02,1,9/1/1993,http://www.epa.gov/iris/subst/0521.htm,9/1/1993,"ICI, Inc. 1988a. MRID No. 41565118; HED Doc No. 008478. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,2,mg/kg/day,NA,"Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and  decreased blood glucose levels; histopathological changes in kidneys and  testes of males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,52,Weeks,liver,Both,None,1071,clinical chemistry,Both,Continuous,decreased blood glucose,,,,,,,,,,,,,,
Aldrin,309002,C12H8Cl6,ATSDR,Chronic Oral MRL (mg/kg/day),0.00003,0.83,,http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf,2-Sep,"Fitzhugh OG, Nelson AA, Quaife ML. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet Toxicol 2:551-562.",LOAEL,0.025,mg/kg/day,NA,"enlarged hepatocyte, increase in cytoplasmic eosinophilia with peripheral migration of basophilic granules, and possible increases in vacuolation and bile duct proliferation",No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,Osborne-Mendel,M/F,Oral diet,,,2,Years,liver,Both,None,4408,nonneoplastic histopathology,Both,Dichotomous,"enlarged hepatocyte, increase in cytoplasmic eosinophilia with peripheral migration of basophilic granules, and possible increases in vacuolation and bile duct proliferation",,,,,,Based on same study and endpoint as IRIS RfD (see IRIS RfD record),,,,,,,,
Aldrin,309002,C12H8Cl6,IRIS,RfD (mg/kg/day),0.00003,0.83,3/1/1988,http://www.epa.gov/iris/subst/0130.htm,3/1/1988,"Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.",LOAEL,0.025,mg/kg/day,,Liver toxicity,No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,None,144,nonneoplastic histopathology,Both,Dichotomous,Liver toxicity,,ppm,,,,"Microscopic liver changes primarily characterized by enlarged centrilobular hepatic cells, with increased cytoplasmic oxyphilia, and perpheral migration of basophilic granules; sum of incidences across all severity categories; severity increased with dose",,0,,,17,1,,
Aldrin,309002,C12H8Cl6,IRIS,RfD (mg/kg/day),0.00003,0.83,3/1/1988,http://www.epa.gov/iris/subst/0130.htm,3/1/1988,"Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.",LOAEL,0.025,mg/kg/day,,Liver toxicity,No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,None,144,nonneoplastic histopathology,Both,Dichotomous,"Liver toxicity (liver lesions were characterized by enlarged centrilobular hepatic cells, with increased cytoplasmic oxyphilia, and peripheral migration of basophilic granules)",,ppm,,,,,,0,,,,,,
Aldrin,309002,C12H8Cl6,IRIS,RfD (mg/kg/day),0.00003,0.83,3/1/1988,http://www.epa.gov/iris/subst/0130.htm,3/1/1988,"Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.",LOAEL,0.025,mg/kg/day,,Liver toxicity,No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,None,145,organ weight,Both,Continuous,Liver toxicity (increased liver-to-body weight ratio),,,,,,,,,,,,,,
Aldrin,309002,C12H8Cl6,IRIS,RfD (mg/kg/day),0.00003,0.83,3/1/1988,http://www.epa.gov/iris/subst/0130.htm,3/1/1988,"Fitzhugh, O.G., A.A. Nelson, and M.L. Quaife. 1964. Chronic oral toxicity of aldrin and dieldrin in rats and dogs. Food Cosmet. Toxicol. 2: 551-562.",LOAEL,0.025,mg/kg/day,,Liver toxicity,No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,None,145,organ weight,Both,Dichotomous,,,,,,,,,,,,,,,
Allyl alcohol,107186,C3H6O,IRIS,RfD (mg/kg/day),0.005,0.96,8/1/1989,http://www.epa.gov/iris/subst/0004.htm,8/1/1989,"Carpanini, F.M.B., I.F. Gaunt, J. Hardy, S.D. Gangalli, K.R. Butterworth and H.G. Lloyd. 1978. Short-term toxicity of allyl alcohol in rats. Toxicology. 9: 29-45.",NOEL,4.8,mg/kg/day,NA,Impaired renal function and increased liver and kidney weights,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral drinking water,,7,15,Weeks,liver,Both,None,67,organ weight,M,Continuous,increased liver weight,,mg/L,mg/100 g BW,mg/kg-day,,relative weight,,0,0,,15,,2.52,
Allyl alcohol,107186,C3H6O,IRIS,RfD (mg/kg/day),0.005,0.96,8/1/1989,http://www.epa.gov/iris/subst/0004.htm,8/1/1989,"Carpanini, F.M.B., I.F. Gaunt, J. Hardy, S.D. Gangalli, K.R. Butterworth and H.G. Lloyd. 1978. Short-term toxicity of allyl alcohol in rats. Toxicology. 9: 29-45.",NOEL,4.8,mg/kg/day,NA,Impaired renal function and increased liver and kidney weights,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral drinking water,,7,15,Weeks,liver,Both,None,68,organ weight,F,Continuous,increased liver weight,,mg/L,mg/100 g BW,mg/kg-day,,relative weight,,0,0,,15,,2.33,
alpha-Hexachlorocyclohexane,319846,C6H6Cl6,ATSDR,Chronic Oral MRL (mg/kg/day),0.008,1,,http://www.atsdr.cdc.gov/ToxProfiles/tp43.pdf,5-Aug,"Fitzhugh OG, Nelson AA, Frawley JP. 1950. The chronic toxicities of technical benzene hexachloride and its _, _ and _ isomers. J Pharmacol Exp Ther 100:59-66..",NOAEL,0.8,mg/kg/day,NA,slight hepatic histological changes with increased liver weight at LOAEL; no hepatic effects at NOAEL,Yes,None,None,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,lifetime,Duration,liver,Both,MOA Evaluation,4409,nonneoplastic histopathology,Both,Dichotomous,slight hepatic histological changes,,,,,,Data reported qualitatively in primary reference,,,,,,,,
alpha-Hexachlorocyclohexane,319846,C6H6Cl6,ATSDR,Chronic Oral MRL (mg/kg/day),0.008,1,,http://www.atsdr.cdc.gov/ToxProfiles/tp43.pdf,5-Aug,"Fitzhugh OG, Nelson AA, Frawley JP. 1950. The chronic toxicities of technical benzene hexachloride and its _, _ and _ isomers. J Pharmacol Exp Ther 100:59-66..",NOAEL,0.8,mg/kg/day,NA,slight hepatic histological changes with increased liver weight at LOAEL; no hepatic effects at NOAEL,Yes,None,None,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,lifetime,Duration,liver,Both,MOA Evaluation,4410,organ weight,Both,Continuous,increased liver weight,,,,,,Number per group not reported in primary reference,,,,,,,,
Ametryne,834128,C9H17N5S,IRIS,RfD (mg/kg/day),0.009,0.96,11/1/1989,http://www.epa.gov/iris/subst/0208.htm,11/1/1989,"Ciba-Geigy Corporation. 1961a. MRID No. 00034843. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,8.6,mg/kg/day,NA,Liver toxicity,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,,M/F,Oral gavage,,6,13,Weeks,liver,Both,None,344,nonneoplastic histopathology,Both,Dichotomous,Fatty degeneration,,,,,,data not reported in IRIS,,,,,,,,
Amicarbazone,129909906,,OPP,Chronic RfD (mg/kg/day),0.023,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2005-0185-0003,4/19/2005,MRID 45121529,NOAEL,2.3,mg/kg/day,NA,"liver effects; including increasedabsolute/relative liver weights,triglycerides and cholesterol; co-critical study, see accomanying record",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,3992,organ weight,M,,,,,,,,,,,,,,,,
Amicarbazone,129909906,,OPP,Chronic RfD (mg/kg/day),0.023,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2005-0185-0003,4/19/2005,MRID 45121529,NOAEL,2.3,mg/kg/day,NA,"liver effects; including increasedabsolute/relative liver weights,triglycerides and cholesterol; co-critical study, see accomanying record",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,3993,clinical chemistry,Both,,,,,,,,,,,,,,,,
Aramite,140578,C15H23ClO4S,HEAST,RfD (mg/kg/day),0.05,1,,http://epa-heast.ornl.gov/heast.php?chemical=Aramite,1989,"Oser B.L., M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-Chloroethyl Sulfite (Aramite) II. Carcinogenicity. Toxicol Appl Pharmacol. 4: 70-88.",NOAEL,5,mg/kg/day,NA,increased liver weight,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,FDRL,M/F,Oral diet,,,104,Weeks,liver,Both,None,3422,organ weight,M,Continuous,increased liver weight,SE,ppm,g,,,Dose-response data are from Table 7 in primary report.,,0,,,100,,4.07,0.12
Aramite,140578,C15H23ClO4S,HEAST,RfD (mg/kg/day),0.05,1,,http://epa-heast.ornl.gov/heast.php?chemical=Aramite,1989,"Oser B.L., M. Oser. 1962. 2-(p-tert-Butylphenoxy)isopropyl 2-Chloroethyl Sulfite (Aramite) II. Carcinogenicity. Toxicol Appl Pharmacol. 4: 70-88.",NOAEL,5,mg/kg/day,NA,increased liver weight,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,FDRL,M/F,Oral diet,,,104,Weeks,liver,Both,None,3658,organ weight,F,Continuous,increased liver weight,SE,ppm,g,,,Dose-response data are from Table 7 in primary report.,,0,,,100,,4.42,0.09
Asulam,3337711,C8H10N2O4S,IRIS,RfD (mg/kg/day),0.05,1,1/1/1995,http://www.epa.gov/iris/subst/0284.htm,1/1/1995,"Rhone-Poulenc Chemical Company. 1981a. MRID No. 00098540. Available from EPA. Write to FOI, EPA, Washington, DC 20460",LEL,50,mg/kg/day,NA,"Lower ovarian weight, lower liver/body weight",No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,CD,M/F,Oral - other,,,2,Generations,liver,F,None,189,organ weight,F,Continuous,lower liver/body weight in F1 females,,ppm,,mg/kg-day,,,,0,0,,,,,
Azoxystrobin,131860338,,OPP,Chronic RfD (mg/kg/day),0.18,1,,http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-128810_22-Sep-00_092.pdf,9/22/2000,MRID 43678139,NOAEL,18,mg/kg/day,NA,"reduced body weights, food consumption and food efficiency; bile duct lesions",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,M,None,3713,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,384,clinical chemistry,F,Continuous,elevated alkaline phosphatase,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,390,gross pathology,F,Dichotomous,brown pigment in the biliary canaliculi,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,389,gross pathology,M,Dichotomous,brown pigment in the biliary canaliculi,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,388,organ weight,F,Continuous,increased liver weights,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,387,organ weight,M,Continuous,increased liver weights,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,385,clinical chemistry,M,Continuous,Elevated SGPT,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,383,clinical chemistry,M,Continuous,elevated alkaline phosphatase,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,386,clinical chemistry,F,Continuous,Elevated SGPT,,ppm,,mg/kg/day,,,,0,0,,,,,
Bensulfuron-Methyl (Ph7),83055996,C16H18N4O7S,IRIS,RfD (mg/kg/day),0.2,1,4/1/1991,http://www.epa.gov/iris/subst/0171.htm,4/1/1991,"E.I. du Pont de Nemours & Company, Inc. 1986a. MRID No. 40089319. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,19.9,mg/kg/day,NA,"Liver effects[The POD reflected above is for the female equivalent dose (750 ppm = 19.9 mg/kg/day F).  The NOEL for males was 21.4 mg/kg/day.]",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,52,Weeks,liver,Both,None,389,gross pathology,M,Continuous,,,,,,,,,,,,,,,
Benthiavalicarb-isopropyl,177406687,,OPP,Chronic RfD (mg/kg/day),0.099,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,177406-68-7",6-Aug,"Murata, K. (2001) (KIF-230 Technical): Chronic Toxicity and Oncogenicity Study in Rats: Lab Project Number: 3822(001-208). Unpublished study prepared by Biosafety Research Center. 2733 p. {OPPTS 870.4300} MRID 45835017 (2001)",NOAEL,9.9,mg/kg-day,NA,nephrotoxicity and hepatotoxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,,,,104,Weeks,liver,Both,MOA Data,4085,organ weight,M,,increased absolute and relative liver weights,,,,,,,,,,,,,,
Benthiavalicarb-isopropyl,177406687,,OPP,Chronic RfD (mg/kg/day),0.099,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,177406-68-7",6-Aug,"Murata, K. (2001) (KIF-230 Technical): Chronic Toxicity and Oncogenicity Study in Rats: Lab Project Number: 3822(001-208). Unpublished study prepared by Biosafety Research Center. 2733 p. {OPPTS 870.4300} MRID 45835017 (2001)",NOAEL,9.9,mg/kg-day,NA,nephrotoxicity and hepatotoxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,,,,104,Weeks,liver,Both,MOA Data,4088,nonneoplastic histopathology,Both,,hepatocyte hypertrophy and gross liver lesions,,,,,,,,,,,,,,
Benzene Sulfonic Acid,68584225,,OPP,Chronic RfD (mg/kg/day),0.5,1.7,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,68584-22-5",6-Jul,Yoneyama et al 1976. Ann Rep Tokyo Metrop.ResLab. Public Health 27(2):105-112),NOAEL,85,mg/kg-day,NA,Decreased body weight gain and serum/biochemical and enzymatic changes in the liver and kidney (weight of evidence from 3 toxicological studies),No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral drinking water,,,9,Months,liver,Both,None,4091,clinical chemistry,Both,,,,,,,,,,,,,,,,
"Benzene, 1,1'-oxybis-, octabromo deriv.",32536520,C12H2Br8O,IRIS,RfD (mg/kg/day),0.003,0.84,8/1/1990,http://www.epa.gov/iris/subst/0180.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,2.51,mg/kg/day,NA,Induction of hepatic enzymes; liver histopathology,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2210,clinical chemistry,Both,Continuous,"Induction of hepatic enzymes (Cytochrome P450, nmol/mg protein)",SE,umol/kg-day,nmol,mg/kg-day,,,,0,0,,6,,1.08,0.09
"Benzene, 1,1'-oxybis-, octabromo deriv.",32536520,C12H2Br8O,IRIS,RfD (mg/kg/day),0.003,0.84,8/1/1990,http://www.epa.gov/iris/subst/0180.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,2.51,mg/kg/day,NA,Induction of hepatic enzymes; liver histopathology,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2208,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (p-Nitroanisole demethylation),SE,umol/kg-day,g,mg/kg-day,,,,0,0,,6,,9,0.4
"Benzene, 1,1'-oxybis-, octabromo deriv.",32536520,C12H2Br8O,IRIS,RfD (mg/kg/day),0.003,0.84,8/1/1990,http://www.epa.gov/iris/subst/0180.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,2.51,mg/kg/day,NA,Induction of hepatic enzymes; liver histopathology,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2209,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (NADPH cytochrome c reductase),SE,umol/kg-day,nmol,mg/kg-day,,,,0,0,,6,,199,14
"Benzene, 1,1'-oxybis-, octabromo deriv.",32536520,C12H2Br8O,IRIS,RfD (mg/kg/day),0.003,0.84,8/1/1990,http://www.epa.gov/iris/subst/0180.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,2.51,mg/kg/day,NA,Induction of hepatic enzymes; liver histopathology,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,1441,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (EPN detoxification),SE,umol/kg-day,g,mg/kg-day,,"Two dosing regiments were administered (high dose regiment: 0, 5.01, 10.02, or 20.04 mg/kg/day and low dose regiment: 0, 0.78, 1.56, or 3.13 mg/kg/day). Data for 4 hepatic enzymes (EPN, p-Nitroanisole demethylation, cytochrome c reductase, cytochrome P450) are presented for each dosing regiment. The IRIS summary states that liver enzyme induction occurred at all dose levels.  In addition, data are reported for both 30 and 60-day recovery periods for the low-dose regiment in the primary source.",,0,0,,6,,7.1,0.3
"Benzene, 1,1'-oxybis-, pentabromo deriv.",32534819,C12H5Br5O,IRIS,RfD (mg/kg/day),0.002,0.89,8/1/1990,http://www.epa.gov/iris/subst/0184.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,1.77,mg/kg/day,NA,Induction of hepatic enzymes,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,1442,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (EPN),SE,umol/kg-day,mg,mg/kg-day,,,,0,0,,6,,5.8,0.1
"Benzene, 1,1'-oxybis-, pentabromo deriv.",32534819,C12H5Br5O,IRIS,RfD (mg/kg/day),0.002,0.89,8/1/1990,http://www.epa.gov/iris/subst/0184.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,1.77,mg/kg/day,NA,Induction of hepatic enzymes,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2518,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (p-Nitroanisole demethylation),SE,umol/kg-day,g,mg/kg-day,,,,0,0,,6,,5.5,0.4
"Benzene, 1,1'-oxybis-, pentabromo deriv.",32534819,C12H5Br5O,IRIS,RfD (mg/kg/day),0.002,0.89,8/1/1990,http://www.epa.gov/iris/subst/0184.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,1.77,mg/kg/day,NA,Induction of hepatic enzymes,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2519,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (NADPH cytochrome c reductase),SE,umol/kg-day,mg,mg/kg-day,,,,0,0,,6,,165,10
"Benzene, 1,1'-oxybis-, pentabromo deriv.",32534819,C12H5Br5O,IRIS,RfD (mg/kg/day),0.002,0.89,8/1/1990,http://www.epa.gov/iris/subst/0184.htm,8/1/1990,"Carlson, G.P. 1980. Induction of xenobiotic metabolism in rats by brominated diphenyl ethers administered for 90 days. Toxicol. Lett. 6: 207-212.",NOAEL,1.77,mg/kg/day,NA,Induction of hepatic enzymes,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,,90,Days,liver,Both,None,2520,clinical chemistry,Both,Continuous,Induction of hepatic enzymes (Cytochrome P-450),SE,umol/kg-day,nmol/mg protein,mg/kg-day,,,,0,0,,6,,1.05,0.02
Benzenethiol ,108985,,HEAST,RfD (mg/kg/day),0.0001,,,http://epa-heast.ornl.gov/heast.php?chemical=Benzenethiol / (Thiophenol),RfD,"American Biogenics Corp. 1989. Ninety-day gavage study in albino rats using Thiophenol. Prepared by Dynamac Corp of Rockville, MD for the U.S. EPA Office of Solid Waste.",LOAEL,0.1,mg/kg/day,NA,centrilobular eosinophilic changes in the liver,NA,None,None,No,1000,,,,,,,FALSE,"No EPA documents were cited, so it is unclear how the cumulative UF is broken down into its components.",,Rat,Sprague-Dawley,M/F,Oral gavage,,,90,Days,liver,Both,,3542,nonneoplastic histopathology,F,Dichotomous,centrilobular eosinophilic changes in the liver,,mg/kg/day,,,,Dose response data are from page 21 of primary report.,,0,,,20,3,,
Benzenethiol ,108985,,HEAST,RfD (mg/kg/day),0.0001,,,http://epa-heast.ornl.gov/heast.php?chemical=Benzenethiol / (Thiophenol),RfD,"American Biogenics Corp. 1989. Ninety-day gavage study in albino rats using Thiophenol. Prepared by Dynamac Corp of Rockville, MD for the U.S. EPA Office of Solid Waste.",LOAEL,0.1,mg/kg/day,NA,centrilobular eosinophilic changes in the liver,NA,None,None,No,1000,,,,,,,FALSE,"No EPA documents were cited, so it is unclear how the cumulative UF is broken down into its components.",,Rat,Sprague-Dawley,M/F,Oral gavage,,,90,Days,liver,Both,,3424,nonneoplastic histopathology,M,Dichotomous,centrilobular eosinophilic changes in the liver,,mg/kg/day,,,,Dose response data are from page 21 of primary report.,,0,,,20,0,,
Benzidine,92875,C12H12N2,IRIS,RfD (mg/kg/day),0.003,0.9,2/1/1995,http://www.epa.gov/iris/subst/0135.htm,2/1/1995,"Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.",LOAEL,2.7,mg/kg/day,NA,Brain cell vacuolization; liver cell alterations in females,No,None,None,Yes,1000,10,10,,10,,,TRUE,,,Mouse,C57/B1,M/F,Oral drinking water,,,33,Months,liver,Both,None,2526,nonneoplastic histopathology,M,Dichotomous,liver cell alterations (MC strain),,ppm,,,,72-120 mice per group,,0,,,,1,,
Benzidine,92875,C12H12N2,IRIS,RfD (mg/kg/day),0.003,0.9,2/1/1995,http://www.epa.gov/iris/subst/0135.htm,2/1/1995,"Littlefield, N.A., C.J. Nelson and C.H. Frith. 1983. Benzidine dihydrochloride: Toxicological assessments in mice during chronic exposures. J. Toxicol. Environ. Health. 12: 671-685.",LOAEL,2.7,mg/kg/day,NA,Brain cell vacuolization; liver cell alterations in females,No,None,None,Yes,1000,10,10,,10,,,TRUE,,,Mouse,C57/B1,M/F,Oral drinking water,,,33,Months,liver,Both,None,2524,nonneoplastic histopathology,F,Dichotomous,liver cell alterations (F1 strain),,ppm,,,,72-120 mice per group,,0,,,,2,,
Bifenazate,149877418,,OPP,Chronic RfD (mg/kg/day),0.01,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,149877-41-8",9/26/2003,No reference cited.,NOAEL,1,mg/kg/day,NA,"changes in hematological and clinical chemistry parameters, and histopathology in bone marrow, liver, and kidney",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,,,,1,Years,liver,Both,None,4100,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Bioallethrin,584792,,OPP,Chronic RfD (mg/kg/day),0.008,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,584-79-2",6/27/2007,"Griggs, L. (1982) 6-month Dietary Toxicity Study in Dogs: Bioallethrine: 406-034: Ref. IRDC-BA-406.034/A1. Unpublished study prepared by International Research and Development Corp. 306 p. MRID 00151447",BMDL,8,mg/kg-day,10% ER,hepatocellular degeneration,No,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,Beagle,,Oral diet,,,6,Months,liver,Both,MOA Evaluation,4101,nonneoplastic histopathology,Both,,doserelated hepatocellular degeneration of the liver was observed in mid- and high-dose males and females,,,,,,,,,,,,,,
Bis(2-Chloroethoxy)Methane,111911,C5H10Cl2O2,PPRTV,RfD (mg/kg/day),0.003,1.11,,http://hhpprtv.ornl.gov/issue_papers/Bis2chloroethoxymethane.pdf,2006,"Bio/Dynamics, Inc. 1990a. A Subchronic (3 Month) Oral Toxicity Study in the Rat with Formal [bis(2-Chloroethoxy)Methane]. Final Report. Project No. 89-3429. East Millstone, NJ. TSCATS Section 4 submission. OTS0526337.",NOAEL,10,mg/kg-day,NA,liver lesions; centrilobular hepatocellular hypertrophy (males),No,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,,90,Days,liver,M,None,3220,nonneoplastic histopathology,M,Dichotomous,liver lesions; centrilobular hepatocellular hypertrophy,,mg/kg-day,,,,,,0,,,10,0,,
Bis(2-Ethylhexyl)Phthalate,117817,C24H38O4,IRIS,RfD (mg/kg/day),0.02,0.95,5/1/1991,http://www.epa.gov/iris/subst/0014.htm,5/1/1991,"Carpenter, C.P., C.S. Weil and H.F. Smyth. 1953. Chronic oral toxicity of di(2-ethylhexyl)phthalate for rats and guinea pigs. Arch. Indust. Hyg. Occup. Med. 8: 219-226.",LOAEL,19,mg/kg/day,NA,Increased relative liver weight,No,None,None,No,1000,10,10,10,,,,TRUE,,,Other,,M/F,Oral diet,,,1,Years,liver,F,None,1619,organ weight,F,,,,,,,,No incidence data reported in primary source,,,,,,,,
Bispyribac sodium,125401925,,OPP,Chronic RfD (mg/kg/day),0.1,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,125401-92-5",2001,MRID 44889314,NOAEL,10,mg/kg/day,NA,increase in hyperplasia of the intrahepatic bile ducts in both sexes and granulation of liver in females,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,,,,chronic,Duration,liver,Both,None,4282,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Boscalid,188425856,,OPP,Chronic RfD (mg/kg/day),0.218,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,188425-85-6",2003,"MRID 45404826 Wiemann, C.; Deckardt, K.; Kaufmann, W. et al. (2000) BAS 510 F: Chronic Oral Toxicity Study in Beagle Dogs Administration in the Diet for 12 Months: Final Report: Lab Project Number: 33D0179/97118: 200/1016881. Unpublished study prepared by BASF Aktiengesellschaft. 779 p.",NOAEL,21.8,mg/kg/day,NA,"elevated ALP activities and elevated hepatic weights in males (co-critical study, see accompanying record)",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,M,MOA Evaluation,4284,organ weight,M,,,,,,,,,,,,,,,,
Boscalid,188425856,,OPP,Chronic RfD (mg/kg/day),0.218,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,188425-85-6",2003,"MRID 45404826 Wiemann, C.; Deckardt, K.; Kaufmann, W. et al. (2000) BAS 510 F: Chronic Oral Toxicity Study in Beagle Dogs Administration in the Diet for 12 Months: Final Report: Lab Project Number: 33D0179/97118: 200/1016881. Unpublished study prepared by BASF Aktiengesellschaft. 779 p.",NOAEL,21.8,mg/kg/day,NA,"elevated ALP activities and elevated hepatic weights in males (co-critical study, see accompanying record)",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,M,MOA Evaluation,4285,clinical chemistry,Both,,,,,,,,,,,,,,,,
Bromobenzene,108861,C6H5Br,IRIS,RfD (mg/kg/day),0.008,1,9/30/2009,http://www.epa.gov/iris/subst/1020.htm,9/30/2009,"NTP. (1985b) Subchronic gavage study of bromobenzene in mice. National Institutes of Health, National Toxicology Program, Research Triangle Park, NC. May, 1985. Unpublished study.",BMDL,24.1,mg/kg/day,10% ER,Hepatocellular cytomegaly in male B6C3F1 mice,Yes,None,None,Yes,3000,10,10,3,,10,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,90,Days,liver,M,MOA Evaluation,1326,nonneoplastic histopathology,M,Dichotomous,Hepatocellular cytomegaly in male B6C3F1 mice,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,10,0,,
Bromoform,75252,CHBr3,IRIS,RfD (mg/kg/day),0.02,0.9,3/1/1991,http://www.epa.gov/iris/subst/0214.htm,3/1/1991,"NTP (National Toxicology Program). 1989. Toxicology and Carcinogenicity Studies of Tribromomethane and Bromoform in F344/N rats and B6C3F1 mice (gavage study). NTP-350. Research Triangle Park, NC",NOEL,17.9,mg/kg/day,NA,Hepatic lesions,Yes,None,None,Yes,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,1998,nonneoplastic histopathology,M,Dichotomous,Hepatocellular vacuolization,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,10,3,,
Bromophos,2104963,,HEAST,RfD (mg/kg/day),0.005,1,,http://epa-heast.ornl.gov/heast.php?chemical=Bromophos,1986,"Leuschner F., A. Leuschner and E. Poppe. 1967. Chronischer reproduktionsversuch uber 3 generationen an Wistar-ratten bei fortdauerner verabreichung von Bromophos. Report CH Boehringer Sohn. (unpublished).",NOAEL,5,mg/kg/day,NA,decrease cholinesterase activity in the liver and blood,NA,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,3,Generations,liver,Both,,3431,enzyme activity,Both,,,,,,,,,,,,,,,,
Butafenacil,134605644,,OPP,Chronic RfD (mg/kg/day),0.012,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,134605-64-4",2003,Mouse oncogenicity study,NOAEL,1.2,mg/kg/day,NA,"enlarged livers with increased weights, and hepatic microscopic lesions including Kupffer cell hyperplasia, inflammatorycell infiltration, and single cell necrosis in both sexes and  deposits of lipofuscin in males",No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,,M/F,,,,18,Months,liver,Both,None,4291,organ weight,Both,,,,,,,,,,,,,,,,
Butafenacil,134605644,,OPP,Chronic RfD (mg/kg/day),0.012,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,134605-64-4",2003,Mouse oncogenicity study,NOAEL,1.2,mg/kg/day,NA,"enlarged livers with increased weights, and hepatic microscopic lesions including Kupffer cell hyperplasia, inflammatorycell infiltration, and single cell necrosis in both sexes and  deposits of lipofuscin in males",No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,,M/F,,,,18,Months,liver,Both,None,4290,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Butyl Benzyl Phthalate,85687,C19H20O4,IRIS,RfD (mg/kg/day),0.2,0.8,2/1/1993,http://www.epa.gov/iris/subst/0293.htm,2/1/1993,"NTP (National Toxicology Program). 1985. Twenty-six week subchronic study and modified mating trial in F344 rats. Butyl benzyl phthalatee. Final Report. Project No. 12307-02, -03. Hazelton Laboratories America, Inc. Unpublished study.",NOAEL,159,mg/kg/day,NA,Significantly increased liver-to-body weight and liver-to-brain weight ratios,NA,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M,Oral diet,,,26,Weeks,liver,Both,None,4440,organ weight,Both,Continuous,Increased liver-to-brain weight ratio,SD,mg/kg-day,g/g x 100,,,,,0,,,12,,617.3,74.3
Butyl Benzyl Phthalate,85687,C19H20O4,IRIS,RfD (mg/kg/day),0.2,0.8,2/1/1993,http://www.epa.gov/iris/subst/0293.htm,2/1/1993,"NTP (National Toxicology Program). 1985. Twenty-six week subchronic study and modified mating trial in F344 rats. Butyl benzyl phthalatee. Final Report. Project No. 12307-02, -03. Hazelton Laboratories America, Inc. Unpublished study.",NOAEL,159,mg/kg/day,NA,Significantly increased liver-to-body weight and liver-to-brain weight ratios,NA,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M,Oral diet,,,26,Weeks,liver,Both,None,2069,organ weight,Both,Continuous,increased liver-to-body weight ratio,SD,mg/kg-day,g/g x 100,,,,,0,,,12,,3.324,0.16
Butylate,2008415,C11H23NOS,OPP,Chronic RfD (mg/kg/day),0.05,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-041405_26-Nov-93.pdf,11/26/1993,"Daly, I. (1987) A Twelve Month Oral Toxicity Study of Sutan Technical in Dogs: Project No. 85-2991: Final Report.  Unpublished study prepared by Bio/dynamics, Inc. 494 p.  MRID 40389101",NOAEL,5,mg/kg/day,NA,increased relative liver weight,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,chronic,Duration,liver,M,,3982,organ weight,M,,,,,,,,Compound was administered via gelatin capsule.,,,,,,,,
Butylate,2008415,C11H23NOS,IRIS,RfD (mg/kg/day),0.05,1,10/1/1994,http://www.epa.gov/iris/subst/0215.htm,10/1/1994,"Stauffer Chemical Company. 1987a. MRID No. 40389101. HED Doc No. 006875. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,5,mg/kg/day,NA,Increased relative liver weight in male dogs,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,12,Months,liver,Both,None,1925,organ weight,M,Continuous,Increased relative liver weight,,,,,,,,,,,,,,
"Butylbenzene, n- ",104518,,PPRTV,RfD (mg/kg/day),0.05,0.91,,http://hhpprtv.ornl.gov/issue_papers/Butylbenzenen.pdf,2010,"Izumi, H., Kimura, E., Ota, T., and Shimazu, S. 2005. A two-generation reproductive toxicity study of n-butylbenzene in rats. The Journal of Toxicological Sciences, 30 (Special Issue): 2138.",BMDL,137,mg/kg-day,10% ER,hepatocellular hypertrophy in F0 and F1 parent male rats,No,None,None,Yes,3000,10,10,3,,10,,TRUE,,,Rat,CD,M/F,Oral gavage,,7,2,Generations,liver,M,None,3245,nonneoplastic histopathology,M,Dichotomous,hepatocellular hypertrophy,,mg/kg-day,,,,F1 males; these data provide the most conservative POD,,0,,,19,0,,
Carbon Tetrachloride,56235,CCl4,IRIS,RfD (mg/kg/day),0.004,0.98,3/31/2010,http://www.epa.gov/iris/subst/0020.htm,3/31/2010,"Bruckner, JV; MacKenzie, WF; Muralidhara, S; et al. (1986) Oral toxicity of carbon tetrachloride: acute, subacute and subchronic studies in rats. Fundam Appl Toxicol 6:16-34.",BMDL,3.9,mg/kg/day,Other,Elevated serum SDH activity,Yes,None,None,Yes,1000,10,10,3,,3,,TRUE,,,Rat,Sprague-Dawley,M,Oral gavage,,5,12,Weeks,liver,Both,MOA Evaluation,1499,clinical chemistry,Both,Continuous,Elevated serum SDH activity,SE,mg/kg-day,U/mL,mg/kg-day (ADJ),,,,0,0,,,,3.2,0.4
Carfentrazone-ethyl,128639021,,OPP,Chronic RfD (mg/kg/day),0.03,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,128639-02-1",7/14/2006,"Hill, R.; Wright, J.; Allan, C. Et Al. (1995) F8426 Technical: 104 Week Oral (Dietary) Combined Carcinogenicity And Chronic Toxicity Study In The Rat: Lab Project Number: Fja/1/95: A92-3707: Fja/1/C. Unpublished Study Prepared By Toxicol Labs. Ltd. 2782 P. MRID 44076501",NOAEL,3,mg/kg-day,NA,"liver histopathology (increases in microscopic red fluorescenceand pigmentation) and increased urinary porphyrin levels (NOEL for females)",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,Both,None,4102,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Chlordane,57749,,ATSDR,Chronic Oral MRL (mg/kg/day),0.0006,0.92,,http://www.atsdr.cdc.gov/ToxProfiles/tp31.pdf,May-94,"Velsicol Chemical Co. 1983a. Thirty-month chronic toxicity and tumorigenicity test in rats by chlordane technical. Unpublished study by Research Institute for Animal Science in Biochemistry and Toxicology (RIASBT), Japan. (Cited in EPA 1985a, 1985b, EPA 1988b).Khasawinah AM, Grutsch JF. 1989a. Chlordane thirty-month tumorigenicity and chronic toxicity test in rats. Regul Toxicol Pharmacol 10:95-109.",NOAEL,0.055,mg/kg/day,NA,hepatocellular hypertrophy females,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,30,Months,liver,F,MOA Data,4198,gross pathology,F,Dichotomous,hepatocellular hypertrophy in females,,ppm diet,,mg/kg-day,,Incidence in nonleukemic females based on pathology working group diagnoses as reported in Khasawihah and Grutsch 1989 Table 4b.  Doses calculated by ATSDR (1994).,,0,0,,37,2,,
"Chlordane, technical grade",12789036,C10H6Cl8,IRIS,RfD (mg/kg/day),0.0005,1,2/7/1998,http://www.epa.gov/iris/subst/0142.htm,2/7/1998,"Khasawinah, A.M. and J.F. Grutsch. 1989a. Chlordane: 24-month tumorigenicity and chronic toxicity test in mice. Reg. Toxicol. Pharmacol. 10: 244-254.",NOAEL,0.15,mg/kg/day,NA,Hepatic Necrosis,NA,None,None,Yes,300,10,10,,,3,,TRUE,,,Mouse,ICR,M/F,Oral diet,,,104,Weeks,liver,Both,MOA Evaluation,1561,nonneoplastic histopathology,M,Dichotomous,Hepatic Necrosis,,ppm,,mg/kg/day,,,,0,0,,80,7,,
Chlorimuron-Ethyl,90982324,C15H15ClN4O6S,IRIS,RfD (mg/kg/day),0.02,1.04,11/1/1989,http://www.epa.gov/iris/subst/0406.htm,11/1/1989,"E.I. duPont de Nemours and Company, Inc. 1985. MRID No. 00149579. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,6.25,mg/kg/day,NA,"Increase in WBC, decreased in RBC in females, increase in alkaline phosphatase in males",No,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,2071,clinical chemistry,M,Continuous,increase in alkaline phosphatase,,,,,,,,,,,,,,
Chlorobenzene,108907,C6H5Cl,IRIS,RfD (mg/kg/day),0.02,0.95,7/1/1993,http://www.epa.gov/iris/subst/0399.htm,7/1/1993,"Monsanto Company. 1967a. 13-week oral administration - dogs. Monchlorobenzene. Final report. Prepared by Hazelton Laboratories, Project No. 241-105, February 24.Knapp, W.K., W.M. Busey and W. Kundzins. 1971. Subacute oral toxicity of monochlorobenzene in dogs and rats. Toxicol. Appl. Pharmacol. 19: 393 (Abstract).",NOAEL,19,mg/kg/day,NA,Histopathologic changes in the liver,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,5,13,Weeks,liver,Both,None,1862,nonneoplastic histopathology,Both,Dichotomous,Histopathologic changes in the liver,,,,,,"slight bile duct proliferation, cytologic alternations, and leukocytic infiltration of thestroma, all in liver. Dose response data not reported in primary source",,,,,,,,
"Chlorobenzotrifluoride, 4- ",98566,,PPRTV,RfD (mg/kg/day),0.003,0.98,,http://hhpprtv.ornl.gov/issue_papers/Chlorobenzotrifluoride4.pdf,2007,"Macri, A., C. Ricciardi, A.V. Stazi et al. 1987. Subchronic oral toxicity of 4-chloro-_-_-_-trifluorotoluene in Sprague-Dawley rats. Food Chem. Toxicol. 25(10):781-786.",BMDL,8.8,mg/kg-day,1SD,changes in serum cholesterol and serum triglycerides,NA,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,4,Weeks,liver,M,None,3288,clinical chemistry,M,Continuous,serum cholesterol,SD,mg/kg-day,mg/100 mL,,,,,0,,,6,,56.5,7.5
"Chlorobenzotrifluoride, 4- ",98566,,PPRTV,RfD (mg/kg/day),0.003,0.98,,http://hhpprtv.ornl.gov/issue_papers/Chlorobenzotrifluoride4.pdf,2007,"Macri, A., C. Ricciardi, A.V. Stazi et al. 1987. Subchronic oral toxicity of 4-chloro-_-_-_-trifluorotoluene in Sprague-Dawley rats. Food Chem. Toxicol. 25(10):781-786.",BMDL,8.8,mg/kg-day,1SD,changes in serum cholesterol and serum triglycerides,NA,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,4,Weeks,liver,M,None,3363,clinical chemistry,M,Continuous,serum triglycerides,SD,mg/kg-day,mg/100 mL,,,,,0,,,6,,33.5,6.05
Chloroform,67663,CHCl3,IRIS,RfD (mg/kg/day),0.01,1,10/19/2001,http://www.epa.gov/iris/subst/0025.htm,10/19/2001,"Heywood, R; Sortwell, RJ; Noel, PRB; et al. (1979) Safety evaluation of toothpaste containing chloroform: III. Long-term study in beagle dogs. J Environ Pathol Toxicol 2:835-851.",BMDL,1,mg/kg/day,10% ER,Moderate/marked fatty cyst formation in the liver and elevated SGPT,Yes,None,NA,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,6,7.5,Years,liver,Both,MOA Evaluation,2863,nonneoplastic histopathology,Both,,BMD dataset for moderate/marked fatty cyst formation in the liver (male and female dogs combined; same data as shown under LOAEL),,mg/kg/day,,mg/kg-day (ADJ),,,,0,0,,27,1,,
Chloroform,67663,CHCl3,IRIS,RfD (mg/kg/day),0.01,1.29,10/19/2001,http://www.epa.gov/iris/subst/0025.htm,10/19/2001,"Heywood, R; Sortwell, RJ; Noel, PRB; et al. (1979) Safety evaluation of toothpaste containing chloroform: III. Long-term study in beagle dogs. J Environ Pathol Toxicol 2:835-851.",LOAEL,12.9,mg/kg/day,NA,Moderate/marked fatty cyst formation in the liver and elevated SGPT,Yes,None,None,Yes,1000,10,10,,10,,,TRUE,,,Dog,Beagle,M/F,Other,,6,7.5,Years,liver,Both,MOA Evaluation,2572,nonneoplastic histopathology,F,Dichotomous,Moderate/marked fatty cyst formation in the liver,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,12,0,,
Chloroform,67663,CHCl3,IRIS,RfD (mg/kg/day),0.01,1.29,10/19/2001,http://www.epa.gov/iris/subst/0025.htm,10/19/2001,"Heywood, R; Sortwell, RJ; Noel, PRB; et al. (1979) Safety evaluation of toothpaste containing chloroform: III. Long-term study in beagle dogs. J Environ Pathol Toxicol 2:835-851.",LOAEL,12.9,mg/kg/day,NA,Moderate/marked fatty cyst formation in the liver and elevated SGPT,Yes,None,None,Yes,1000,10,10,,10,,,TRUE,,,Dog,Beagle,M/F,Other,,6,7.5,Years,liver,Both,MOA Evaluation,2077,nonneoplastic histopathology,M,Dichotomous,Moderate/marked fatty cyst formation in the liver,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,15,1,,
Chloroform,67663,CHCl3,IRIS,RfD (mg/kg/day),0.01,1.29,10/19/2001,http://www.epa.gov/iris/subst/0025.htm,10/19/2001,"Heywood, R; Sortwell, RJ; Noel, PRB; et al. (1979) Safety evaluation of toothpaste containing chloroform: III. Long-term study in beagle dogs. J Environ Pathol Toxicol 2:835-851.",LOAEL,12.9,mg/kg/day,NA,Moderate/marked fatty cyst formation in the liver and elevated SGPT,Yes,None,None,Yes,1000,10,10,,10,,,TRUE,,,Dog,Beagle,M/F,Other,,6,7.5,Years,liver,Both,MOA Evaluation,2032,clinical chemistry,Both,Continuous,elevated SGPT,,,,,,Effect at end of treatment (data also given in primary source for end of post-treatment recovery period). No variability measure provided in primary reference.,,,,,,,,
Chloroneb,2675776,,OPP,Chronic RfD (mg/kg/day),0.013,0.96,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2675-77-6",5-Sep,"MRID 1421: Busey, W.M.; Kundzins, W. (1967) Two Year Dietary Feeding--Dogs: Fungicide 1823: Final Report: Project No. 201-125. (Unpublished study received Jul 8, 1968 under 8F0657; prepared by Hazleton Laboratories, Inc., submitted by E.I. du Pont de Nemours & Co., Inc., Wilmington, Del.; CDL:091147-A)",NOAEL,12.5,mg/kg-day,NA,"body weight loss, increased absolute and relative liver weight, increased alanine aminotransferase (ALT) and/or alkaline phosphates, hepatocyte pigmentation, moderate thyroid activity",No,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,,,Oral diet,,,2,Years,liver,Both,None,4114,organ weight,Both,,,,,,,,,,,,,,,,
Chloroneb,2675776,,OPP,Chronic RfD (mg/kg/day),0.013,0.96,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2675-77-6",5-Sep,"MRID 1421: Busey, W.M.; Kundzins, W. (1967) Two Year Dietary Feeding--Dogs: Fungicide 1823: Final Report: Project No. 201-125. (Unpublished study received Jul 8, 1968 under 8F0657; prepared by Hazleton Laboratories, Inc., submitted by E.I. du Pont de Nemours & Co., Inc., Wilmington, Del.; CDL:091147-A)",NOAEL,12.5,mg/kg-day,NA,"body weight loss, increased absolute and relative liver weight, increased alanine aminotransferase (ALT) and/or alkaline phosphates, hepatocyte pigmentation, moderate thyroid activity",No,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,,,Oral diet,,,2,Years,liver,Both,None,4115,clinical chemistry,Both,,,,,,,,,,,,,,,,
Chloroneb,2675776,,OPP,Chronic RfD (mg/kg/day),0.013,0.96,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2675-77-6",5-Sep,"MRID 1421: Busey, W.M.; Kundzins, W. (1967) Two Year Dietary Feeding--Dogs: Fungicide 1823: Final Report: Project No. 201-125. (Unpublished study received Jul 8, 1968 under 8F0657; prepared by Hazleton Laboratories, Inc., submitted by E.I. du Pont de Nemours & Co., Inc., Wilmington, Del.; CDL:091147-A)",NOAEL,12.5,mg/kg-day,NA,"body weight loss, increased absolute and relative liver weight, increased alanine aminotransferase (ALT) and/or alkaline phosphates, hepatocyte pigmentation, moderate thyroid activity",No,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,,,Oral diet,,,2,Years,liver,Both,None,4116,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Chlorpropham,101213,C10H12ClNO2,IRIS,RfD (mg/kg/day),0.2,0.83,6/30/1988,http://www.epa.gov/iris/subst/0283.htm,6/30/1988,"PPG Industries, Inc. 1983a. MRID No. 00129545, 00125691. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,50,mg/kg/day,NA,"Kidney, spleen, liver, and bone marrow toxicity",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,CD,M/F,Oral diet,,,2,Generations,liver,Both,None,1838,organ weight,Both,Continuous,liver toxicity,,,,,,organ weight changes in the liver,,,,,,,,
Chlorpropham,101213,C10H12ClNO2,IRIS,RfD (mg/kg/day),0.2,0.83,6/30/1988,http://www.epa.gov/iris/subst/0283.htm,6/30/1988,"PPG Industries, Inc. 1983a. MRID No. 00129545, 00125691. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,50,mg/kg/day,NA,"Kidney, spleen, liver, and bone marrow toxicity",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,CD,M/F,Oral diet,,,2,Generations,liver,Both,None,1837,nonneoplastic histopathology,Both,Dichotomous,liver toxicity,,,,,,microscopic lesions in the liver,,,,,,,,
Chlorpyrifos Methyl,5598130,,HEAST,RfD (mg/kg/day),0.01,1,,http://epa-heast.ornl.gov/heast.php?chemical=Chlorpyrifos Methyl,,"Confidential business information (CBI) as cited in: U.S. EPA. 1984. Health and environmental effects profile for Chlorpyrifos and Chlorpyrifosmethyl. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste and Emergency Response, Washington, DC",NOAEL,1,mg/kg-day,,decreased fertility and liver effects,,,,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,3,Generations,liver,,None,4054,,,,"Not specified in HEEP (U.S. EPA, 1984).",,,,,,Primary data are considered Confidential Business Information (CBI),,,,,,,,
Clethodim,99129212,,OPP,Chronic RfD (mg/kg/day),0.01,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,99129-21-2",3/7/2007,MRID 41030111,NOAEL,1,mg/kg-day,NA,Alterations in hematology and clinical chemistry parameters and increased absolute and relative liver weights,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,,,,1,Years,liver,Both,None,4119,organ weight,Both,,,,,,,,,,,,,,,,
Clodinafop-propargyl,105511964,,OPP,RfD (mg/kg/day),0.0003,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,105511-96-4",5/15/2000,"MRID 44399147: Frankhauser H (1992). 24-month carcinogenicity and chronic toxicity study in rats. Novartis Crop Protection, Inc. (formaly Ciba-Geigy Crop Protection, Stein, Switzerland), Greensboro, NC 27419. Report No. 861139; October, 21, 1992 (Unpublished)",NOAEL,0.03,mg/kg-day,NA,"hepatocytic hypertrophy, chronic progressive nephropathy, and tubular pigmentation",NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Albino,M/F,Oral diet,,,2,Years,liver,Both,MOA Evaluation,3705,nonneoplastic histopathology,F,Dichotomous,hepatocytic hypertrophy,,ppm diet,,mg/kg-day,,,,0,0,,80,1,,
Clodinafop-propargyl,105511964,,OPP,RfD (mg/kg/day),0.0003,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,105511-96-4",5/15/2000,"MRID 44399147: Frankhauser H (1992). 24-month carcinogenicity and chronic toxicity study in rats. Novartis Crop Protection, Inc. (formaly Ciba-Geigy Crop Protection, Stein, Switzerland), Greensboro, NC 27419. Report No. 861139; October, 21, 1992 (Unpublished)",NOAEL,0.03,mg/kg-day,NA,"hepatocytic hypertrophy, chronic progressive nephropathy, and tubular pigmentation",NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Albino,M/F,Oral diet,,,2,Years,liver,Both,MOA Evaluation,3703,nonneoplastic histopathology,M,Dichotomous,hepatocytic hypertrophy,,ppm diet,,mg/kg-day,,,,0,0,,80,0,,
Clofentezine,74115245,C14H8Cl2N4,IRIS,RfD (mg/kg/day),0.013,0.96,11/1/1989,http://www.epa.gov/iris/subst/0008.htm,11/1/1989,"BFC Chemicals, Inc. 1984. MRID No. 00149491, 00159080. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",NOEL,1.25,mg/kg/day,NA,Liver effects; organ weight changes,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,2078,organ weight,Both,,,,,,,,,,,,,,,,
Clofentezine,74115245,C14H8Cl2N4,IRIS,RfD (mg/kg/day),0.013,0.96,11/1/1989,http://www.epa.gov/iris/subst/0008.htm,11/1/1989,"BFC Chemicals, Inc. 1984. MRID No. 00149491, 00159080. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",NOEL,1.25,mg/kg/day,NA,Liver effects; organ weight changes,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,2079,clinical chemistry,Both,,,,,,,,,,,,,,,,
Clofentezine,74115245,C14H8Cl2N4,IRIS,RfD (mg/kg/day),0.013,0.96,11/1/1989,http://www.epa.gov/iris/subst/0008.htm,11/1/1989,"BFC Chemicals, Inc. 1984. MRID No. 00149491, 00159080. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",NOEL,1.25,mg/kg/day,NA,Liver effects; organ weight changes,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,2038,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Cyproconazole,94361065,,OPP,Chronic RfD (mg/kg/day),0.01,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,94361-06-5",1993,"Warren, S. et al. 1988.  Chronic oral toxicity by dietary administration to Beagle dogs for one year.  MRID No. 41212901, HED Doc No 007871.",NOEL,1,mg/kg/day,NA,hepatotoxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4314,nonneoplastic histopathology,M,,laminar eosinophilic intrahepatocytic bodies,,,,,,,,,,,,,,
Cyproconazole,94361065,,OPP,Chronic RfD (mg/kg/day),0.01,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,94361-06-5",1993,"Warren, S. et al. 1988.  Chronic oral toxicity by dietary administration to Beagle dogs for one year.  MRID No. 41212901, HED Doc No 007871.",NOEL,1,mg/kg/day,NA,hepatotoxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4315,clinical chemistry,F,,P450 induction,,,,,,,,,,,,,,
Cyprodinil,121552612,,OPP,Chronic RfD (mg/kg/day),0.027,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,121552-61-2",7/31/2012,MRID 43737602,NOEL,2.7,mg/kg/day,NA,"degenerative liver lesions (spongiosishepatitis) in males",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,M,None,4316,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
d-Allethrin (Pynamin Forte),584792,,OPP,Chronic RfD (mg/kg/day),0.008,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2010-0022-0003,3/5/2010,"Griggs, L. (1982) 6-month Dietary Toxicity Study in Dogs: Bioallethrine: 406-034: Ref. IRDC-BA-406.034/A1. Unpublished study prepared by International Research and Development Corp. 306 p. MRID 00151447",BMDL,8,mg/kg-day,10% ER,microscopic liver changes (hepatocellular degeneration),,None,None,No,1000,10,10,,,10,,TRUE,,Bioallethrin,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,3727,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
DDT,50293,C14H9Cl5,IRIS,RfD (mg/kg/day),0.0005,1,2/1/1996,http://www.epa.gov/iris/subst/0147.htm,2/1/1996,"Laug, E.P., A.A. Nelson, O.G. Fitzhugh and F.M. Kunze. 1950. Liver cell alteration and DDT storage in the fat of the rat induced by dietary levels of 1-50 ppm DDT. J. Pharmacol. Exp. Therap. 98: 268-273.",NOEL,0.05,mg/kg/day,NA,Liver lesions,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,15-27,Weeks,liver,Both,None,634,nonneoplastic histopathology,Both,Dichotomous,Liver lesions,,,,,,"Lesions included hepatocellular hypertrophy, especially centrilobularly, increased cytoplasmic oxyphilia, and peripheral basophilic cytoplasmic granules.  Incidence data were not reported in Laug et al (1950).",,,,,,,,
Di-2-Ethylhexyl Adipate,103231,C22H42O4,IRIS,RfD (mg/kg/day),0.6,0.94,7/1/1992,http://www.epa.gov/iris/subst/0420.htm,7/1/1992,ICI (ICI Central Toxicology Laboratory). 1988b. Di-(2-ethylhexyl)adipate (DEHA) fertility study in rats. Report CTL/P/2229 (unpublished study).,NOAEL,170,mg/kg/day,NA,"Reduced maternal weight gain, increased liver weights in parents, offspring weight gain, total litter weight, and litter size",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,F,Oral diet,,,1,Generations,liver,Both,None,2961,organ weight,Both,Continuous,Increased absolute liver weights in female parents,95% CI,ppm,g,mg/kg/day,,Data are from Table 22 of primary report. Single average 95 CI value presented as measure of variability.,,0,0,,30,,13.2,0.7
Di-2-Ethylhexyl Adipate,103231,C22H42O4,IRIS,RfD (mg/kg/day),0.6,0.94,7/1/1992,http://www.epa.gov/iris/subst/0420.htm,7/1/1992,ICI (ICI Central Toxicology Laboratory). 1988b. Di-(2-ethylhexyl)adipate (DEHA) fertility study in rats. Report CTL/P/2229 (unpublished study).,NOAEL,170,mg/kg/day,NA,"Reduced maternal weight gain, increased liver weights in parents, offspring weight gain, total litter weight, and litter size",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,F,Oral diet,,,1,Generations,liver,Both,None,2962,organ weight,Both,Continuous,Increased relative liver weights in female parents,95% CI,ppm,g,mg/kg/day,,Data are from Table 22 of primary report. Single average 95 CI value presented as measure of variability.,,0,0,,30,,13.2,0.6
Di-2-Ethylhexyl Adipate,103231,C22H42O4,IRIS,RfD (mg/kg/day),0.6,0.94,7/1/1992,http://www.epa.gov/iris/subst/0420.htm,7/1/1992,ICI (ICI Central Toxicology Laboratory). 1988b. Di-(2-ethylhexyl)adipate (DEHA) fertility study in rats. Report CTL/P/2229 (unpublished study).,NOAEL,170,mg/kg/day,NA,"Reduced maternal weight gain, increased liver weights in parents, offspring weight gain, total litter weight, and litter size",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,F,Oral diet,,,1,Generations,liver,Both,None,2959,organ weight,M,Continuous,increased absolute liver weights in male parents,95% CI,ppm,g,mg/kg/day,,Data are from Table 22 of primary report. Single average 95 CI value presented as measure of variability.,,0,0,,15,,19.1,1
Di-2-Ethylhexyl Adipate,103231,C22H42O4,IRIS,RfD (mg/kg/day),0.6,0.94,7/1/1992,http://www.epa.gov/iris/subst/0420.htm,7/1/1992,ICI (ICI Central Toxicology Laboratory). 1988b. Di-(2-ethylhexyl)adipate (DEHA) fertility study in rats. Report CTL/P/2229 (unpublished study).,NOAEL,170,mg/kg/day,NA,"Reduced maternal weight gain, increased liver weights in parents, offspring weight gain, total litter weight, and litter size",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,F,Oral diet,,,1,Generations,liver,Both,None,2960,organ weight,Both,Continuous,Increased relative liver weights in male parents,95% CI,ppm,g,mg/kg/day,,Data are from Table 22 of primary report. Single average 95 CI value presented as measure of variability.,,0,0,,15,,19,0.8
Dibromochloromethane,124481,CHBr2Cl,IRIS,RfD (mg/kg/day),0.02,1.07,3/1/1991,http://www.epa.gov/iris/subst/0222.htm,3/1/1991,NTP (National Toxicology Program). 1985. Toxicology and Carcinogenesis Studies of Chlorodibromomethane in F344/N Rats and B6C3F1 mice (gavage studies). NTP TR282.,NOEL,21.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,Yes,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,469,nonneoplastic histopathology,M,Dichotomous,hepatic lesions (vacuolar changes),,mg/kg-day,,mg/kg-day (ADJ),,Incidence data are from Table 6 in primary report.,,0,0,,10,4,,
Dichlormid,,,OPP,Chronic RfD (mg/kg/day),0.065,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2005-0477-0009,1/13/2011,"MRID 44529402, 44751801",NOAEL,6.5,mg/kg/day,NA,liver clinical pathology/histopathology and increased liver weight.,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,3998,organ weight,Both,,,,,,,,,,,,,,,,
Dichlormid,,,OPP,Chronic RfD (mg/kg/day),0.065,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2005-0477-0009,1/13/2011,"MRID 44529402, 44751801",NOAEL,6.5,mg/kg/day,NA,liver clinical pathology/histopathology and increased liver weight.,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,3997,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Dichlormid,,,OPP,Chronic RfD (mg/kg/day),0.065,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2005-0477-0009,1/13/2011,"MRID 44529402, 44751801",NOAEL,6.5,mg/kg/day,NA,liver clinical pathology/histopathology and increased liver weight.,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,4004,clinical chemistry,Both,,,,,,,,,,,,,,,,
Dichloroacetic acid,79436,C2H2Cl2O2,IRIS,RfD (mg/kg/day),0.004,1.04,9/11/2003,http://www.epa.gov/iris/subst/0654.htm,9/11/2003,"Cicmanec, JL; Condie, LW; Olson, GR; et al. (1991) 90-day toxicity study of dichloroacetate in dogs. Fundam Appl Toxicol 17:376-389.",LOAEL,12.5,mg/kg/day,NA,"Lesions observed in the testes, cerebrum, cerebellum, and liver.",No,None,None,Yes,3000,3,10,3,10,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,90,Days,liver,Both,MOA Evaluation,2091,nonneoplastic histopathology,Both,Dichotomous,Lesions observed in the liver,,,,,,mild to moderate hepatic vacuolization,,,,,,,,
"Dichloroethylene, 1,2- (Mixed Isomers)",540590,,HEAST,RfD (mg/kg/day),0.009,5.56,,"http://epa-heast.ornl.gov/heast.php?chemical=Dichloroethylene, 1,2- (Mixed Isomers)",1991,"Quast, JF, C.G. Humiston, C.E. Wade, et al. 1983. A chronic toxicity and oncogenicity study in rats and subchronic toxicity study in dogs on ingested Vinylidine Chloride. Fund Appl Toxicol. 3: 55-62.",LOAEL,50,ppm,NA,liver lesions,NA,None,None,No,1000,10,10,,10,,,TRUE,,"1,1-dichloroethylene",Rat,Sprague-Dawley,M/F,Oral drinking water,,,2,Years,liver,Both,MOA Data,3439,nonneoplastic histopathology,F,Dichotomous,liver lesions (hepatocellular midzonal fatty change),,"ppm 1,1-dichloroethylene/kg/day",,mg/kg-day,,"The RfD of 0.009 mg/kg/day for 1,1-dichloroethylene derived from Quast et al (1983) was adopted for mixed 1,2-dichloroethylene based on sufficient similarity of the compounds.  Note:  the RfD for 1,1-dichloroethylene has been revised since this assessment.",,0,0,,80,10,,
Dichloromethane,75092,CH2Cl2,IRIS,RfD (mg/kg/day),0.006,1.06,11/18/2011,http://www.epa.gov/iris/subst/0070.htm,11/18/2011,"Serota, DG; Thakur, AK; Ulland, BM; et al. (1986a) A two-year drinking water study of dichloromethane in rodents. I. Rats. Food Chem Toxicol 24(9):951958.",BMDL,0.19,mg/kg/day,10% ER,"Hepatic effects (hepatic vacuolation, liver foci)",No,None,BW3/4,Yes,30,3,3,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral drinking water,,,2,Years,liver,Both,MOA Determination,1516,nonneoplastic histopathology,M,Dichotomous,"Hepatic effects (hepatic vacuolation, liver foci)",,mg/kg-day,incidence,mg dichloromethane metabolized via CYP pathway/L liver tissue/day,,"Administered doses were converted to internal doses using a rat PBPK model.  Because the dose metric is a rate of metabolism and the clearance of these metabolites may be slower per volume tissue in the human compared with the rat, this rodent internal dose metric was adjusted by dividing by a pharmacokinetic allometric scaling factor of body weight (BW)0.75 (operationalized as [Bwhuman/Bwrat]0.25  4.09) to obtain a human equivalent internal BMDL10. The human equivalent internal BMDL10 was then converted to the human equivalent dose (HED) using a human PBPK model (adapted from David et al., 2006) that provided a distribution of HEDs. The 1st percentile of the distribution of HEDs, 0.19 mg/kg-day, was used as the point of departure for the RfD.",,0,0,,76,52,,
"Dichloropropane, 1,3- ",142289,,PPRTV,RfD (mg/kg/day),0.02,0.83,,http://hhpprtv.ornl.gov/issue_papers/Dichloropropane13.pdf,2006,"Terrill, J.B., M. Robinson, G.W. Wolfe and L.H. Billups. 1991. The subacute and subchronic oral toxicity of 1,3-dichloropropane in the rat. J. Am. Coll. Toxicol. 10: 421-430.",NOAEL,50,mg/kg-day,NA,"histopathological lesions (minimal-to-slight centrilobularhypertrophy in the liver, minimal chronic progressive nephropathy in the kidney)",NA,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,MOA Data,3265,nonneoplastic histopathology,M,Dichotomous,minimal-to-slight centrilobular hypertrophy,,mg/kg-day,,,,,,0,,,10,0,,
"Dichloropropane, 1,3- ",142289,,PPRTV,RfD (mg/kg/day),0.02,0.83,,http://hhpprtv.ornl.gov/issue_papers/Dichloropropane13.pdf,2006,"Terrill, J.B., M. Robinson, G.W. Wolfe and L.H. Billups. 1991. The subacute and subchronic oral toxicity of 1,3-dichloropropane in the rat. J. Am. Coll. Toxicol. 10: 421-430.",NOAEL,50,mg/kg-day,NA,"histopathological lesions (minimal-to-slight centrilobularhypertrophy in the liver, minimal chronic progressive nephropathy in the kidney)",NA,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,MOA Data,3266,nonneoplastic histopathology,F,Dichotomous,minimal-to-slight centrilobular hypertrophy,,mg/kg-day,,,,,,0,,,10,0,,
Dieldrin,60571,C12H8Cl6O,ATSDR,Chronic Oral MRL (mg/kg/day),0.00005,1,,http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf,2-Sep,"Walker AIT, Stevenson DE, Robinson J, et al. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol Appl Pharmacol 15:345-373.",NOAEL,0.005,mg/kg/day,NA,increased absolute and relative liver weight,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Carworth farm,M/F,Oral diet,,,2,Years,liver,Both,,4138,organ weight,F,Continuous,increased relative liver weight,SD,ppm diet,g/100 g BW,mg/kg-day,,Measure of variability was not stated but appears to be standard deviation,,0,0,,18,,4.08,0.147
Dieldrin,60571,C12H8Cl6O,ATSDR,Chronic Oral MRL (mg/kg/day),0.00005,1,,http://www.atsdr.cdc.gov/ToxProfiles/tp1.pdf,2-Sep,"Walker AIT, Stevenson DE, Robinson J, et al. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol Appl Pharmacol 15:345-373.",NOAEL,0.005,mg/kg/day,NA,increased absolute and relative liver weight,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Carworth farm,M/F,Oral diet,,,2,Years,liver,Both,,4139,organ weight,F,Continuous,increased absolute liver weight,SD,ppm diet,g,mg/kg-day,,Measure of variability was not stated but appears to be standard deviation,,0,0,,18,,13.54,0.448
Dieldrin,60571,C12H8Cl6O,IRIS,RfD (mg/kg/day),0.00005,1,9/1/1990,http://www.epa.gov/iris/subst/0225.htm,9/1/1990,"Walker, A.I.T., D.E. Stevenson, J. Robinson, R. Thorpe and M. Roberts. 1969. The toxicology and pharmacodynamics of dieldrin (HEOD): Two-year oral exposures of rats and dogs. Toxicol. Appl. Pharmacol. 15: 345-373.",NOAEL,0.005,mg/kg/day,NA,Liver lesions,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,CFE,M/F,Oral diet,,,2,Years,liver,Both,MOA Data,663,nonneoplastic histopathology,Both,Dichotomous,Liver lesions,,,,,,Lesions were liver parenchymal cell changes including focal proliferation and focal hyperplasia.  Incidences of specific lesions were incompletely reported in the primary reference.,,,,,,,,
Diethyl Phthalate,84662,C12H14O4,IRIS,RfD (mg/kg/day),0.8,0.94,2/1/1993,http://www.epa.gov/iris/subst/0226.htm,2/1/1993,"Brown, D., K.R. Butterworth, I.F. Gaunt, P. Grasso and S.D. Gangolli. 1978. Short-term oral toxicity study of diethyl phthalate in the rat. Food Cosmet. Toxicol. 16: 415-422.",NOAEL,750,mg/kg/day,NA,"Decreased growth rate, food consumption and altered organ weights",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,CD,M/F,Oral diet,,,16,Weeks,liver,Both,None,1530,organ weight,Both,Continuous,altered organ weights,,,,,,increased relative weight of the liver; organ weight data were without variability measure in primary report,,,,,,,,
Diethylene Glycol Monoethyl Ether ,111900,,PPRTV,RfD (mg/kg/day),0.06,0.93,,http://hhpprtv.ornl.gov/issue_papers/DiethyleneGlycolMonoethylEther.pdf,2009,"Gaunt, I.F., J. Colley, P. Grasso et al. 1968. Short-term toxicity of diethylene glycol monoethylether in the rat, mouse and pig. Food Cosmet. Toxicol. 6:689705.",NOAEL,167,mg/kg-day,NA,hydropic degeneration in the kidneys and liver and fatty changes in the live,No,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Other,CFE,M/F,Oral diet,,,90,Days,liver,Both,None,3302,nonneoplastic histopathology,F,Dichotomous,hydropic degeneration and fattay changes in the liver of pigs,,mg/kg-day,,,,,,0,,,3,0,,
Diethylene Glycol Monoethyl Ether ,111900,,PPRTV,RfD (mg/kg/day),0.06,0.93,,http://hhpprtv.ornl.gov/issue_papers/DiethyleneGlycolMonoethylEther.pdf,2009,"Gaunt, I.F., J. Colley, P. Grasso et al. 1968. Short-term toxicity of diethylene glycol monoethylether in the rat, mouse and pig. Food Cosmet. Toxicol. 6:689705.",NOAEL,167,mg/kg-day,NA,hydropic degeneration in the kidneys and liver and fatty changes in the live,No,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Other,CFE,M/F,Oral diet,,,90,Days,liver,Both,None,3301,nonneoplastic histopathology,M,Dichotomous,hydropic degeneration and fattay changes in the liver of pigs,,mg/kg-day,,,,,,0,,,3,0,,
Dimethenamid-P,163515148,,OPP,Chronic RfD (mg/kg/day),0.05,1.02,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,163515-14-8",6/20/2006,"MRIDs 41706808 Ruckman, S.; Waterson, L.; Crook, D.; et al. (1990) SAN 582 H: Potential Tumorigenic and Toxic Effects in Prolonged Dietary Administration to Rats: Lab Project Number: SDZ 335/891445. Unpublished study prepared by Huntingdon Research Centre Ltd. 1407 p.MRID 42030102 Sandoz Crop Protection Corp. (1990) Potential Tumorigenic and Toxic Effects Study of SAN 582H in Prolonged Dietary Administration to Rats: Historical Control Data: Lab Project Number: SDZ 335/891445. Unpublished study. 55 p.",NOAEL,5.1,mg/kg/day,NA,"decreased body weight and body weight gain, and increasedmicroscopic hepatic lesions",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,Both,None,4322,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Dimethipin,55290647,C6H10O4S2,IRIS,RfD (mg/kg/day),0.02,1,5/1/1990,http://www.epa.gov/iris/subst/0043.htm,5/1/1990,"Uniroyal Chemical Company. 1981a. MRID No. 00145225. Available from EPA. Write to FOI, EPA, Washington DC 20460.",NOEL,2,mg/kg/day,NA,Increased absolute and relative liver weight,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Albino,M/F,Oral diet,,,2,Years,liver,Both,None,679,organ weight,Both,Continuous,Increased absolute and relative liver weight,,,,,,,,,,,,,,
Dimethomorph,110488705,,OPP,Chronic RfD (mg/kg/day),0.1,1.1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-268800_30-Sep-98.pdf,9/15/2011,"MRID 42233916 Everett, D.; Perry, C.; Mulhern, M.; Et Al. (1988) 104 Week Dietary Carcinogenicity Study In Rats: Lab Project Number: 435140. Unpublished Study Prepared By Inveresk Research International. 1204 P.",NOAEL,11,mg/kg/day,NA,body weight decrement and liver effects in female rats,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,Both,None,4324,nonneoplastic histopathology,Both,,"increased incidences of pigmented or hypertrophied hepatocytes, and _ground glass_ foci in livers",,,,,,,,,,,,,,
Dimethyl Tetrachloroterephthalate,1861321,C10H6Cl4O4,IRIS,RfD (mg/kg/day),0.01,1,8/1/1994,http://www.epa.gov/iris/subst/0221.htm,8/1/1994,"ISK Biotech Corporation. 1993. MRID No. 42731001, 42998401. HED Doc. No. 010513. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1,mg/kg/day,NA,"Effects on the lungs, liver, kidney, thyroid and thyroid hormonesin males and females and eyes of females",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,Both,None,1006,nonneoplastic histopathology,Both,Continuous,effects on the liver,,,,,,Cholesterol clefts,,,,,,,,
Dimethyl Tetrachloroterephthalate,1861321,C10H6Cl4O4,IRIS,RfD (mg/kg/day),0.01,1,8/1/1994,http://www.epa.gov/iris/subst/0221.htm,8/1/1994,"ISK Biotech Corporation. 1993. MRID No. 42731001, 42998401. HED Doc. No. 010513. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1,mg/kg/day,NA,"Effects on the lungs, liver, kidney, thyroid and thyroid hormonesin males and females and eyes of females",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Years,liver,Both,None,1006,nonneoplastic histopathology,Both,Dichotomous,effects on the liver,,,,,,"dose-related increase in the incidence and severity of centrilobular hepatocytic swelling (hepatocytic hypertrophy). This lesion was characterized by an increase in cellular size, accompanied by a ground-glass appearance to the cytoplasm of the hepatocytes located in close proximity to the central vein of each hepatic lobule. As the severity of the lesion increased, larger portions of the lobule were affected. An increased incidence of eosinophilic foci in both sexes was observed. Eosinophilic foci are focal areas of cellular alteration in the liver characterized by areas of hepatocytes with intensely eosinophilic cytoplasm, enlarged hepatocytes, increases in hepatocyte numbers, and distinct lesion borders occasionally resulting in compression of the adjacent parenchyma.",,,,,,,,
"Dinitrotoluene, 2,6- ",606202,,PPRTV,RfD (mg/kg/day),0.001,1.33,,http://hhpprtv.ornl.gov/issue_papers/Dinitrotoluene26.pdf,2004,"Lee, C-C., H.V. Ellis, J.J. Kowalski et al. 1976. Mammalian toxicity of munition compounds. Phase II: Effects of multiple doses. Part III: 2,6-Dinitrotoluene. Study conducted by theMidwest Research Institute for the U.S. Medical Bioengineering Research and DevelopmentLaboratory. Fort Detrick, Frederick, MD. AD A 062 015.",NOAEL,4,mg/kg-day,NA,"neurological (incoordination and rigid paralysis), hematological (methemoglobin and sequelae) and liver histopathology (degeneration, bile duct hyperplasia)",No,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,13,Weeks,liver,Both,None,3563,nonneoplastic histopathology,Both,Dichotomous,liver histopathology ( bile duct hyperplasia),,mg/kg-d,,,,,,0,,,2,0,,
"Dinitrotoluene, 2,6- ",606202,,PPRTV,RfD (mg/kg/day),0.001,1.33,,http://hhpprtv.ornl.gov/issue_papers/Dinitrotoluene26.pdf,2004,"Lee, C-C., H.V. Ellis, J.J. Kowalski et al. 1976. Mammalian toxicity of munition compounds. Phase II: Effects of multiple doses. Part III: 2,6-Dinitrotoluene. Study conducted by theMidwest Research Institute for the U.S. Medical Bioengineering Research and DevelopmentLaboratory. Fort Detrick, Frederick, MD. AD A 062 015.",NOAEL,4,mg/kg-day,NA,"neurological (incoordination and rigid paralysis), hematological (methemoglobin and sequelae) and liver histopathology (degeneration, bile duct hyperplasia)",No,None,None,Yes,3000,10,10,10,,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,13,Weeks,liver,Both,None,3477,nonneoplastic histopathology,Both,Dichotomous,liver histopathology (degeneration),,mg/kg-d,,,,,,0,,,2,0,,
Diphenamid,957517,C16H17NO,IRIS,RfD (mg/kg/day),0.03,1,3/1/1991,http://www.epa.gov/iris/subst/0232.htm,3/1/1991,"Upjohn Company. 1966a. MRID No. 00076382. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,3,mg/kg/day,NA,Liver toxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,None,1545,nonneoplastic histopathology,Both,Dichotomous,Liver toxicity,,,,,,increase in portal macrophages and fibroblasts,,,,,,,,
Diphenamid,957517,C16H17NO,IRIS,RfD (mg/kg/day),0.03,1,3/1/1991,http://www.epa.gov/iris/subst/0232.htm,3/1/1991,"Upjohn Company. 1966a. MRID No. 00076382. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,3,mg/kg/day,NA,Liver toxicity,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,None,1546,organ weight,Both,Continuous,Liver toxicity,,,,,,slight increase in liver weight,,,,,,,,
Diphenylamine,122394,C12H11N,IRIS,RfD (mg/kg/day),0.025,1,9/1/1990,http://www.epa.gov/iris/subst/0048.htm,9/1/1990,"Thomas, J.O., W.E. Ribelin, J.R. Woodward and F. Deeds. 1967. The chronic toxicity of diphenylamine for dogs. Toxicol. Appl. Pharmacol. 11: 184-194.",NOEL,2.5,mg/kg/day,NA,"Decreased body weight gain, and increased liver and kidney weights",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,None,482,organ weight,Both,Continuous,increased liver weight,,,,,,Observed at 250 mg/kg/day; dose-response data were not reported in Thomas et al 1967.,,,,,,,,
d-Phenothrin (Sumithrin),26002802,,OPP,Chronic RfD (mg/kg/day),0.007,1.01,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-069005_25-Sep-08.pdf,9/22/2008,"Cox, R. (1987) Chronic Toxicity Study in Dogs with Sumithrin, T.G.: Final Report: HLA Study No. 343-173. Unpublished study prepared by Hazleton Laboratories America, Inc. 408 p.  MRID 40276401.",NOAEL,7.1,mg/kg/day,NA,hepatocellular enlargement in the liver and focal degeneration in the adrenal cortex,,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,,M/F,,,,chronic,Duration,liver,Both,None,4055,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Endosulfan,115297,C9H6Cl6O3S,ATSDR,Chronic Oral MRL (mg/kg/day),0.002,0.9,,http://www.atsdr.cdc.gov/ToxProfiles/tp41.pdf,Sep-00,"Hoechst. 1989c. Endosulfan - substance technical (code HOE 02671 OI ZD96 0002):Testing for toxicity by repeated oral administration (1-year feeding study) to Beagle dogs. Conducted forHoechst Aktiengesellschaft, Frankfurt, Germany. Project no. 87.0643.",NOAEL,0.18,mg/kg/day,NA,increase in serum alkaline phosphatase activity,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4441,clinical chemistry,Both,Continuous,increase in serum alkaline phosphatase activity,,,,,,Data reported for individual animals in primary reference; means and SDs not reported.,,,,,,,,
Endrin,72208,C12H8Cl6O,IRIS,RfD (mg/kg/day),0.0003,0.83,4/1/1991,http://www.epa.gov/iris/subst/0363.htm,4/1/1991,"Velsicol Chemical Corporation. 1969. MRID. No. 00030198. Available from EPA. Write FOI, EPA, Washington, DC. 20460.",NOAEL,0.025,mg/kg/day,NA,"Mild histological lesions in liver, occasional convulsions",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,2,Years,liver,Both,None,694,nonneoplastic histopathology,Both,Dichotomous,mild histological lesions,,,,,,slight vacuolization of hepatic cells,,,,,,,,
Esbiothrin,584792,,OPP,Chronic RfD (mg/kg/day),0.008,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2006-0986-0012,6/27/2007,MRID 00151447,BMDL,8,mg/kg/day,10% ER,microscopic liver changes (hepatocellular degeneration),No,None,None,No,1000,10,10,,10,,,TRUE,,Bioallethrin,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,3771,nonneoplastic histopathology,Both,,"A 10% response for the BMDL was selected because of the mild nature of the lesions, characterized as ""acute swelling of hepatocytes"", which did not progress in severity at the high dose. The lesions were accompanied by increased relative liver weight and moderate increases in alkaline phosphatase in males.",,,,,,,,,,,,,,
Ethalfluralin,55283686,,OPP,Chronic RfD (mg/kg/day),0.04,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-113101_1-Mar-95.pdf,3/1/1995,"Adams, E.; Bernhard, N. 1985. The Toxicity of Ethalfluralin Administered Orally to Beagle Dogs for One Year. Study No. DO 1684. Unpublished study conducted by Lilly. MRID 00153371 (also 00262711, 260434-A, 92062014)",NOEL,4,mg/kg/day,NA,"increased urinary bilirubin, variations in erythrocytemorphology, increased thrombocyte count, and increased erythroid series of the bone marrow",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,Unspecified,Oral - other,,7,1,Years,liver,Both,None,3775,clinical chemistry,Both,,,,,,,,Compound was administered daily by capsule.,,,,,,,,
Ethoxyquin,91532,,OPP,Chronic RfD (mg/kg/day),0.02,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,91-53-2",4-Nov,"MRID 44148901 Baasm DJ (1996) A 90-day oral (capsule) toxicity study of ethoxyquin in dogs. WIL Research Laboratories, Inc. Ashland, Oh. Study No. WIL-273013, October 24, 1996. Unpublished.",NOAEL,2,mg/kg-day,NA,elevated liver enzymes and microscopic findings in the liver (cytoplasmic vacuolation and minimal hepatocelular necrosis).,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,90,Days,liver,Both,MOA Evaluation,4125,enzyme activity,Both,,,,,,,,,,,,,,,,
Ethoxyquin,91532,,OPP,Chronic RfD (mg/kg/day),0.02,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,91-53-2",4-Nov,"MRID 44148901 Baasm DJ (1996) A 90-day oral (capsule) toxicity study of ethoxyquin in dogs. WIL Research Laboratories, Inc. Ashland, Oh. Study No. WIL-273013, October 24, 1996. Unpublished.",NOAEL,2,mg/kg-day,NA,elevated liver enzymes and microscopic findings in the liver (cytoplasmic vacuolation and minimal hepatocelular necrosis).,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,90,Days,liver,Both,MOA Evaluation,4126,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Ethylbenzene,100414,C8H10,IRIS,RfD (mg/kg/day),0.1,0.97,6/1/1991,http://www.epa.gov/iris/subst/0051.htm,6/1/1991,"Wolf, M.A., V.K. Rowe, D.D. McCollister, R.L. Hollingsworth and F. Oyen. 1956. Toxicological studies of certain alkylated benzenes and benzene. Arch. Ind. Health. 14: 387-398",NOEL,97.1,mg/kg/day,NA,Liver and kidney toxicity,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Albino,F,Oral gavage,,5,182,Days,liver,,None,8,nonneoplastic histopathology,,Dichotomous,histopathologic changes in the liver,,,,,,No incidence data in primary report,,,,,,,,
Ethylene Chlorohydrin,107073,,OPP,Chronic RfD (mg/kg/day),0.045,,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,107-07-3",,"Oser, B.L., K. Morgareidge, G.E. Cox et al., 1975. Short-term toxicity of ethylene chlorohydrin (ECH) in rats, dogs and monkeys. Food Cosmet. Toxicol. 13: 313-316.",NOAEL,45,mg/kg/day,NA,"Decreased mean body weight in males, poor survival, laboredbreathing and gross effects such as dark liver and lungs andhemorrhagic gastro intestinal tissues and adrenal and pituitaryglands . Histopathological effects include subacutemyocarditis, colloid depletion in thyroid, thyroid congestion,fatty liver and congestive pulmonary changes.",No,None,None,No,1000,10,10,,,,10,TRUE,,,Rat,Albino,M/F,Oral gavage,,,12,Weeks,liver,Both,None,4134,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Ethylene Chlorohydrin,107073,,OPP,Chronic RfD (mg/kg/day),0.045,,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,107-07-3",,"Oser, B.L., K. Morgareidge, G.E. Cox et al., 1975. Short-term toxicity of ethylene chlorohydrin (ECH) in rats, dogs and monkeys. Food Cosmet. Toxicol. 13: 313-316.",NOAEL,45,mg/kg/day,NA,"Decreased mean body weight in males, poor survival, laboredbreathing and gross effects such as dark liver and lungs andhemorrhagic gastro intestinal tissues and adrenal and pituitaryglands . Histopathological effects include subacutemyocarditis, colloid depletion in thyroid, thyroid congestion,fatty liver and congestive pulmonary changes.",No,None,None,No,1000,10,10,,,,10,TRUE,,,Rat,Albino,M/F,Oral gavage,,,12,Weeks,liver,Both,None,4132,gross pathology,Both,,,,,,,,,,,,,,,,
Ethylenediamine,107153,C2H8N2,PPRTV,RfD (mg/kg/day),0.09,1,,http://hhpprtv.ornl.gov/issue_papers/EthyleneDiamine.pdf,8/4/2006,"Hermansky, S.J., R.S. Yang, R.H. Garman and H.W. Leung. 1999. Chronic toxicity and carcinogenicity studies of ethylenediamine dihydrochloride by dietary incorporation in Fischer344 rats. Food Chem. Toxicol. 37: 765-776.",NOAEL,9,mg/kg-day,NA,"liver and kidney toxicity (changes in organ weight, histopathology)",NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4417,organ weight,Both,Continuous,Liver weight (absolute and relative),,,,,,"Too many datasets to include.  Absolute and relative liver and kidney weights were generally increased at the mid- and high-dose in both males and females from 12 months onward, although not all of the changes achieved statistical significance. The authors considered these effects to be treatment-related.  Histopathology changes were only significant at the high dose.",,,,,,,,
Etoxazole,153233911,,OPP,Chronic RfD (mg/kg/day),0.046,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,153233-91-1",11-Sep,MRID 45089942,NOAEL,4.62,mg/kg-day,NA,"increased akaline phosphatase activity, increased liver weights, liver enlargement and incidence of centrilobular hepatocellular swelling the liver",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,4147,clinical chemistry,Both,,,,,,,,,,,,,,,,
Etoxazole,153233911,,OPP,Chronic RfD (mg/kg/day),0.046,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,153233-91-1",11-Sep,MRID 45089942,NOAEL,4.62,mg/kg-day,NA,"increased akaline phosphatase activity, increased liver weights, liver enlargement and incidence of centrilobular hepatocellular swelling the liver",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,4149,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Etoxazole,153233911,,OPP,Chronic RfD (mg/kg/day),0.046,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,153233-91-1",11-Sep,MRID 45089942,NOAEL,4.62,mg/kg-day,NA,"increased akaline phosphatase activity, increased liver weights, liver enlargement and incidence of centrilobular hepatocellular swelling the liver",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,4148,organ weight,Both,,,,,,,,,,,,,,,,
Fenbuconazole,114369436,,OPP,Chronic RfD (mg/kg/day),0.03,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,114369-43-6",8/3/2006,"MRID 41635301, 41635302",NOAEL,3,mg/kg/day,NA,"decreased body weight gain, increased thyroid weight, and histopathological lesions in the liver and thyroid gland",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,,M/F,,,,,Duration,liver,F,None,4333,nonneoplastic histopathology,F,,,,,,,,,,,,,,,,
Fenpropimorph,67564914,,OPP,Chronic RfD (mg/kg/day),0.032,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-121402_01-Mar-06.pdf,6-Mar,MRID 44323911 Hellwig (1990) Report on the Study of Fenpropimorph...in Beagle Dogs--Administration via the Diet over 12 Months: Lab Project Number: 90/0172: 33D0133/87021. Unpublished study prepared by BASF Aktiengesellschaft. 842 p.,NOAEL,3.2,mg/kg/day,NA,"elevated blood enzyme activity (ALT, liver)",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,12,Months,liver,Both,None,4341,clinical chemistry,Both,,,,,,,,,,,,,,,,
Fenpropimorph,67564914,,OPP,Chronic RfD (mg/kg/day),0.032,,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-121402_01-Mar-06.pdf,6-Mar,"MRID 44380106 Hunter, B.; Barnard, A.; Hayman, R. et al. (1992) Fenpropimorph (Reg. No. 108 406): Assessment of Potential Tumorigenic and Toxic Effects in Prolonged Dietary Administration to Rats: Lab Project Number: BAF/308/81138: 82/092. Unpublished study prepared by Huntingdon Research Centre. 1974 p.",NOAEL,1.7,mg/kg/day,,histopathological liver findings (co-critical study),,,,No,,,,,,,,,,,Rat,Sprague-Dawley,M/F,Oral diet,,,114,Weeks,liver,Both,None,4342,nonneoplastic histopathology,Both,,"eosinophilic, enlarged centrilobular, multinucleated and foci of ballooned hepatocytes",,,,,,,,,,,,,,
Ferbam,14484641,,OPP,Chronic RfD (mg/kg/day),0.015,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,14484-64-1",5-Sep,,NOAEL,1.5,mg/kg-day,NA,"changes in hematology, clinical chemistry, incidences of bile duct hyperplasia, and reduction in mean body weight gain",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,,,,,,chronic,,liver,Both,None,4152,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Florasulam,145701231,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,145701-23-1",5/31/2007,"MRID: 46808229. Stebbins, K.; Haut, K. (1997) XDE-570: One Year Dietary Toxicity Study in Beagle Dogs. Project Number: 960018. Unpublished study prepared by The Dow Chemical Co. 419 p.",NOAEL,5,mg/kg-day,NA,decreased body weights and food consumption in females; increased liver enzymes (alanine aminotransferase and alkaline phosphatase) and slight vacuolation of the zona reticularis and zona fasciculata in the adrenal gland in both sexes.,No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,52,Weeks,liver,Both,MOA Data,3802,clinical chemistry,F,Continuous,increased liver enzymes (alanine aminotransferase),SD,mg/kg-day,U/L,,,Data at 3 months; significant findings at this time,,0,,,4,,44,13
Florasulam,145701231,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,145701-23-1",5/31/2007,"MRID: 46808229. Stebbins, K.; Haut, K. (1997) XDE-570: One Year Dietary Toxicity Study in Beagle Dogs. Project Number: 960018. Unpublished study prepared by The Dow Chemical Co. 419 p.",NOAEL,5,mg/kg-day,NA,decreased body weights and food consumption in females; increased liver enzymes (alanine aminotransferase and alkaline phosphatase) and slight vacuolation of the zona reticularis and zona fasciculata in the adrenal gland in both sexes.,No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,52,Weeks,liver,Both,MOA Data,3803,clinical chemistry,M,Continuous,increased liver enzymes (alkaline phosphatase),SD,mg/kg-day,U/L,,,Data at 3 months; significant findings at this time,,0,,,4,,72,55
Florasulam,145701231,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,145701-23-1",5/31/2007,"MRID: 46808229. Stebbins, K.; Haut, K. (1997) XDE-570: One Year Dietary Toxicity Study in Beagle Dogs. Project Number: 960018. Unpublished study prepared by The Dow Chemical Co. 419 p.",NOAEL,5,mg/kg-day,NA,decreased body weights and food consumption in females; increased liver enzymes (alanine aminotransferase and alkaline phosphatase) and slight vacuolation of the zona reticularis and zona fasciculata in the adrenal gland in both sexes.,No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,52,Weeks,liver,Both,MOA Data,3804,clinical chemistry,F,Continuous,increased liver enzymes (alkaline phosphatase),SD,mg/kg-day,U/L,,,Data at 3 months; significant findings at this time,,0,,,4,,78,14
Florasulam,145701231,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,145701-23-1",5/31/2007,"MRID: 46808229. Stebbins, K.; Haut, K. (1997) XDE-570: One Year Dietary Toxicity Study in Beagle Dogs. Project Number: 960018. Unpublished study prepared by The Dow Chemical Co. 419 p.",NOAEL,5,mg/kg-day,NA,decreased body weights and food consumption in females; increased liver enzymes (alanine aminotransferase and alkaline phosphatase) and slight vacuolation of the zona reticularis and zona fasciculata in the adrenal gland in both sexes.,No,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,52,Weeks,liver,Both,MOA Data,3801,clinical chemistry,M,Continuous,increased liver enzymes (alanine aminotransferase),SD,mg/kg-day,U/L,,,Data at 3 months; significant findings at this time,,0,,,4,,31,9
Fluazinam,79622596,,OPP,Chronic RfD (mg/kg/day),0.011,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-129098_10-Aug-01.pdf,8/10/2001,"Mayfield, R., S. Burton, D. Crook,et al.  (1988) Fuazinam technical (B-1216): potential carcinogenicity sutdy in dietary administration to mice fore 104 weeks.  Huntingdon Research Centre, LTD., Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264, Septemeber 29, 1998.  Unpublished.  MRID 42208405.Mayfield, R., (1996) Amendment to addendum to report no ISK 9/87264: technical fluazinam potential carcinogenicity to mice (MRID 42208405).  Huntingdon Research Centre, LTD., P.O. Box 2, Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264 , December 19, 1996.  Unpublished.  MRID 44807220.Amyes, S.J., S.M. Macrae, J.C. Whitney (1983) B-1216: Four-week toxicity study in mice.  Life Science Research, Stock, Essex, CM4 9PE, England, Document Nos. 82/ISK036/067 and 82/ISK036/215, June 9, 1983.  Unpublished.  MRID 44807212.",NOAEL,1.1,mg/kg/day,NA,liver histopathology and increased liver weight,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,104,Weeks,liver,Both,None,3783,nonneoplastic histopathology,M,Dichotomous,liver histopathology (brown macrophages),,ppm,,,,Dose-response data are from Table 6 in the Data Evaluation Record.,,0,,,104,14,,
Fluazinam,79622596,,OPP,Chronic RfD (mg/kg/day),0.011,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-129098_10-Aug-01.pdf,8/10/2001,"Mayfield, R., S. Burton, D. Crook,et al.  (1988) Fuazinam technical (B-1216): potential carcinogenicity sutdy in dietary administration to mice fore 104 weeks.  Huntingdon Research Centre, LTD., Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264, Septemeber 29, 1998.  Unpublished.  MRID 42208405.Mayfield, R., (1996) Amendment to addendum to report no ISK 9/87264: technical fluazinam potential carcinogenicity to mice (MRID 42208405).  Huntingdon Research Centre, LTD., P.O. Box 2, Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264 , December 19, 1996.  Unpublished.  MRID 44807220.Amyes, S.J., S.M. Macrae, J.C. Whitney (1983) B-1216: Four-week toxicity study in mice.  Life Science Research, Stock, Essex, CM4 9PE, England, Document Nos. 82/ISK036/067 and 82/ISK036/215, June 9, 1983.  Unpublished.  MRID 44807212.",NOAEL,1.1,mg/kg/day,NA,liver histopathology and increased liver weight,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,104,Weeks,liver,Both,None,3784,nonneoplastic histopathology,F,Dichotomous,liver histopathology (brown macrophages),,ppm,,,,Dose-response data are from Table 6 in the Data Evaluation Record.,,0,,,104,16,,
Fluazinam,79622596,,OPP,Chronic RfD (mg/kg/day),0.011,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-129098_10-Aug-01.pdf,8/10/2001,"Mayfield, R., S. Burton, D. Crook,et al.  (1988) Fuazinam technical (B-1216): potential carcinogenicity sutdy in dietary administration to mice fore 104 weeks.  Huntingdon Research Centre, LTD., Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264, Septemeber 29, 1998.  Unpublished.  MRID 42208405.Mayfield, R., (1996) Amendment to addendum to report no ISK 9/87264: technical fluazinam potential carcinogenicity to mice (MRID 42208405).  Huntingdon Research Centre, LTD., P.O. Box 2, Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264 , December 19, 1996.  Unpublished.  MRID 44807220.Amyes, S.J., S.M. Macrae, J.C. Whitney (1983) B-1216: Four-week toxicity study in mice.  Life Science Research, Stock, Essex, CM4 9PE, England, Document Nos. 82/ISK036/067 and 82/ISK036/215, June 9, 1983.  Unpublished.  MRID 44807212.",NOAEL,1.1,mg/kg/day,NA,liver histopathology and increased liver weight,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,104,Weeks,liver,Both,None,3785,nonneoplastic histopathology,M,Dichotomous,liver histopathology (eosinophilic vacuolated hepatocytes),,ppm,,,,Dose-response data are from Table 6 in the Data Evaluation Record.,,0,,,104,1,,
Fluazinam,79622596,,OPP,Chronic RfD (mg/kg/day),0.011,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-129098_10-Aug-01.pdf,8/10/2001,"Mayfield, R., S. Burton, D. Crook,et al.  (1988) Fuazinam technical (B-1216): potential carcinogenicity sutdy in dietary administration to mice fore 104 weeks.  Huntingdon Research Centre, LTD., Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264, Septemeber 29, 1998.  Unpublished.  MRID 42208405.Mayfield, R., (1996) Amendment to addendum to report no ISK 9/87264: technical fluazinam potential carcinogenicity to mice (MRID 42208405).  Huntingdon Research Centre, LTD., P.O. Box 2, Huntingdon, Cambridgeshire, PE18 6ES, England, Document No. ISK 9/87264 , December 19, 1996.  Unpublished.  MRID 44807220.Amyes, S.J., S.M. Macrae, J.C. Whitney (1983) B-1216: Four-week toxicity study in mice.  Life Science Research, Stock, Essex, CM4 9PE, England, Document Nos. 82/ISK036/067 and 82/ISK036/215, June 9, 1983.  Unpublished.  MRID 44807212.",NOAEL,1.1,mg/kg/day,NA,liver histopathology and increased liver weight,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,104,Weeks,liver,Both,None,3786,organ weight,F,,increased liver weight,,,,,,Dose-response data from the Data Evaluation Record were presented without variabilty measures.,,,,,,,,
Flucarbazone-sodium,181274179,,OPP,Chronic RfD (mg/kg/day),0.36,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-114009_29-Sep-00.pdf,9/29/2000,,NOAEL,35.9,mg/kg/day,NA,"decreased body weight gain, decreased thyroxine, increased N-demethylase, and increased liver weight",,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,F,None,3790,organ weight,F,,,,,,,,,,,,,,,,
Flufenpyr-ethyl,188489078,,OPP,Chronic RfD (mg/kg/day),0.4,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2003-0166-0002,9/13/2003,,NOAEL,40,mg/kg/day,NA,liver toxicity (hepatocyte necrosis) in both sexes and mild anemia in males,,None,None,No,100,10,10,,,,,TRUE,,,Mouse,,M/F,,,,18,Months,liver,Both,None,4006,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Flumetsulam (XRD-,98967409,,OPP,Chronic RfD (mg/kg/day),1,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2008-0625-0005,8/12/2008,MRID 41952103,NOAEL,100,mg/kg/day,NA,"renal inflammatory and atrophic changes secondary to renal calculi and hepatic effects (inflammation, focal necreosis, biliary stasis)",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,Unspecified,Oral diet,,,chronic,Duration,liver,Both,None,3795,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Fluoranthene,206440,C16H10,IRIS,RfD (mg/kg/day),0.04,,7/1/1993,http://www.epa.gov/iris/subst/0444.htm,7/1/1993,"U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.",NOAEL,125,mg/kg/day,NA,"Nephropathy, increased liver weights, hematological alterations, and clinical effects",No,None,None,No,3000,10,10,,,,30,TRUE,UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,None,2191,clinical chemistry,M,Continuous,increased SGPT levels,SD,mg/kg/day,U/l,,,Dose-response data are from Table 6 in primary report.,,0,,,10,,21.9,5.79
Fluoranthene,206440,C16H10,IRIS,RfD (mg/kg/day),0.04,,7/1/1993,http://www.epa.gov/iris/subst/0444.htm,7/1/1993,"U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.",NOAEL,125,mg/kg/day,NA,"Nephropathy, increased liver weights, hematological alterations, and clinical effects",No,None,None,No,3000,10,10,,,,30,TRUE,UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,None,1928,organ weight,F,Continuous,increased absolute liver weights,SD,mg/kg/day,g,,,Dose-response data are from Appendix I of primary report,,0,,,20,,1.443,0.102
Fluoranthene,206440,C16H10,IRIS,RfD (mg/kg/day),0.04,,7/1/1993,http://www.epa.gov/iris/subst/0444.htm,7/1/1993,"U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.",NOAEL,125,mg/kg/day,NA,"Nephropathy, increased liver weights, hematological alterations, and clinical effects",No,None,None,No,3000,10,10,,,,30,TRUE,UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,None,1044,organ weight,M,Continuous,increased absolute liver weights,SD,mg/kg/day,g,,,Dose-response data are from Appendix I of primary report,,0,,,20,,1.742,0.235
Fluoranthene,206440,C16H10,IRIS,RfD (mg/kg/day),0.04,,7/1/1993,http://www.epa.gov/iris/subst/0444.htm,7/1/1993,"U.S. EPA. 1988. 13-Week mouse oral subchronic toxicity study. Prepared by Toxicity Research Laboratories, Ltd., Muskegon, MI for the Office of Solid Waste, Washington, DC.",NOAEL,125,mg/kg/day,NA,"Nephropathy, increased liver weights, hematological alterations, and clinical effects",No,None,None,No,3000,10,10,,,,30,TRUE,UF (subchronic to chronic extrapolation) and UF(database incomplete) were reported collectively as 30.,,Mouse,CD-1,M/F,Oral gavage,,,13,Weeks,liver,Both,None,2192,clinical chemistry,F,Continuous,increased SGPT levels,SD,mg/kg/day,U/l,,,Dose-response data are from Table 6 in primary report.,,0,,,10,,20.2,4.62
Fluoxastrobin,361377299,,OPP,Chronic RfD (mg/kg/day),0.015,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-028869_01-Nov-05.pdf,4/15/2010,"MRID 45865701 Jones, R.; Hastings, T. (2002) Technical Grade HEC 5725: A Chronic Toxicity 04-Feb-2003Feeding Study in the Beagle Dog: Lab Project Number: 99-C76-BD: 110920-1. Unpublished study prepared by Bayer Corp. 1047 p.",NOAEL,1.5,mg/kg/day,NA,body weight reductions and liver toxicity (cholestasis),No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4357,nonneoplastic histopathology,Both,,hepatocytomegaly and cytoplasmic changes indicative of cholestasis,,,,,,,,,,,,,,
Fluoxastrobin,361377299,,OPP,Chronic RfD (mg/kg/day),0.015,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-028869_01-Nov-05.pdf,4/15/2010,"MRID 45865701 Jones, R.; Hastings, T. (2002) Technical Grade HEC 5725: A Chronic Toxicity 04-Feb-2003Feeding Study in the Beagle Dog: Lab Project Number: 99-C76-BD: 110920-1. Unpublished study prepared by Bayer Corp. 1047 p.",NOAEL,1.5,mg/kg/day,NA,body weight reductions and liver toxicity (cholestasis),No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4358,clinical chemistry,Both,,increased serum liver alkaline phosphatase indicative of cholestasis,,,,,,,,,,,,,,
Flurprimidol,56425913,C15H15F3N2O2,IRIS,RfD (mg/kg/day),0.02,0.9,4/1/1990,http://www.epa.gov/iris/subst/0383.htm,4/1/1990,"Eli Lilly and Company. 1986a. MRID No. 00162770. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,1.8,mg/kg/day,NA,"Increased incidence of hepatocellular changes including fatty change and vacuolation (males); increased susceptibility to stress factors (females)",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,2,Generations,liver,M,None,716,nonneoplastic histopathology,M,Dichotomous,Increased incidence of hepatocellular changes including fatty change and vacuolation,,,,,,"An increased incidence of altered hepatocellular histology was observed in both generations of males. Hepatocellular changes included fatty change, vacuolation and centrilobular hypertrophy.",,,,,,,,
Flusilazole,85509199,C16H15F2N3Si,IRIS,RfD (mg/kg/day),0.0007,0.95,2/1/1991,http://www.epa.gov/iris/subst/0299.htm,2/1/1991,"E.I. du Pont de Nemours and Company. 1985. MRID No. 40042113. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.2,mg/kg/day,NA,Liver cell enlargement,No,None,None,No,300,10,10,,,3,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,1565,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Fluthiacet methyl,117337196,,OPP,Chronic RfD (mg/kg/day),0.001,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-108803_01-Apr-99.pdf,Apr-99,"MRID 43830015 Chang, J.; Morrissey, R. (1995) Cga-248757 Technical: 18-Month Dietary Oncogenicity Study In Mice: Final Report: Lab Project Number: F-00069. Unpublished Study Prepared By Ciba-Geigy Corp. 1530 P",NOAEL,0.1,mg/kg/day,NA,non-neoplastic liver findings,No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,18,Months,liver,Both,None,4361,nonneoplastic histopathology,Both,,"karyomegaly, necrosis",,,,,,,,,,,,,,
Flutolanil,66332965,C17H16F3NO2,IRIS,RfD (mg/kg/day),0.06,1.06,5/1/1990,http://www.epa.gov/iris/subst/0394.htm,5/1/1990,"NOR-AM Chemical Company. 1982a. MRID No. 40342923. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",LEL,63.7,mg/kg/day,NA,"Decreased body weight  and body weight gains in both doses;Increased liver weights at high dose",No,None,None,No,1000,10,10,,10,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,3,Generations,liver,Both,None,720,organ weight,Both,Continuous,Increased liver weights,,,,,,,,,,,,,,
Flutriafol,76674210,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,76674-21-0",4/27/2010,"MRID 47090353 Stonard, M. D. (1988) Flutriafol: one year oral dosing study in dogs. Imperial Chemical Industries, PLC, Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK. Laboratory Study No.: PD0667; Report No.: CTL/P/2019, May 18, 1988. Unpublished.",NOAEL,5,mg/kg/day,NA,"adverse liver, adrenal, spleen, and blood effects, and initial body weight losses, decreased cumulative body-weight gains",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,1,Years,liver,Both,None,4364,clinical chemistry,Both,,"increases in alkaline phosphatase, albumin, and triglycerides",,,,,,,,,,,,,,
Flutriafol,76674210,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,76674-21-0",4/27/2010,"MRID 47090353 Stonard, M. D. (1988) Flutriafol: one year oral dosing study in dogs. Imperial Chemical Industries, PLC, Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK. Laboratory Study No.: PD0667; Report No.: CTL/P/2019, May 18, 1988. Unpublished.",NOAEL,5,mg/kg/day,NA,"adverse liver, adrenal, spleen, and blood effects, and initial body weight losses, decreased cumulative body-weight gains",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,1,Years,liver,Both,None,4363,nonneoplastic histopathology,Both,,"increased centrilobular hepatocyte lipid, marked hemosiderin pigmentation",,,,,,,,,,,,,,
Flutriafol,76674210,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,76674-21-0",4/27/2010,"MRID 47090353 Stonard, M. D. (1988) Flutriafol: one year oral dosing study in dogs. Imperial Chemical Industries, PLC, Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK. Laboratory Study No.: PD0667; Report No.: CTL/P/2019, May 18, 1988. Unpublished.",NOAEL,5,mg/kg/day,NA,"adverse liver, adrenal, spleen, and blood effects, and initial body weight losses, decreased cumulative body-weight gains",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,1,Years,liver,Both,None,4362,organ weight,Both,,,,,,,,,,,,,,,,
Fonophos,944229,C10H15OPS2,IRIS,RfD (mg/kg/day),0.002,1,3/1/1991,http://www.epa.gov/iris/subst/0158.htm,3/1/1991,"Stauffer Chemical Company. 1969. MRID 00082233. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.2,mg/kg/day,NA,"Cholinesterase inhibition, cholinergic symptoms, and increased liver weight",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,,1569,organ weight,Both,,,,,,,,,,,,,,,,
Fufural,98011,C5H4O2,IRIS,RfD (mg/kg/day),0.003,0.88,2/1/1996,http://www.epa.gov/iris/subst/0317.htm,2/1/1996,NTP (National Toxicology Program). 1981a. 90-day Rat Report. Unpublished study performed by Southern Research Institute,LOAEL,7.9,mg/kg/day,NA,Mild hepatocellular vacuolization,Yes,None,None,Yes,3000,10,10,10,3,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,1572,nonneoplastic histopathology,M,Dichotomous,Mild hepatocellular vacuolization,,mg/kg-day,,mg/kg-day (ADJ),,"Dose response data are from the published version of primary report (NTP TR382).  (Incidence in the 180 mg/kg/day group was not reported, as 9/10 animals died before the end of the study).",,0,0,,10,4,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,499,nonneoplastic histopathology,M,Dichotomous,Hepatic lesions (cytomegaly),,mg/kg-day,,mg/kg-day (ADJ),,"Data are from published version of this report (NTP TR402), Table 19.  The NOAEL was identified in the mouse study, the LOAEL was identified in the rat study.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,2194,nonneoplastic histopathology,M,Dichotomous,Hepatic lesions (degeneration),,mg/kg-day,,mg/kg-day (ADJ),,"Data are from published version of this report (NTP TR402), Table 19.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,13,Weeks,liver,Both,None,2195,nonneoplastic histopathology,M,Dichotomous,Hepatic lesions (necrosis),,mg/kg-day,,mg/kg-day (ADJ),,"Data are from published version of this report (NTP TR402), Table 19.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,,2203,nonneoplastic histopathology,F,Dichotomous,hepatic lesions (biliary tract hyperplasia),,mg/kg-day,,mg/kg-day (ADJ),,"Incidence data are from the published version of this report (NTP TR402), Table 4.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,,2205,none,M,Dichotomous,Hepatic lesions (Kupffer cell pigmentation),,mg/kg-day,,mg/kg-day (ADJ),,"Incidence data are from the published version of this report (NTP TR402), Table 4.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,,2202,nonneoplastic histopathology,M,Dichotomous,hepatic lesions (biliary tract hyperplasia),,mg/kg-day,,mg/kg-day (ADJ),,"Incidence data are from the published version of this report (NTP TR402), Table 4.  The NOAEL was identified in the mouse study, the LOAEL was identified in the rat study.",,0,0,,10,0,,
Furan,110009,C4H4O,IRIS,RfD (mg/kg/day),0.001,1.4,12/1/1989,http://www.epa.gov/iris/subst/0056.htm,12/1/1989,"NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD. NTP (National Toxicology Program). 1982. Subchronic toxicity report on furan in B6C3F1 mice. Prepared by Southern Research Institute under Contract No. 1- CP-95641-01 for NTP, Bethesda, MD.",NOAEL,1.4,mg/kg/day,NA,Hepatic lesions,Yes,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral gavage,,5,13,Weeks,liver,Both,,2204,nonneoplastic histopathology,M,Dichotomous,hepatic lesions (biliary tract cholangiofibrosis),,mg/kg-day,,mg/kg-day (ADJ),,"Incidence data are from the published version of this report (NTP TR402), Table 4.",,0,0,,10,0,,
Furilazole,,,OPP,Chronic RfD (mg/kg/day),0.0009,0.96,,"http://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:3:0::no:1,3,31,7,12,25:p3_xchemical_id:4986",,MRID 43700801 (1995) and 43042701 (1999),NOAEL,0.26,mg/kg/day,NA,increased absolute and relative liver and kidney weights,No,None,None,0,300,10,10,,,3,,TRUE,,,Rat,,M/F,,,,chronic,Duration,liver,Both,MOA Data,4169,organ weight,Both,,,,,,,,,,,,,,,,
Gamma-Hexachlorocyclohexane,58899,C6H6Cl6,IRIS,RfD (mg/kg/day),0.0003,1.1,3/1/1988,http://www.epa.gov/iris/subst/0065.htm,3/1/1988,"Zoecon Corporation. 1983. MRID No. 00128356. Available from EPA. Write to FOI, EPA, Washington D.C. 20460.",NOAEL,0.33,mg/kg/day,NA,Liver and kidney toxicity,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,12,Weeks,liver,Both,None,738,nonneoplastic histopathology,Both,Dichotomous,Liver toxicity,,,,,,liver hypertrophy,,,,,,,,
Heptachlor,76448,C10H5Cl7,IRIS,RfD (mg/kg/day),0.0005,1,3/1/1991,http://www.epa.gov/iris/subst/0243.htm,3/1/1991,"Velsicol Chemical Corporation. 1955a. MRID No. 00062599. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.15,mg/kg/day,NA,liver weight increases in males,No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Carworth farm,M/F,Oral diet,,,2,Years,liver,Both,None,1589,organ weight,M,,,,,,,,,,,,,,,,
Heptachlor Epoxide,1024573,C10H5Cl7O,IRIS,RfD (mg/kg/day),0.000013,0.96,3/1/1991,http://www.epa.gov/iris/subst/0160.htm,3/1/1991,"Dow Chemical Company. 1958. MRID No. 00061912. Available from EPA. Write to FOI, EPA,Washington, DC 20460.",LEL,0.0125,mg/kg/day,NA,Increased liver-to-body weight ratio in both males and females,No,None,None,No,1000,10,10,,10,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,60,Weeks,liver,Both,None,268,organ weight,Both,,,,,,,,,,,,,,,,
Hexachlorobenzene,118741,C6Cl6,ATSDR,Chronic Oral MRL (mg/kg/day),0.00005,1.07,,http://www.atsdr.cdc.gov/ToxProfiles/tp90.pdf,2-Sep,"Arnold DL, Moodie CA, Charbonneau SM, Grice HC, et al. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A. Food Chem Toxicol, 23(9): 779793.",LOAEL,0.016,mg/kg/day,NA,peribiliary lymphocytosis and fibrosis of the liver,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,130,Weeks,liver,M,MOA Data,3608,nonneoplastic histopathology,M,Dichotomous,peribiliary fibrosis,,mg/kg-day,,,,Animals were also exposed in utero,,0,,,48,13,,
Hexachlorobenzene,118741,C6Cl6,ATSDR,Chronic Oral MRL (mg/kg/day),0.00005,1.07,,http://www.atsdr.cdc.gov/ToxProfiles/tp90.pdf,2-Sep,"Arnold DL, Moodie CA, Charbonneau SM, Grice HC, et al. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary vitamin A. Food Chem Toxicol, 23(9): 779793.",LOAEL,0.016,mg/kg/day,NA,peribiliary lymphocytosis and fibrosis of the liver,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,130,Weeks,liver,M,MOA Data,4442,nonneoplastic histopathology,M,Dichotomous,peribiliary lymphocytosis,,mg/kg-day,,,,Animals were also exposed in utero,,0,,,48,16,,
Hexachlorobenzene,118741,C6Cl6,IRIS,RfD (mg/kg/day),0.0008,1,4/1/1991,http://www.epa.gov/iris/subst/0374.htm,4/1/1991,"Arnold, D.L., C.A. Moodie, S.M. Charbonneau, et al. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Fd. Chem. Toxic. 23(9): 779-793.",NOAEL,0.08,mg/kg/day,NA,Liver effects,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,1,Generations,liver,Both,None,2098,nonneoplastic histopathology,M,Dichotomous,Increase in hepatic centrilobular basophilic chromogenesis in F1 pups,,ppm diet,,,,Incidence data are from Table 1 in primary report,,0,,,48,3,,
Hexachlorobenzene,118741,C6Cl6,IRIS,RfD (mg/kg/day),0.0008,1,4/1/1991,http://www.epa.gov/iris/subst/0374.htm,4/1/1991,"Arnold, D.L., C.A. Moodie, S.M. Charbonneau, et al. 1985. Long-term toxicity of hexachlorobenzene in the rat and the effect of dietary Vitamin A. Fd. Chem. Toxic. 23(9): 779-793.",NOAEL,0.08,mg/kg/day,NA,Liver effects,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,1,Generations,liver,Both,None,2173,nonneoplastic histopathology,F,Dichotomous,Increase in hepatic centrilobular basophilic chromogenesis in F1 pups,,ppm diet,,,,Incidence data are from Table 1 in primary report,,0,,,49,2,,
Hydramethylnon,67485294,C25H24F6N4,IRIS,RfD (mg/kg/day),0.0003,1.1,9/30/1987,http://www.epa.gov/iris/subst/0207.htm,9/30/1987,"American Cyanamid Company. 1980. MRID No. 00035529. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.33,mg/kg/day,NA,Increased organ weights,No,None,None,No,1000,10,10,10,,,,TRUE,,,Dog,,M/F,Oral diet,,,26,Weeks,liver,Both,None,764,organ weight,Both,Continuous,"Increased organ weights (increased liver weight, increased liver/body weight ratio)",,,,,,,,,,,,,,
Iprovalicarb,140923177,,OPP,Chronic RfD (mg/kg/day),0.0262,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,140923-17-7",3/1/2002,MRID 44865721,NOAEL,2.62,mg/kg-day,,"Effects on liver (increased weight, increased enzyme levels and hepatocellular hyperplasia)",,,,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4189,clinical chemistry,Both,,,,,,,,,,,,,,,,
Iprovalicarb,140923177,,OPP,Chronic RfD (mg/kg/day),0.0262,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,140923-17-7",3/1/2002,MRID 44865721,NOAEL,2.62,mg/kg-day,,"Effects on liver (increased weight, increased enzyme levels and hepatocellular hyperplasia)",,,,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4187,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Iprovalicarb,140923177,,OPP,Chronic RfD (mg/kg/day),0.0262,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,140923-17-7",3/1/2002,MRID 44865721,NOAEL,2.62,mg/kg-day,,"Effects on liver (increased weight, increased enzyme levels and hepatocellular hyperplasia)",,,,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4188,organ weight,Both,,,,,,,,,,,,,,,,
Isophorone,78591,C9H14O,ATSDR,Chronic Oral MRL (mg/kg/day),0.2,0.9,,http://www.atsdr.cdc.gov/ToxProfiles/tp138.pdf,Sep-89,NTP 1986.  Toxicology and carcinogenesis studies of isophorone (Cas No. 78-59-1) in F344/N rats and B6C3F1 mice (gavage studies).  U.S. Department of Health and Human Services.,LOAEL,179,mg/kg/day,NA,"gastrointestinal, hepatic, and renal lesions",Yes,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,103,Weeks,liver,M,,4144,nonneoplastic histopathology,M,Dichotomous,hepatic lesions - coagulative necrosis,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,48,3,,
Isophorone,78591,C9H14O,ATSDR,Chronic Oral MRL (mg/kg/day),0.2,0.9,,http://www.atsdr.cdc.gov/ToxProfiles/tp138.pdf,Sep-89,NTP 1986.  Toxicology and carcinogenesis studies of isophorone (Cas No. 78-59-1) in F344/N rats and B6C3F1 mice (gavage studies).  U.S. Department of Health and Human Services.,LOAEL,179,mg/kg/day,NA,"gastrointestinal, hepatic, and renal lesions",Yes,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,B6C3F1,M/F,Oral gavage,,5,103,Weeks,liver,M,,4446,nonneoplastic histopathology,M,Dichotomous,hepatic lesions - hepatocytomegaly,,mg/kg-day,,mg/kg-day (ADJ),,,,0,0,,48,23,,
Isoxaben,82558507,C18H24N2O4,IRIS,RfD (mg/kg/day),0.05,1,4/1/1991,http://www.epa.gov/iris/subst/0339.htm,4/1/1991,"Elanco Products Company. 1985a. MRID No. 00164553. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,5,mg/kg/day,NA,Increased BUN; decreased serum AP and AST; decreased food consumption efficiency; increased heart/body weight,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,1706,clinical chemistry,Both,,,,,,,,,,,,,,,,
Isoxaflutole,141112290,,OPP,Chronic RfD (mg/kg/day),0.02,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2010-0979-0007,6/17/2011,MRID 43904806,NOAEL,2,mg/kg/day,NA,"liver, thyroid, ocular, and nervous system toxicity (M) and liver toxicity (F)",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral diet,,,104,Weeks,liver,Both,MOA Evaluation,3810,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Kresoxim-methyl,143390890,,OPP,Chronic RfD (mg/kg/day),0.36,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-129111_01-Sep-98.pdf,9/1/1998,MRID 43864247,NOAEL,36,mg/kg/day,NA,"decreased body weights and body weight gains and increasedgross and microscopic liver and biliary lesions, and (in females) increased incidences of liver masses",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,24,Months,liver,Both,None,4065,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Lactofen,77501634,C19H15ClF3NO7,IRIS,RfD (mg/kg/day),0.002,0.75,4/1/1991,http://www.epa.gov/iris/subst/0280.htm,4/1/1991,"PPG Industries. 1985a. MRID No. 00150343, 00150366. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",LEL,1.5,mg/kg-day,NA,Increased absolute and relative liver weight; hepatocytomegaly in males,No,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,Albino,M/F,Oral diet,,,78,Weeks,liver,M,None,3916,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Lactofen,77501634,C19H15ClF3NO7,IRIS,RfD (mg/kg/day),0.002,0.75,4/1/1991,http://www.epa.gov/iris/subst/0280.htm,4/1/1991,"PPG Industries. 1985a. MRID No. 00150343, 00150366. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",LEL,1.5,mg/kg-day,NA,Increased absolute and relative liver weight; hepatocytomegaly in males,No,None,None,No,1000,10,10,,10,,,TRUE,,,Mouse,Albino,M/F,Oral diet,,,78,Weeks,liver,M,None,1756,organ weight,M,,,,ppm,,mg/kg-d,,,,,,,,,,
Malononitrile ,109773,,PPRTV,RfD (mg/kg/day),0.0001,1.33,,http://hhpprtv.ornl.gov/issue_papers/Malononitrile.pdf,2007,"Lonza (Lonza Incorporated). 1989. P0070: 90 Day Oral (Gavage) Subchronic Toxicity Study inthe Rat with a Four Week Treatment-Free Period. Hazleton Report No. 6055-733/277. TSCASection 4 Submission. EPA Document No. 40-8915337. Fiche No. OTS0526378.",NOAEL,0.4,mg/kg-day,NA,"hepatic effects(increased relative liver weight andhepatocellular hypertrophy and vacuolization)",,,,No,3000,10,10,10,,3,,TRUE,,,Rat,CRL/CD,M/F,Oral gavage,,,90,Days,liver,M,None,3324,organ weight,M,,,,,,,,,,,,,,,,
Malononitrile ,109773,,PPRTV,RfD (mg/kg/day),0.0001,1.33,,http://hhpprtv.ornl.gov/issue_papers/Malononitrile.pdf,2007,"Lonza (Lonza Incorporated). 1989. P0070: 90 Day Oral (Gavage) Subchronic Toxicity Study inthe Rat with a Four Week Treatment-Free Period. Hazleton Report No. 6055-733/277. TSCASection 4 Submission. EPA Document No. 40-8915337. Fiche No. OTS0526378.",NOAEL,0.4,mg/kg-day,NA,"hepatic effects(increased relative liver weight andhepatocellular hypertrophy and vacuolization)",,,,No,3000,10,10,10,,3,,TRUE,,,Rat,CRL/CD,M/F,Oral gavage,,,90,Days,liver,M,None,3722,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Mandipropamid,374726622,,OPP,Chronic RfD (mg/kg/day),0.05,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-036602_01-Jan-08.pdf,1/1/2008,"Brammer, A. (2005) NOA4466510: 1 Year Oral Toxicity Study in Dogs: Final Report. Project Number: PD1273/REG, T004622/02. Unpublished study prepared by Central Toxicology Lab. (Syngenta). 506 p. MRID 46800232 (2005)",NOAEL,5,mg/kg/day,NA,liver toxicity,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral - other,,,1,Years,liver,Both,MOA Evaluation,3838,nonneoplastic histopathology,Both,,liver toxicity (increased incidence and severity of microscopic pigment in the liver),,,,,,Compound was administed via capsule.,,,,,,,,
Mandipropamid,374726622,,OPP,Chronic RfD (mg/kg/day),0.05,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-036602_01-Jan-08.pdf,1/1/2008,"Brammer, A. (2005) NOA4466510: 1 Year Oral Toxicity Study in Dogs: Final Report. Project Number: PD1273/REG, T004622/02. Unpublished study prepared by Central Toxicology Lab. (Syngenta). 506 p. MRID 46800232 (2005)",NOAEL,5,mg/kg/day,NA,liver toxicity,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral - other,,,1,Years,liver,Both,MOA Evaluation,3839,clinical chemistry,Both,,liver toxicity (increased alkaline phosphatase activity in both sexes as well as increased alanine aminotransferase activity in males),,,,,,,,,,,,,,
MCPA,94746,C9H9ClO3,OPP,Chronic RfD (mg/kg/day),0.0044,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-030501_30-Sep-04.pdf,9/30/2004,"Kirsch, P. (1986) Report: Study on the Chronic Toxicity and Oncogenic Potential of MCPA in Rats: Final Report: Project No. 71S0046/8345. Unpublished study prepared by BASF Ag. 2026 p.  MRID 40634101",NOAEL,4.4,mg/kg/day,NA,hepatotoxicity and nephrotoxicity,NA,None,None,No,1000,10,10,,,10,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,F,,3844,clinical chemistry,F,,hepatotoxicity (increased SGPT levels),,,,,,,,,,,,,,
MCPA,94746,C9H9ClO3,IRIS,RfD (mg/kg/day),0.0005,1,1/1/1991,http://www.epa.gov/iris/subst/0066.htm,1/1/1991,"Industry Task Force on MCPA Research Data. 1986a. MRID No. 00152152, 00164352. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.15,mg/kg/day,NA,Kidney and liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,1722,clinical chemistry,Both,,,,,,,,,,,,,,,,
MCPA,94746,C9H9ClO3,IRIS,RfD (mg/kg/day),0.0005,1,1/1/1991,http://www.epa.gov/iris/subst/0066.htm,1/1/1991,"Industry Task Force on MCPA Research Data. 1986a. MRID No. 00152152, 00164352. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.15,mg/kg/day,NA,Kidney and liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,1724,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
MCPA,94746,C9H9ClO3,IRIS,RfD (mg/kg/day),0.0005,1,1/1/1991,http://www.epa.gov/iris/subst/0066.htm,1/1/1991,"Industry Task Force on MCPA Research Data. 1986a. MRID No. 00152152, 00164352. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.15,mg/kg/day,NA,Kidney and liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,1723,organ weight,Both,,,,,,,,,,,,,,,,
MCPB,94815,C11H13ClO3,OPP,Chronic RfD (mg/kg/day),0.015,0.98,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-019201_27-Mar-06.pdf,3/27/2006,"Kirsch, P. (1986) Report: Study on the Chronic Toxicity and Oncogenic Potential of MCPA in Rats: Final Report: Project No. 71S0046/8345. Unpublished study prepared by BASF Ag. 2026 p.  MRID 40634101",NOAEL,4.4,mg/kg/day,NA,hepatotoxicity and nephrotoxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,MCPA,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,F,,3847,clinical chemistry,F,,hepatotoxicity (increased SGPT levels),,,,,,,,,,,,,,
MCPB,94815,C11H13ClO3,IRIS,RfD (mg/kg/day),0.01,1.2,12/1/1990,http://www.epa.gov/iris/subst/0325.htm,12/1/1990,"Rhodia, Inc. 1970b. MRID No. 00116344. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,12,mg/kg/day,NA,Increased liver and kidney weights,NA,None,None,No,1000,10,10,3,,3,,TRUE,,,Rat,CD,M/F,Oral diet,,,13,Weeks,liver,Both,None,1735,organ weight,Both,,,,,,,,,,,,,,,,
Mefenoxam,70630170,,OPP,Chronic RfD (mg/kg/day),0.074,1,,http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-113502_4-Nov-97_a.pdf,11/4/1997,MRID 00071598,NOEL,7.4,mg/kg/day,NA,Liver effects (elevated serum alkaline phosphatase and an increase in liver weight),NA,None,None,No,100,10,10,,,,,TRUE,,metalaxyl,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,3852,clinical chemistry,Both,,,,,,,,,,,,,,,,
Mefenoxam,70630170,,OPP,Chronic RfD (mg/kg/day),0.074,1,,http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-113502_4-Nov-97_a.pdf,11/4/1997,MRID 00071598,NOEL,7.4,mg/kg/day,NA,Liver effects (elevated serum alkaline phosphatase and an increase in liver weight),NA,None,None,No,100,10,10,,,,,TRUE,,metalaxyl,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,3853,organ weight,Both,,,,,,,,,,,,,,,,
Mepanipyrim,110235477,,OPP,Chronic RfD (mg/kg/day),0.073,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2004-0299-0001,10/13/2004,,NOAEL,7.3,mg/kg/day,NA,"increased incidence of clinical signs of toxicity in males, decreased body weight, body weight gain and food efficiencyin both sexes, and evidence of hepatotoxicity, nephrotoxicity, and fatty acid/lipid metabolism disruption in both sexes",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,104,Weeks,liver,Both,None,4014,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Mepanipyrim,110235477,,OPP,Chronic RfD (mg/kg/day),0.073,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2004-0299-0001,10/13/2004,,NOAEL,7.3,mg/kg/day,NA,"increased incidence of clinical signs of toxicity in males, decreased body weight, body weight gain and food efficiencyin both sexes, and evidence of hepatotoxicity, nephrotoxicity, and fatty acid/lipid metabolism disruption in both sexes",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,104,Weeks,liver,Both,None,4018,organ weight,Both,,,,,,,,,,,,,,,,
Mephosfolan,950107,,HEAST,RfD (mg/kg/day),0.00009,1,,http://epa-heast.ornl.gov/heast.php?chemical=Mephosfolan,,"1984 U.S. EPA. 1984. Health and environmental effects profile for Mephosfolan. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste, Washington, DC",NOEL,0.09,mg/kg-day,,"Altered liver and kidney weights, decreased cholinesterase activity in the blood, erythrocytes and brain",,,,No,1000,10,10,10,,,,TRUE,,,Rat,,,Oral diet,,,17,Weeks,liver,Both,None,3573,organ weight,Both,,Reduced liver weights,,,,,,Data are considered Confidential Business Information (CBI),,,,,,,,
Metalaxyl,57837191,C15H21NO4,IRIS,RfD (mg/kg/day),0.06,1.04,1/1/1995,http://www.epa.gov/iris/subst/0068.htm,1/1/1995,"Ciba-Geigy Corporation. 1981a. MRID No. 00071598. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,6.25,mg/kg/day,NA,"Increased serum alkaline phosphatase levels and increasedliver-to-brain weight ratio",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,6,Months,liver,Both,None,785,organ weight,F,Continuous,increased liver-to-brain weight ratio,,,,,,,,,,,,,,
Metalaxyl,57837191,C15H21NO4,IRIS,RfD (mg/kg/day),0.06,1.04,1/1/1995,http://www.epa.gov/iris/subst/0068.htm,1/1/1995,"Ciba-Geigy Corporation. 1981a. MRID No. 00071598. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,6.25,mg/kg/day,NA,"Increased serum alkaline phosphatase levels and increasedliver-to-brain weight ratio",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,6,Months,liver,Both,None,1436,clinical chemistry,Both,Continuous,Increased serum alkaline phosphatase levels,,,,,,,,,,,,,,
Methacrylonitrile,126987,C4H5N,IRIS,RfD (mg/kg/day),0.0001,,2/1/1996,http://www.epa.gov/iris/subst/0359.htm,2/1/1996,"Pozzani, U.C., E.R. Kinhead and J.M. King. 1968. The mammalian toxicity of methacrylonitrile. Am. Ind. Hyg. Assoc. J. 29:202-210.",NOAEL,0.34,mg/kg/day,NA,Increased SGOT and SGPT levels,Yes,Other,None,No,3000,10,10,10,,3,,TRUE,,,Dog,Beagle,M,Inhalation,7,5,90,Days,liver,Both,None,531,clinical chemistry,Both,Dichotomous,Increased SGOT and SGPT levels,,ppm,,mg/m3,,"Conversion factors:  The inhalation concentration was multiplied by 7 hours/24 hours and 5 days/7 days, by 4.3 cu.m/day (dog inhalation rate), by an absorption factor of 0.5 and divided by 12.7 kg, the assumed dog body weight.  The primary study reported dichotomized data for transitory elevation of SGOT and SGPT (Table 5).",,0,0,,3,0,,
Methanol,67561,CH4O,IRIS,RfD (mg/kg/day),0.5,1,7/1/1993,http://www.epa.gov/iris/subst/0305.htm,7/1/1993,"U.S. EPA. 1986. Rat oral subchronic toxicity study with methanol. Office of Solid Waste, Washington, DC.",NOEL,500,mg/kg/day,NA,"Increased SAP and SGPT, and decreased brain weight",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,26,clinical chemistry,M,Continuous,Increased SAP,SD,mg/kg/day,U/l,,,Data at study termination,,0,,,30,,98.2,30.72
Methanol,67561,CH4O,IRIS,RfD (mg/kg/day),0.5,1,7/1/1993,http://www.epa.gov/iris/subst/0305.htm,7/1/1993,"U.S. EPA. 1986. Rat oral subchronic toxicity study with methanol. Office of Solid Waste, Washington, DC.",NOEL,500,mg/kg/day,NA,"Increased SAP and SGPT, and decreased brain weight",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,60,clinical chemistry,M,Continuous,Increased SGPT,SD,mg/kg-day,U/l,,,Data at study termination,,0,,,30,,38.2,11.82
Methanol,67561,CH4O,IRIS,RfD (mg/kg/day),0.5,1,7/1/1993,http://www.epa.gov/iris/subst/0305.htm,7/1/1993,"U.S. EPA. 1986. Rat oral subchronic toxicity study with methanol. Office of Solid Waste, Washington, DC.",NOEL,500,mg/kg/day,NA,"Increased SAP and SGPT, and decreased brain weight",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,69,clinical chemistry,F,Continuous,Increased SAP,SD,mg/kg/day,U/l,,,Data at study termination,,0,,,30,,71.4,23.03
Methanol,67561,CH4O,IRIS,RfD (mg/kg/day),0.5,1,7/1/1993,http://www.epa.gov/iris/subst/0305.htm,7/1/1993,"U.S. EPA. 1986. Rat oral subchronic toxicity study with methanol. Office of Solid Waste, Washington, DC.",NOEL,500,mg/kg/day,NA,"Increased SAP and SGPT, and decreased brain weight",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,70,clinical chemistry,F,Continuous,Increased SGPT,SD,mg/kg/day,U/l,,,Data at study termination,,0,,,30,,42.3,13.82
Methidathion,950378,C6H11N2O4PS3,IRIS,RfD (mg/kg/day),0.001,1,8/1/1990,http://www.epa.gov/iris/subst/0341.htm,8/1/1990,"Ciba-Geigy Corporation. 1967. MRID No. 00011839. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,0.1,mg/kg/day,NA,"Liver toxicity:Enzyme changes (increased alkaline phosphatase and ALT) and histologic alterations (pigmentation (porphyrin), serositis, fibrosis, nodularity, and phlebitis).",No,,,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral gavage,,,2,Years,liver,Both,None,2097,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Methidathion,950378,C6H11N2O4PS3,IRIS,RfD (mg/kg/day),0.001,1,8/1/1990,http://www.epa.gov/iris/subst/0341.htm,8/1/1990,"Ciba-Geigy Corporation. 1967. MRID No. 00011839. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,0.1,mg/kg/day,NA,"Liver toxicity:Enzyme changes (increased alkaline phosphatase and ALT) and histologic alterations (pigmentation (porphyrin), serositis, fibrosis, nodularity, and phlebitis).",No,,,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral gavage,,,2,Years,liver,Both,None,2096,clinical chemistry,Both,,,,,,,,,,,,,,,,
Methyl Acetate,79209,,HEAST,RfD (mg/kg/day),1,1.16,,http://epa-heast.ornl.gov/heast.php?chemical=Methyl Acetate,,"Toxicity Research Laboratory. 1986. Rat oral subchronic toxicity study with Methanol. Sponsored by Office of Solid Waste, U.S. EPA, Washington, DC",NOEL,1156,mg/kg-day,NA,Increased alkaline phosphatase and SGPT in the liver,NA,None,None,No,1000,10,10,10,,,,TRUE,,Methanol,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,Both,None,3574,clinical chemistry,Both,Continuous,Increased alkaline phosphatase and SGPT in the liver,,,,,,The NOEL for methanol was corrected for moleular weight differences to give a NOEL of 1156 mg/kg-day for methyl acetate. No dose-response data in EPA 1986 document. See data in record for methanol,,,,,,,,
Metribuzin,21087649,C8H14N4OS,IRIS,RfD (mg/kg/day),0.025,1,1/1/1995,http://www.epa.gov/iris/subst/0075.htm,1/1/1995,"Mobay Chemical Corporation. 1974a. MRID No. 00061260, 00139397. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,2.5,mg/kg/day,NA,"Liver and kidney effects, decreased body weight, mortality",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,MOA Data,1111,clinical chemistry,Both,Continuous,liver effects,,,,,,"alterations in ""related clinical tests""",,,,,,,,
Metribuzin,21087649,C8H14N4OS,IRIS,RfD (mg/kg/day),0.025,1,1/1/1995,http://www.epa.gov/iris/subst/0075.htm,1/1/1995,"Mobay Chemical Corporation. 1974a. MRID No. 00061260, 00139397. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,2.5,mg/kg/day,NA,"Liver and kidney effects, decreased body weight, mortality",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,MOA Data,1110,nonneoplastic histopathology,Both,Dichotomous,liver effects,,,,,,histopathologic findings of liver,,,,,,,,
Metribuzin,21087649,C8H14N4OS,IRIS,RfD (mg/kg/day),0.025,1,1/1/1995,http://www.epa.gov/iris/subst/0075.htm,1/1/1995,"Mobay Chemical Corporation. 1974a. MRID No. 00061260, 00139397. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,2.5,mg/kg/day,NA,"Liver and kidney effects, decreased body weight, mortality",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,MOA Data,1109,organ weight,Both,Continuous,liver effects,,,,,,increased relative liver weight,,,,,,,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4110,nonneoplastic histopathology,F,Dichotomous,necrosis of hepatocytes,,ppm,,mg/kg-day,,"results of second, higher dose study in females",,0,0,,52,4,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4107,nonneoplastic histopathology,F,Dichotomous,fatty metamorphosis,,ppm,,mg/kg-day,,"results of second, higher dose study in females",,0,0,,52,14,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4109,nonneoplastic histopathology,F,Dichotomous,necrosis of hepatocytes,,ppm,,mg/kg-day,,results of first study in females,,0,0,,52,3,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,3604,nonneoplastic histopathology,M,Dichotomous,fatty metamorphosis,,ppm,,mg/kg-day,,,,0,0,,52,10,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4104,nonneoplastic histopathology,F,Dichotomous,fatty metamorphosis,,ppm,,mg/kg-day,,results of first study in females,,0,0,,52,11,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4108,nonneoplastic histopathology,M,Dichotomous,necrosis of hepatocytes,,ppm,,mg/kg-day,,,,0,0,,52,7,,
Mirex,2385855,C10Cl12,ATSDR,Chronic Oral MRL (mg/kg/day),0.0008,0.94,,http://www.atsdr.cdc.gov/toxprofiles/tp66.pdf,1995,"NTP. 1990. National Toxicology Program. Toxicology and carcinogenesis studies of mirex (CAS No. 2385-85-5) in F344/N rats (feed studies). Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program. NTP TR 3 13.",NOAEL,0.075,mg/kg-day,NA,hepatic damage (focal and centrilobular necrosis; fatty metamorphosis; dilation of sinusoids),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,None,4452,nonneoplastic histopathology,M,Dichotomous,Dilation of sinusoids (angiectasis),,ppm diet,,mg/kg-day,,,,0,0,,52,20,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,4385,nonneoplastic histopathology,F,Dichotomous,fatty metamorphosis,,ppm,,mg/kg-day,,data from second study,,0,0,,52,14,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,1118,nonneoplastic histopathology,M,Dichotomous,Liver cytomegaly,,ppm,,mg-kg/day,,Incidence data are from Table 5 in primary report.,,0,0,,52,2,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,2178,nonneoplastic histopathology,F,Dichotomous,fatty metamorphosis,,ppm,,mg/kg/day,,Incidence data are from Table 5 in primary report (first study),,0,0,,52,11,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,2179,nonneoplastic histopathology,M,Dichotomous,angiectasis,,ppm,,mg/kg/day,,Incidence data are from Table 5 in primary report,,0,0,,52,20,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,4386,nonneoplastic histopathology,F,Dichotomous,hepatocytomegaly,,ppm,,mg/kg-day,,data from second study,,0,0,,52,4,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,2176,nonneoplastic histopathology,F,Dichotomous,Liver cytomegaly,,ppm,,mg/kg/day,,Incidence data are from Table 5 in primary report (first study),,0,0,,52,4,,
Mirex,2385855,C10Cl12,IRIS,RfD (mg/kg/day),0.0002,1.17,10/1/1992,http://www.epa.gov/iris/subst/0251.htm,10/1/1992,NTP (National Toxicology Program). 1990. Toxicology and Carcinogenesis Studies of MIREX (CAS No. 2385-85-5) in F344/N Rats (Feed Studies). NTP TR 313.,NOAEL,0.07,mg/kg/day,NA,"Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles",NA,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,104,Weeks,liver,Both,None,2177,nonneoplastic histopathology,M,Dichotomous,fatty metamorphosis,,ppm,,mg/kg/day,,Incidence data are from Table 5 in primary report,,0,0,,52,10,,
"N,N-Diethyl-2-(1-Naphthalenyloxy)Propanamide",15299997,C17H21NO2,OPP,Chronic RfD (mg/kg/day),0.12,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-103001_1-Sep-05.pdf,9/1/2005,"Pettersen, J.; Walberg, J. (1992) Two-Year Chronic Toxicity/Oncogenicity Study with R-7465 inRats: Final Report: Lab Project Number: T-13276. Unpublished study prepared by Ciba-Geigy Corp. 1085 p. MRID 42189102 Hodge, M. (1993) Two-year Chronic Toxicity/ Oncogenicity Study with R-7465 (Napropamide) inRats: Supplement to T-13276 Histopathology Report and Study Discussion: Addendum to MRID 42189102: Lab Project Number: CTL/P/4137: PR0873. Unpublished study prepared by Zeneca Central Toxicology Lab. 1416 p.  MRID 43068801",NOAEL,12,mg/kg/day,NA,Decreased weight gain in females and an increased incidence of liver lesions in males,NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,M,,3861,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,3557,organ weight,M,Continuous,increased liver weight (absolute),SE,ppm diet,g,mg/kg-day,,,,0,0,,30,,2,0.1
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,3558,organ weight,F,Continuous,increased liver weight (absolute),SE,ppm diet,g,mg/kg-day,,,,0,0,,30,,1.6,0.1
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,3559,organ weight,M,Continuous,increased liver weight (relative to body weight),SE,ppm diet,% BW,mg/kg-day,,,,0,0,,30,,5.3,0.1
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,3560,organ weight,F,Continuous,increased liver weight (relative to body weight),SE,ppm diet,% BW,mg/kg-day,,,,0,0,,30,,5.1,0.2
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,4418,clinical chemistry,F,Continuous,Increased serum ALT,,,,,,Clinical chemistry data reported in primary reference for high dose only.,,,,,,,,
"N,N'-Dimethylformamide",68122,C3H7NO,PPRTV,RfD (mg/kg/day),0.1,0.96,,http://hhpprtv.ornl.gov/issue_papers/Dimethylformamide.pdf,9/27/2007,"Becci, P.J., K.A. Voss, W.D. Johnson, et al. 1983. Subchronic feeding study of N,N-dimethylformamide in rats and mice. J. Am. Coll. Toxicol. 2:371-378.",NOAEL,96,mg/kg-day,NA,"increased liver weight, hepatocytomegaly and serum ALT in high-dose mice",NA,None,None,Yes,1000,10,10,10,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,119,Days,liver,Both,MOA Data,4419,nonneoplastic histopathology,Both,Dichotomous,Increased incidence hepatocytomegaly,,,,,,"Hepatocytomegaly observed in ""majority"" of high dose males and females; incidences not reported in primary reference.",,,,,,,,
Nickel,7440020,Ni,IRIS,RfD (mg/kg/day),0.02,0.83,12/1/1996,http://www.epa.gov/iris/subst/0271.htm,12/1/1996,"Ambrose, A.M., D.S. Larson, J.R. Borzelleca and G.R. Hennigar, Jr. 1976. Long-term toxicologic assessment of nickel in rats and dogs. J. Food Sci. Technol. 13: 181-187.",NOAEL,5,mg/kg/day,NA,Decreased body and organ weights,No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,2,Years,liver,F,None,1412,organ weight,F,Continuous,decreased organ weight (lower liver-to-body weight ratio),SD,ppm,g/kg bw,mg/kg/day,,Data are from Table 3 in primary report.,,0,0,,4,,36.6,5.2
Nicosulfuron,111991094,,OPP,Chronic RfD (mg/kg/day),1.25,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0372-0004,6/11/2012,"Cook, J.C. 1989.  Chronic Toxicity Study with IN V9360-27 - One-year Feeding Study with Dogs. Lab Project Number 390-89.  Unpublished study prepared Dupont/Haskell Laboratory.  MRID 413601",NOEL,125,mg/kg/day,NA,Decreased body weight gain and increased relative liver and kidney weights in males,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,M,None,3865,organ weight,M,Continuous,increased relative liver weight,SD,ppm,%,,,Dose-response data are from Table 3 in the Data Evaluation Record,,0,,,5,,2.8,0.4
Nitrapyrin,1929824,,OPP,Chronic RfD (mg/kg/day),0.03,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-069203_29-Apr-05.pdf,4/29/2005,"Barna-Lloyd, T.; Szabo, J.; Rachunek, B. (1989) Nitrapyrin: Chronic (One-Year) Dietary Toxicity Study in Dogs: Lab Project Number: K-031304-029. Unpublished study prepared by The Dow Chemical Co., Lake Jackson Research Center. 142 p.  MRID 41345401",NOAEL,3,mg/kg/day,NA,liver effects,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,52,Weeks,liver,Both,None,3867,clinical chemistry,Both,,liver effects (increased alakline phosphatase),,,,,,,,,,,,,,
Nitrapyrin,1929824,,OPP,Chronic RfD (mg/kg/day),0.03,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-069203_29-Apr-05.pdf,4/29/2005,"Barna-Lloyd, T.; Szabo, J.; Rachunek, B. (1989) Nitrapyrin: Chronic (One-Year) Dietary Toxicity Study in Dogs: Lab Project Number: K-031304-029. Unpublished study prepared by The Dow Chemical Co., Lake Jackson Research Center. 142 p.  MRID 41345401",NOAEL,3,mg/kg/day,NA,liver effects,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,52,Weeks,liver,Both,None,3868,organ weight,Both,,liver effects (increased absolute and relative liver weight),,,,,,,,,,,,,,
Nitrapyrin,1929824,,OPP,Chronic RfD (mg/kg/day),0.03,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-069203_29-Apr-05.pdf,4/29/2005,"Barna-Lloyd, T.; Szabo, J.; Rachunek, B. (1989) Nitrapyrin: Chronic (One-Year) Dietary Toxicity Study in Dogs: Lab Project Number: K-031304-029. Unpublished study prepared by The Dow Chemical Co., Lake Jackson Research Center. 142 p.  MRID 41345401",NOAEL,3,mg/kg/day,NA,liver effects,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,52,Weeks,liver,Both,None,3869,nonneoplastic histopathology,Both,,liver effects (hypertrophy),,,,,,,,,,,,,,
"Nitrotoluene, o- ",88722,,PPRTV,RfD (mg/kg/day),0.0009,1.04,,http://hhpprtv.ornl.gov/issue_papers/Nitrotolueneo.pdf,2008,NTP (National Toxicology Program). 2002a. Toxicology and carcinogenesis studies of o-nitrotoluene (CAS No. 88-72-2) in F344/N rats and B6C3F1 mice (feed studies). NTP TR 504. NIH Publication No. 01-4438. Online. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr504.pdf.,BMDL,0.94,mg/kg-day,10% ER,"bone marrow hyperplasia in male ratsliver cell necrosis of in male mice",No,None,None,No,1000,10,10,,,10,,TRUE,,,Mouse,B6C3F1,M/F,Oral diet,,,24,Months,liver,Both,MOA Data,4045,nonneoplastic histopathology,M,Dichotomous,liver cell necrosis,,ppm,,mg/kg-day,,,,0,0,,60,1,,
Norflurazon,27314132,C12H9ClF3N3O,OPP,Chronic RfD (mg/kg/day),0.015,1.05,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-105801_2-Mar-99.pdf,3/2/1999,"Klotzsche, C.; Carpy, S.; De Rijk; et al. (1973) San 9789 (Zorial), 6 Months Feeding Study in Dogs: Bericht Nr. 56/73. (Unpublished study received May 13, 1974 under 4F1506; prepared by Sandoz-Wander, Inc., Homestead, FL; CDL: 093995-A).  MRID 00111618",NOEL,1.58,mg/kg/day,NA,increased absolute and relative liver weight and increased cholesterol,NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,,3870,organ weight,Both,,,,,,,,,,,,,,,,
Norflurazon,27314132,C12H9ClF3N3O,IRIS,RfD (mg/kg/day),0.04,0.94,4/1/1991,http://www.epa.gov/iris/subst/0082.htm,4/1/1991,"Sandoz-Wander, Inc. 1973. MRID No. 00111618. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,3.75,mg/kg/day,NA,Liver and thyroid effects,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,822,nonneoplastic histopathology,Both,Dichotomous,liver effects,,,,,,congestion and swelling of hepatocytes,,,,,,,,
Norflurazon,27314132,C12H9ClF3N3O,IRIS,RfD (mg/kg/day),0.04,0.94,4/1/1991,http://www.epa.gov/iris/subst/0082.htm,4/1/1991,"Sandoz-Wander, Inc. 1973. MRID No. 00111618. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,3.75,mg/kg/day,NA,Liver and thyroid effects,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,6,Months,liver,Both,None,823,organ weight,Both,Continuous,liver effects,,,,,,increased liver weights,,,,,,,,
Octogen,2691410,C4H8N8O8,IRIS,RfD (mg/kg/day),0.05,1,2/1/1993,http://www.epa.gov/iris/subst/0311.htm,2/1/1993,"U.S. Department of Defense. 1985a. AD-A171 601. Available from Defense Technical Information Center. Write to Documents, Cameron Station, Alexandria, VA 22314, or call (703)274-7633.",NOAEL,50,mg/kg/day,NA,Hepatic lesions,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,13,Weeks,liver,M,None,828,nonneoplastic histopathology,M,Dichotomous,hepatic lesions,,mg/kg/day,,,,"Hepatic lesions included enlarged centrilobular cells with pale nuclei and dark cytoplasm, dilation of sinusoids, and necrosis.  Incidence data are from pg. 18 of primary report.",,0,,,20,0,,
Oryzalin,19044883,C12H18N4O6S,IRIS,RfD (mg/kg/day),0.05,1,2/1/1991,http://www.epa.gov/iris/subst/0083.htm,2/1/1991,"Eli Lilly Company. 1986. MRID No. 46624800. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,5,mg/kg/day,NA,"Increases in serum cholesterol, alkaline phosphatase, and relative liver and kidney weights, and decreases in alanine transaminase and adrenal weights",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral gavage,,,1,Years,liver,Both,None,1923,clinical chemistry,Both,Continuous,Increases in serum cholesterol and alkaline phosphatase; decrease in alanine transaminase,,,,,,,,,,,,,,
Oryzalin,19044883,C12H18N4O6S,IRIS,RfD (mg/kg/day),0.05,1,2/1/1991,http://www.epa.gov/iris/subst/0083.htm,2/1/1991,"Eli Lilly Company. 1986. MRID No. 46624800. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,5,mg/kg/day,NA,"Increases in serum cholesterol, alkaline phosphatase, and relative liver and kidney weights, and decreases in alanine transaminase and adrenal weights",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral gavage,,,1,Years,liver,Both,None,1143,organ weight,Both,Continuous,Increase in relative liver weights,,,,,,,,,,,,,,
Oxadiazon,19666309,C15H18Cl2N2O3,IRIS,RfD (mg/kg/day),0.005,1,3/1/1991,http://www.epa.gov/iris/subst/0253.htm,3/1/1991,"Rhone-Poulenc Company. 1981. MRID No. 00149003. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.5,mg/kg/day,NA,Increased levels of serum proteins and increased liver weights,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,1924,clinical chemistry,Both,Continuous,Increased levels of serum proteins,,,,,,,,,,,,,,
Oxadiazon,19666309,C15H18Cl2N2O3,IRIS,RfD (mg/kg/day),0.005,1,3/1/1991,http://www.epa.gov/iris/subst/0253.htm,3/1/1991,"Rhone-Poulenc Company. 1981. MRID No. 00149003. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.5,mg/kg/day,NA,Increased levels of serum proteins and increased liver weights,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,1149,organ weight,Both,Continuous,increased liver weights,,,,,,,,,,,,,,
Oxyfluorfen,42874033,C15H11ClF3NO4,IRIS,RfD (mg/kg/day),0.003,1,3/1/1991,http://www.epa.gov/iris/subst/0084.htm,3/1/1991,"Rohm and Haas Company. 1977a. MRID No. 00037939. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.3,mg/kg/day,NA,Increased absolute liver weight and nonneoplastic lesions,No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,20,Months,liver,Both,None,836,organ weight,Both,Continuous,Increased absolute liver weight,,,,,,,,,,,,,,
Oxyfluorfen,42874033,C15H11ClF3NO4,IRIS,RfD (mg/kg/day),0.003,1,3/1/1991,http://www.epa.gov/iris/subst/0084.htm,3/1/1991,"Rohm and Haas Company. 1977a. MRID No. 00037939. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.3,mg/kg/day,NA,Increased absolute liver weight and nonneoplastic lesions,No,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,20,Months,liver,Both,None,837,nonneoplastic histopathology,Both,Dichotomous,nonneoplastic lesions,,,,,,"necrosis, regeneration, and hyperplastic nodules",,,,,,,,
Paclobutrazol,76738620,C15H20ClN3O,IRIS,RfD (mg/kg/day),0.013,0.96,1/1/1992,http://www.epa.gov/iris/subst/0182.htm,1/1/1992,"ICI Americas, Inc. 1983a. MRID No. 00132689; HED Doc. No. 003813. Available from EPA. Write to FOI, EPA, Washington, DC 20460",NOAEL,12.5,mg/kg-d,,"Elevated liver weights, serum cholesterol, hepatic  aminopyrine N-demethylase activity, and alanine transaminase levels",,,,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,90,Days,liver,F,None,1917,clinical chemistry,Both,,,,,,,,,,,,,,,,
Paclobutrazol,76738620,C15H20ClN3O,IRIS,RfD (mg/kg/day),0.013,0.96,1/1/1992,http://www.epa.gov/iris/subst/0182.htm,1/1/1992,"ICI Americas, Inc. 1983a. MRID No. 00132689; HED Doc. No. 003813. Available from EPA. Write to FOI, EPA, Washington, DC 20460",NOAEL,12.5,mg/kg-d,,"Elevated liver weights, serum cholesterol, hepatic  aminopyrine N-demethylase activity, and alanine transaminase levels",,,,No,1000,10,10,10,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,90,Days,liver,F,None,1916,organ weight,Both,,,,,,,,,,,,,,,,
Pendimethalin,40487421,C13H19N3O4,IRIS,RfD (mg/kg/day),0.04,1.04,2/1/1991,http://www.epa.gov/iris/subst/0292.htm,2/1/1991,"American Cyanamid Co. 1979. MRID No. 00058657. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,12.5,mg/kg/day,NA,"Increase in serum alkaline phosphatase and liver weight, andhepatic lesions",No,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,2,Years,liver,Both,None,1503,clinical chemistry,Both,Continuous,increase in serum alkaline phosphatase,,,,,,,,,,,,,,
Pendimethalin,40487421,C13H19N3O4,IRIS,RfD (mg/kg/day),0.04,1.04,2/1/1991,http://www.epa.gov/iris/subst/0292.htm,2/1/1991,"American Cyanamid Co. 1979. MRID No. 00058657. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,12.5,mg/kg/day,NA,"Increase in serum alkaline phosphatase and liver weight, andhepatic lesions",No,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,2,Years,liver,Both,None,863,nonneoplastic histopathology,Both,Dichotomous,increase in hepatic lesions,,,,,,lesions consisting of inflammation and hemosiderosis,,,,,,,,
Pendimethalin,40487421,C13H19N3O4,IRIS,RfD (mg/kg/day),0.04,1.04,2/1/1991,http://www.epa.gov/iris/subst/0292.htm,2/1/1991,"American Cyanamid Co. 1979. MRID No. 00058657. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,12.5,mg/kg/day,NA,"Increase in serum alkaline phosphatase and liver weight, andhepatic lesions",No,None,None,No,300,10,10,,,3,,TRUE,,,Dog,Beagle,M/F,Oral - other,,7,2,Years,liver,Both,None,862,organ weight,Both,Continuous,Increased liver weight,,,,,,,,,,,,,,
Pentachlorobenzene,608935,C6HCl5,IRIS,RfD (mg/kg/day),0.0008,1.04,3/1/1998,http://www.epa.gov/iris/subst/0085.htm,3/1/1998,"Linder, R., T. Scotti, J. Goldstein, K. McElroy and D. Walsh. 1980. Acute and subchronic toxicity of pentachlorobenzene. J. Environ. Pathol. Toxicol. 4: 183-196.",LOAEL,8.3,mg/kg/day,NA,Liver and kidney toxicity,No,None,None,No,10000,10,10,10,10,,,TRUE,,,Rat,Unspecified,M/F,Oral - other,,,1,Generations,liver,Both,None,867,organ weight,F,Continuous,liver toxicity (increased liver:body weight ratio),SE,ppm,g/100 g bw,,,F0 females were exposed before and during breeding through gestations and lactation (180 days).  Dose response data are from Table 5 in primary report.  Male and female offspring also demonstrate increased liver: weight body weight ratios at weaning.,,0,0,,10,,3.08,0.05
Pentachloronitrobenzene,82688,C6Cl5NO2,IRIS,RfD (mg/kg/day),0.003,0.83,1/1/1992,http://www.epa.gov/iris/subst/0254.htm,1/1/1992,"Olin Mathieson Chemical Corporation. 1968a. MRID No. 00001667, 00083328, 00114201; HED Doc. No. 005188. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.75,mg/kg/day,NA,Liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,,M/F,Oral diet,,,2,Years,liver,Both,None,1776,organ weight,Both,,,,,,,,,,,,,,,,
Pentachloronitrobenzene,82688,C6Cl5NO2,IRIS,RfD (mg/kg/day),0.003,0.83,1/1/1992,http://www.epa.gov/iris/subst/0254.htm,1/1/1992,"Olin Mathieson Chemical Corporation. 1968a. MRID No. 00001667, 00083328, 00114201; HED Doc. No. 005188. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.75,mg/kg/day,NA,Liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,,M/F,Oral diet,,,2,Years,liver,Both,None,1777,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Pentachloronitrobenzene,82688,C6Cl5NO2,IRIS,RfD (mg/kg/day),0.003,0.83,1/1/1992,http://www.epa.gov/iris/subst/0254.htm,1/1/1992,"Olin Mathieson Chemical Corporation. 1968a. MRID No. 00001667, 00083328, 00114201; HED Doc. No. 005188. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.75,mg/kg/day,NA,Liver toxicity,NA,None,None,No,300,10,10,,,3,,TRUE,,,Dog,,M/F,Oral diet,,,2,Years,liver,Both,None,1778,clinical chemistry,Both,,,,,,,,,,,,,,,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1787,nonneoplastic histopathology,M,Dichotomous,liver pigmentation,,mg/kg/day,incidence,,,,,0,,,4,0,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1791,nonneoplastic histopathology,M,Dichotomous,chronic inflammation,,mg/kg/day,incidence,,,,,0,,,4,0,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1793,nonneoplastic histopathology,F,Dichotomous,chronic inflammation,,mg/kg/day,incidence,,,,,0,,,4,2,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1790,nonneoplastic histopathology,M,Dichotomous,cytoplasmic vacuolization,,mg/kg/day,incidence,,,,,0,,,4,1,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1789,nonneoplastic histopathology,F,Dichotomous,liver pigmentation,,mg/kg/day,incidence,,,,,0,,,4,0,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1783,organ weight,Both,Continuous,increases in relative and absolute (females only) weight,,,,,,Dose response data not reported for this endpoint,,,,,,,,
Pentachlorophenol,87865,C6HCl5O,IRIS,RfD (mg/kg/day),0.005,1,9/30/2010,http://www.epa.gov/iris/subst/0086.htm,9/30/2010,"Mecler, F. (1996) Fifty-two week repeated dose chronic oral study of pentachlorophenol administered via capsule to dogs.  Study conducted by TSI Mason Laboratories, Worcester, MA; TSI Report #ML-PTF-J31-95-94. Submitted to the Pentachlorophenol Task Force, c/o SRA International, Inc., Washington, DC. U.S. Environmental Protection Agency, Washington, DC; MRID 439827-01.  Unpublished report.",LOAEL,1.5,mg/kg/day,Other,Hepatotoxicity,No,None,None,Yes,300,10,10,,3,,,TRUE,,,Dog,Beagle,M/F,Oral - other,,,52,Weeks,liver,Both,MOA Evaluation,1782,clinical chemistry,Both,Continuous,Increased serum enzyme activity,,,,,,Chemical was administered orally in gelatin capsules. Dose response data not reported for this endpoint.,,,,,,,,
Permethrin,52645531,C21H20Cl2O3,IRIS,RfD (mg/kg/day),0.05,1,1/1/1992,http://www.epa.gov/iris/subst/0185.htm,1/1/1992,"FMC Corporation. 1977. MRID No. 00057105, 00070950, 00110686. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,5,mg/kg/day,NA,Increased liver weights,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Long-Evans,M/F,Oral diet,,,104,Weeks,liver,Both,,873,organ weight,Both,Continuous,Increased liver weights,,,,,,,,,,,,,,
Phosmet,732116,C11H12NO4PS2,IRIS,RfD (mg/kg/day),0.02,1,1/1/1992,http://www.epa.gov/iris/subst/0091.htm,1/1/1992,"Stauffer Chemical Company. 1967. MRID No. 00062651, 00075419, 00076436, 00080431, 00080556; HED Doc. No. 001999. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,2,mg/kg/day,NA,"Reduced body weight (males), liver cell vacuolation, cholinesterase inhibition",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,879,nonneoplastic histopathology,Both,Continuous,,,,,,,,,,,,,,,
Phosmet,732116,C11H12NO4PS2,IRIS,RfD (mg/kg/day),0.02,1,1/1/1992,http://www.epa.gov/iris/subst/0091.htm,1/1/1992,"Stauffer Chemical Company. 1967. MRID No. 00062651, 00075419, 00076436, 00080431, 00080556; HED Doc. No. 001999. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,2,mg/kg/day,NA,"Reduced body weight (males), liver cell vacuolation, cholinesterase inhibition",No,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,879,nonneoplastic histopathology,Both,Dichotomous,Liver cell vacuolization,,,,,,moderate,,,,,,,,
Picloram,1918021,C6H3Cl3N2O2,OPP,Chronic RfD (mg/kg/day),0.2,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,1918-02-1",1/3/1986,"MRID 00155940: Landry, T.; Johnson, K.; Cieszlak, F.; et al. (1986) Picloram: A Two-year Dietary Chronic Toxicity-oncogenicity Study in Fischer 344 Rats. Unpublished study prepared by Dow Chemical U.S.A. 1243 p.",NOEL,20,mg/kg-day,NA,increase in size and altered tinctorial properties of centrilobular hepatocytes in males and females,No,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,,3920,nonneoplastic histopathology,M,Dichotomous,increase in size and altered tinctorial properties of centrilobular hepatocytes,,mg/kg-day,,,,data at 24 months,,0,,,50,2,,
Picloram,1918021,C6H3Cl3N2O2,OPP,Chronic RfD (mg/kg/day),0.2,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,1918-02-1",1/3/1986,"MRID 00155940: Landry, T.; Johnson, K.; Cieszlak, F.; et al. (1986) Picloram: A Two-year Dietary Chronic Toxicity-oncogenicity Study in Fischer 344 Rats. Unpublished study prepared by Dow Chemical U.S.A. 1243 p.",NOEL,20,mg/kg-day,NA,increase in size and altered tinctorial properties of centrilobular hepatocytes in males and females,No,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,,3921,nonneoplastic histopathology,F,Dichotomous,increase in size and altered tinctorial properties of centrilobular hepatocytes,,mg/kg-day,,,,data at 24 months,,0,,,50,2,,
Picloram,1918021,C6H3Cl3N2O2,IRIS,RfD (mg/kg/day),0.07,1,5/1/1992,http://www.epa.gov/iris/subst/0256.htm,5/1/1992,"Dow Chemical Company. 1982a. MRID No. 000110534, 00110535; HED Doc. No. 003954. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,7,mg/kg/day,NA,Increased liver weights,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,6,Months,liver,Both,None,1161,organ weight,M,Continuous,Increased liver weights,,,,,,increased absolute and relative liver weights,,,,,,,,
Piperonyl butoxide,51036,,OPP,Chronic RfD (mg/kg/day),0.155,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,51-03-6",6/14/2006,"MRID: 42926001, 42926002. Could not find full citations",NOAEL,15.5,mg/kg-day,NA,"decrease in body weight gain, and increases in alkaline phosphatase activity, liver weight and hepatocellular hypertrophy",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4202,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Piperonyl butoxide,51036,,OPP,Chronic RfD (mg/kg/day),0.155,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,51-03-6",6/14/2006,"MRID: 42926001, 42926002. Could not find full citations",NOAEL,15.5,mg/kg-day,NA,"decrease in body weight gain, and increases in alkaline phosphatase activity, liver weight and hepatocellular hypertrophy",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4201,organ weight,Both,,,,,,,,,,,,,,,,
Piperonyl butoxide,51036,,OPP,Chronic RfD (mg/kg/day),0.155,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,51-03-6",6/14/2006,"MRID: 42926001, 42926002. Could not find full citations",NOAEL,15.5,mg/kg-day,NA,"decrease in body weight gain, and increases in alkaline phosphatase activity, liver weight and hepatocellular hypertrophy",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,1,Years,liver,Both,None,4200,clinical chemistry,Both,,,,,,,,,,,,,,,,
Polybrominated Biphenyls,59536651,,HEAST,RfD (mg/kg/day),0.000007,1,,http://epa-heast.ornl.gov/heast.php?chemical=Polybrominated Biphenyls,1989,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",LOAEL,0.07,mg/kg/day,NA,"increased liver weight, hepatic lesions",Yes,None,None,No,10000,10,10,10,10,,,TRUE,,commercial hexabromobiphenyl Firemaster FF-1,Rat,Fischer 344,M/F,Oral gavage,,5,25,Weeks,liver,Both,MOA Data,3659,organ weight,F,Continuous,increased liver weight,SE,mg/kg/day,g,mg/kg/day (ADJ),,"These results are from analysis immediately following the 25-week exposure period. Note: Section 8.2.2. of the U.S. EPA 1989 HEED contains a unit error, the RfD is listed as 0.007 mg/kg/day instead of 0.007 ug/kg/day.  Dose-response data are from Table 9 of the primary report.",,0,0,,10,,6.2,0.12
Polybrominated Biphenyls,59536651,,HEAST,RfD (mg/kg/day),0.000007,1,,http://epa-heast.ornl.gov/heast.php?chemical=Polybrominated Biphenyls,1989,"NTP (National Toxicology Program). 1983. Carcinogenesis studies of Polybrominated Biphenyl mixture in F344/N rats and B6C3F1 mice (gavage studies). Firemaster FF-1. Case No. 67774-32-7. NTP, Research Triangle Park, NC.",LOAEL,0.07,mg/kg/day,NA,"increased liver weight, hepatic lesions",Yes,None,None,No,10000,10,10,10,10,,,TRUE,,commercial hexabromobiphenyl Firemaster FF-1,Rat,Fischer 344,M/F,Oral gavage,,5,25,Weeks,liver,Both,MOA Data,3475,nonneoplastic histopathology,M,Dichotomous,hepatic lesions (foamy hepatocytes),,,,,,Noted in males at doses (adjusted) of 0.07 mg/kg-day and above.,,,,,,,,
Prallethrin,23031369,,OPP,Chronic RfD (mg/kg/day),0.05,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-1009-0005,5/10/2012,,NOAEL,5,mg/kg/day,NA,"trembling, rapid eye blinking, hunched posture, panting, increased serum cholesterol, phopholipids, and alkaline phosphatase activity",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,Unspecified,Oral - other,,,chronic,Duration,liver,Both,MOA Evaluation,3892,clinical chemistry,Both,,,,,,,,,,,,,,,,
Primisulfuron-methyl,86209510,,OPP,Chronic RfD (mg/kg/day),0.25,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-0844-0004,3/7/2012,,NOAEL,25,mg/kg/day,NA,"decreased erthyrocytes, hemoglobin, and hematocrit; increased platelets; increased relative liver weights; increased incidence of pale livers, vacuolar liver changes, and thyroid hyperplasia",,None,None,No,100,10,10,,,,,TRUE,,,Dog,,Unspecified,,,,1,Years,liver,Both,None,3894,organ weight,Both,,,,,,,,,,,,,,,,
Primisulfuron-methyl,86209510,,OPP,Chronic RfD (mg/kg/day),0.25,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-0844-0004,3/7/2012,,NOAEL,25,mg/kg/day,NA,"decreased erthyrocytes, hemoglobin, and hematocrit; increased platelets; increased relative liver weights; increased incidence of pale livers, vacuolar liver changes, and thyroid hyperplasia",,None,None,No,100,10,10,,,,,TRUE,,,Dog,,Unspecified,,,,1,Years,liver,Both,None,3895,gross pathology,Both,,,,,,,,,,,,,,,,
Primisulfuron-methyl,86209510,,OPP,Chronic RfD (mg/kg/day),0.25,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-0844-0004,3/7/2012,,NOAEL,25,mg/kg/day,NA,"decreased erthyrocytes, hemoglobin, and hematocrit; increased platelets; increased relative liver weights; increased incidence of pale livers, vacuolar liver changes, and thyroid hyperplasia",,None,None,No,100,10,10,,,,,TRUE,,,Dog,,Unspecified,,,,1,Years,liver,Both,None,3896,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Prochloraz,67747095,C15H16Cl3N3O2,IRIS,RfD (mg/kg/day),0.009,1,1/1/1989,http://www.epa.gov/iris/subst/0378.htm,1/1/1989,"FBC Limited. 1981. MRID No. 40267708; HED Doc. No. 004456. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.9,mg/kg/day,NA,"Increase in SAP and liver weights, liver histopathology",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,104,Weeks,liver,Both,None,1580,clinical chemistry,Both,Continuous,Increase in SAP,,,,,,,,,,,,,,
Prochloraz,67747095,C15H16Cl3N3O2,IRIS,RfD (mg/kg/day),0.009,1,1/1/1989,http://www.epa.gov/iris/subst/0378.htm,1/1/1989,"FBC Limited. 1981. MRID No. 40267708; HED Doc. No. 004456. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.9,mg/kg/day,NA,"Increase in SAP and liver weights, liver histopathology",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,104,Weeks,liver,Both,None,890,organ weight,Both,Continuous,Increase in liver weights,,,,,,,,,,,,,,
Prochloraz,67747095,C15H16Cl3N3O2,IRIS,RfD (mg/kg/day),0.009,1,1/1/1989,http://www.epa.gov/iris/subst/0378.htm,1/1/1989,"FBC Limited. 1981. MRID No. 40267708; HED Doc. No. 004456. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.9,mg/kg/day,NA,"Increase in SAP and liver weights, liver histopathology",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,104,Weeks,liver,Both,None,891,nonneoplastic histopathology,Both,Dichotomous,Liver histopathology,,,,,,,,,,,,,,
Prometryne,7287196,C10H19N5S,OPP,Chronic RfD (mg/kg/day),0.04,0.94,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-080805_1-sep-95.pdf,9/1/1995,"Woodard, M.W.; Cockrell, K.O.; Lobdell, B.J.; et al. (1965) Prometryne Safety Evaluation by Oral Administration to Rats for 104 Weeks and to Dogs for 106 Weeks. (Unpublished study received Oct 7, 1977 under 100-566; prepared by Woodard Research Corp., submitted by Ciba-Geigy Corp., Greensboro, N.C.; CDL:231965-C) MRID 00042794",NOEL,3.75,mg/kg/day,NA,"bone marrow atrophy and degenerative changes in theliver and kidneys.",NA,None,None,Yes,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,106,Weeks,liver,M,,3905,nonneoplastic histopathology,M,,slight to moderate degenerative changes in the liver,,ppm,,mg/kg/day,,Dose-response data are from Tox Review No. 005665.,,0,0,,3,0,,
Prometryne,7287196,C10H19N5S,IRIS,RfD (mg/kg/day),0.004,0.94,7/1/1992,http://www.epa.gov/iris/subst/0258.htm,7/1/1992,"Ciba-Geigy Corporation. 1965a. MRID No. 00042794; HED Doc. No. 001830, 003500, 005665, 005666. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,3.75,mg/kg/day,NA,Liver and kidney degeneration and bone marrow atrophy,No,None,None,No,1000,10,10,,,10,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,106,Weeks,liver,Both,None,897,nonneoplastic histopathology,Both,Dichotomous,liver degeneration,,,,,,degenerative hepatic changes,,,,,,,,
Pronamide,23950585,C12H11Cl2NO,OPP,Chronic RfD (mg/kg/day),0.08,1.06,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/tred_PC-101701_1-Aug-02.pdf,8/1/2002,"MRID 41714001, 41714002",NOAEL,8.46,mg/kg/day,NA,"increased relative liver weight and non-neoplastic histological changes in the liver, thyroid, and ovaries",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,,3907,organ weight,Both,,increased relative liver weight,,,,,,,,,,,,,,
Pronamide,23950585,C12H11Cl2NO,OPP,Chronic RfD (mg/kg/day),0.08,1.06,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/tred_PC-101701_1-Aug-02.pdf,8/1/2002,"MRID 41714001, 41714002",NOAEL,8.46,mg/kg/day,NA,"increased relative liver weight and non-neoplastic histological changes in the liver, thyroid, and ovaries",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,,M/F,Oral diet,,,2,Years,liver,Both,,3908,nonneoplastic histopathology,Both,,non-neoplastic histological changes in the liver (centrilobular hypertrophy and hepatocellular eosinophilic alteration),,,,,,,,,,,,,,
Propachlor,1918167,C11H14ClNO,OPP,Chronic RfD (mg/kg/day),0.054,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-019101_1-Sep-98.pdf,9/1/1998,MRID 44168301,NOEL,5.4,mg/kg/day,NA,stomach lesions in males and liver lesions in both sexes,,None,None,No,100,10,10,,,,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,24,Months,liver,Both,,3912,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Propachlor,1918167,C11H14ClNO,IRIS,RfD (mg/kg/day),0.013,1.02,1/1/1992,http://www.epa.gov/iris/subst/0096.htm,1/1/1992,"Monsanto Company. 1964a. MRID No. 00093270; HED Doc. No. 001381. Available from EPA. Write to FOI, EPA, Washington DC 20460.",NOEL,13.3,mg/kg/day,NA,"Decreased weight gain, food consumption; increased relative liver weights.",No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,90,Days,liver,Both,None,1176,organ weight,Both,Continuous,Increased relative liver weights,,,,,,,,,,,,,,
Propargyl Alcohol,107197,C3H4O,IRIS,RfD (mg/kg/day),0.002,0.83,1/1/1994,http://www.epa.gov/iris/subst/0468.htm,1/1/1994,"U.S. EPA. 1987. Rat oral subchronic toxicity study with propargyl alcohol. Study conducted by the Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.",NOAEL,5,mg/kg/day,NA,Renal and hepatotoxicity,No,None,None,No,3000,10,10,10,,3,,TRUE,,,Rat,Unspecified,M/F,Oral - other,,,13,Weeks,liver,Both,None,2116,organ weight,Both,Continuous,increased liver weights,,,,,,,,,,,,,,
Propargyl Alcohol,107197,C3H4O,IRIS,RfD (mg/kg/day),0.002,0.83,1/1/1994,http://www.epa.gov/iris/subst/0468.htm,1/1/1994,"U.S. EPA. 1987. Rat oral subchronic toxicity study with propargyl alcohol. Study conducted by the Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.",NOAEL,5,mg/kg/day,NA,Renal and hepatotoxicity,No,None,None,No,3000,10,10,10,,3,,TRUE,,,Rat,Unspecified,M/F,Oral - other,,,13,Weeks,liver,Both,None,342,nonneoplastic histopathology,Both,Dichotomous,Hepatocytic megalocytosis with a less prominent proliferation of the bile ducts and cytoplasmic vacuolation of hepatocytes observed in all rats at the POD,,mg/kg/day,,,,,,,,,,,,
Propargyl Alcohol,107197,C3H4O,IRIS,RfD (mg/kg/day),0.002,0.83,1/1/1994,http://www.epa.gov/iris/subst/0468.htm,1/1/1994,"U.S. EPA. 1987. Rat oral subchronic toxicity study with propargyl alcohol. Study conducted by the Toxicity Research Laboratory for the Office of Solid Waste, Washington, DC.",NOAEL,5,mg/kg/day,NA,Renal and hepatotoxicity,No,None,None,No,3000,10,10,10,,3,,TRUE,,,Rat,Unspecified,M/F,Oral - other,,,13,Weeks,liver,Both,None,342,nonneoplastic histopathology,Both,Continuous,,,,,,,,,,,,,,,
Propiconazole,60207901,C15H17Cl2N3O2,OPP,Chronic RfD (mg/kg/day),0.1,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-122101_18-Jul-06.pdf,7/18/2006,"Hunter, B.; Scholey, D.; Haywood, R.; et al. (1982) CGA 64 250: Long-term Feeding Study in Mice: CBG/196/81827. Final rept. (Unpublished study received Jul 21, 1983 under 100-641; prepared by Huntingdon Research Centre, Eng., submitted by Ciba-Geigy Corp., Greensboro, NC; CDL:250784-A; 250785; 250786)  MRID 00129570Gillis, J.; Tisdel, M. (1990) Ciba-Geigy Corp. Phase 3 Summary of MRID 00129570 and Related MRIDs 00084153, 00151503, 00130844. Long-Term Feeding Study in Mice: Propiconazole: Study # 196/81827. 14 p.  MRID 93194037",NOAEL,10,mg/kg/day,NA,"Liver toxicity (increased liver weight in males, and increase in liver lesions)",NA,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,24,Months,liver,Both,,3925,organ weight,M,,,,,,,,,,,,,,,,
Propiconazole,60207901,C15H17Cl2N3O2,OPP,Chronic RfD (mg/kg/day),0.1,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/reregistration/red_PC-122101_18-Jul-06.pdf,7/18/2006,"Hunter, B.; Scholey, D.; Haywood, R.; et al. (1982) CGA 64 250: Long-term Feeding Study in Mice: CBG/196/81827. Final rept. (Unpublished study received Jul 21, 1983 under 100-641; prepared by Huntingdon Research Centre, Eng., submitted by Ciba-Geigy Corp., Greensboro, NC; CDL:250784-A; 250785; 250786)  MRID 00129570Gillis, J.; Tisdel, M. (1990) Ciba-Geigy Corp. Phase 3 Summary of MRID 00129570 and Related MRIDs 00084153, 00151503, 00130844. Long-Term Feeding Study in Mice: Propiconazole: Study # 196/81827. 14 p.  MRID 93194037",NOAEL,10,mg/kg/day,NA,"Liver toxicity (increased liver weight in males, and increase in liver lesions)",NA,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,24,Months,liver,Both,,3926,nonneoplastic histopathology,Both,,liver lesions  (masses/raised areas/swellings/nodular areas),,,,,,,,,,,,,,
Prosulfuron,94125345,,OPP,Chronic RfD (mg/kg/day),0.053,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2011-1010-0005,4/17/2012,MRID 42685230,NOAEL,5.3,mg/kg/day,NA,"decreased body-weight gain and feed efficiency, hematological findings and hepatotoxicity",NA,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,subchronic,Duration,liver,Both,MOA Data,3931,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Prothioconazole,178928706,,OPP,Chronic RfD (mg/kg/day),0.001,1.1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-113961_14-Mar-07.pdf,3/11/2007,"Schladt, L.; Hartmann, E.; Rinke, M. (1999) SXX 0665: Combined Study on Chronic Toxicity and Carcinogrnicity in Wistar Rats (Dietary Administration Over 2 Years). Project Number: PH/29419, T7037250, 109447. Unpublished study prepared by Bayer Ag Inst. of Toxicology. 1854 p.  MRID 46246342",NOAEL,1.1,mg/kg/day,NA,liver histopathology (hepatocellular vacuolation and fatty change),NA,None,None,No,1000,10,10,,,10,,TRUE,,Prothioconazole-Desthio,Rat,Wistar,M/F,Oral diet,,,2,Years,liver,Both,,3932,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Pymetrozine,123312890,,OPP,Chronic RfD (mg/kg/day),0.0038,0.99,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-101103_01-Aug-00.pdf,8/1/2000,MRID  44024951,NOAEL,0.377,mg/kg/day,NA,Liver hypertrophy and pathology,,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,,,,chronic,Duration,liver,Both,MOA Evaluation,3933,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Pyraclostrobin,175013180,,OPP,Chronic RfD (mg/kg/day),0.034,1,,http://www.epa.gov/opp00001/chem_search/cleared_reviews/csr_PC-099100_21-Aug-02_a.pdf,8/21/2002,"Mellert, W., Deckardt, K., Gembardt, Chr., et al. (1999) BAS 500 F- Carcinogenicity Study in Wistar Rats Administration in Diet for 24 months.  BASF Aktiengesellschaft, Department of Toxicology, Ludwigshafen, Germany.  Laboratory Project ID.: 82S0494/96086, November 22, 1999. MRID 45118331.  Unpublished.",NOAEL,3.4,mg/kg/day,NA,"decreased body weight/body weight gain, kidney tubular casts and atrophy in both sexes; increased incidence of liver necrosis and erosion/ulceration of the glandular stomach and forestomach in males",NA,None,None,Yes,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,104,Weeks,liver,M,None,3936,nonneoplastic histopathology,M,Dichotomous,liver necrosis,,ppm,,mg/kg/day,,Dose response data are from page 14 of the Data Evaluation Record,,0,0,,50,1,,
Pyraflufen ethyl,129630199,,OPP,Chronic RfD (mg/kg/day),0.2,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2007-0366-0005,4/17/2008,MRID No. 45282916,NOAEL,20,mg/kg/day,NA,liver toxicity at interim sacrifice,NA,None,None,No,100,10,10,,,,,TRUE,,,Mouse,Unspecified,M/F,Oral diet,,,78,Weeks,liver,Both,None,,,,,,,,,,,,,,,,,,,
Pyrasulfotole,365400119,,OPP,Chronic RfD (mg/kg/day),0.01,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-000692_01-Aug-07.pdf,8/1/2007,"Wason, S. (2006) 6-Month Toxicity, Chronic Toxicity and Carcinogenicity Study of AE 0317309 in the Wistar Rat by Dietary Administration. Project Number: SA/02453, K04/004, K03/046. Unpublished study prepared by Bayer Cropscience. 3775 p.  MRID 46801910",NOAEL,1,mg/kg/day,NA,"corneal opacity, neovascularization of the cornea, inflammation of the cornea, regenerative corneal hyperplasia, corneal atrophy, and/or retinal atrophy (both sexes); hepatocellular hypertrophy along with increased serum cholesterol (males)",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,chronic,,liver,M,MOA Evaluation,3943,nonneoplastic histopathology,M,,,,,,,,chronic toxicity and carcinogenicity test,,,,,,,,
Pyrasulfotole,365400119,,OPP,Chronic RfD (mg/kg/day),0.01,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-000692_01-Aug-07.pdf,8/1/2007,"Wason, S. (2006) 6-Month Toxicity, Chronic Toxicity and Carcinogenicity Study of AE 0317309 in the Wistar Rat by Dietary Administration. Project Number: SA/02453, K04/004, K03/046. Unpublished study prepared by Bayer Cropscience. 3775 p.  MRID 46801910",NOAEL,1,mg/kg/day,NA,"corneal opacity, neovascularization of the cornea, inflammation of the cornea, regenerative corneal hyperplasia, corneal atrophy, and/or retinal atrophy (both sexes); hepatocellular hypertrophy along with increased serum cholesterol (males)",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,chronic,,liver,M,MOA Evaluation,3944,clinical chemistry,M,,,,,,,,,,,,,,,,
Pyridine,110861,C5H5N,IRIS,RfD (mg/kg/day),0.001,1,6/1/1989,http://www.epa.gov/iris/subst/0261.htm,6/1/1989,"U.S. EPA. 1986. Pyridine. 90-Day subchronic oral toxicity in rats. Sponsored by Office of Solid Waste, Washington, DC.",NOAEL,1,mg/kg/day,NA,Increased liver Weight,No,None,None,No,1000,10,10,10,,,,TRUE,,,Rat,Sprague-Dawley,M/F,Oral gavage,,7,90,Days,liver,F,None,911,organ weight,F,Continuous,increased liver weight (liver-to-body weight ratio),SD,mg/kg/day,% body weight,,,Dose-response data are from Table 11 in primary report.,,0,,,4,,3.042,0.232
Pyrimethanil,53112280,,OPP,Chronic RfD (mg/kg/day),0.17,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2008-0609-0005,7/17/2008,MRID 43301612-3 (1993),NOAEL,17,mg/kg/day,NA,"decreased bodyweight gains, increased serum cholesterol and GGT, increased relative liver/body-weight ratios, and necropsy and histopathological findings in the liver and thyroid",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,4029,organ weight,Both,,,,,,,,,,,,,,,,
Pyrimethanil,53112280,,OPP,Chronic RfD (mg/kg/day),0.17,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2008-0609-0005,7/17/2008,MRID 43301612-3 (1993),NOAEL,17,mg/kg/day,NA,"decreased bodyweight gains, increased serum cholesterol and GGT, increased relative liver/body-weight ratios, and necropsy and histopathological findings in the liver and thyroid",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,4030,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Pyrimethanil,53112280,,OPP,Chronic RfD (mg/kg/day),0.17,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2008-0609-0005,7/17/2008,MRID 43301612-3 (1993),NOAEL,17,mg/kg/day,NA,"decreased bodyweight gains, increased serum cholesterol and GGT, increased relative liver/body-weight ratios, and necropsy and histopathological findings in the liver and thyroid",NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,4031,clinical chemistry,Both,,,,,,,,,,,,,,,,
Pyroxsulam,422556089,,OPP,Chronic RfD (mg/kg/day),1,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-108702_27-Feb-08.pdf,2/27/2008,"Johnson, K.; Dryzga, M.; Yano, B. (2005) XDE-742: 18-Month Dietary Oncogenicity Study in CD-1 Mice. Project Number: 031015. Unpublished study prepared by Dow Chemical, USA. 1504 p.  MRID 46908406",NOAEL,100,mg/kg/day,NA,increased absolute and relative liver weights and increased incidence of hepatocellular clear cell foci of alteration,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,18,Months,liver,M,None,3954,nonneoplastic histopathology,M,Dichotomous,hepatocellular clear cell foci of alteration,,mg/kg/day,,,,Dose response data are from Table 5 in the Data Evaluation Record.,,0,,,50,0,,
Pyroxsulam,422556089,,OPP,Chronic RfD (mg/kg/day),1,1,,http://www.epa.gov/opp00001/chem_search/reg_actions/registration/fs_PC-108702_27-Feb-08.pdf,2/27/2008,"Johnson, K.; Dryzga, M.; Yano, B. (2005) XDE-742: 18-Month Dietary Oncogenicity Study in CD-1 Mice. Project Number: 031015. Unpublished study prepared by Dow Chemical, USA. 1504 p.  MRID 46908406",NOAEL,100,mg/kg/day,NA,increased absolute and relative liver weights and increased incidence of hepatocellular clear cell foci of alteration,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,18,Months,liver,M,None,3953,organ weight,M,,,,,,,,Data Evaluation Record reports liver weights without variability measures,,,,,,,,
Quizalofop-Ethyl (Assure),76578148,C19H17ClN2O4,IRIS,RfD (mg/kg/day),0.009,1,9/26/1988,http://www.epa.gov/iris/subst/0335.htm,9/26/1988,"E.I. du Pont de Nemours and Company, Inc. 1985. MRID No. 00146682. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.9,mg/kg-d,NA,Liver cell enlargement,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,CD,M/F,Oral diet,,7,104,Weeks,liver,M,None,2104,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Ronnel,299843,,HEAST,RfD (mg/kg/day),0.05,,,http://epa-heast.ornl.gov/heast.php?chemical=Ronnel,,"McCollister D.D., F. Oyen and V.K. Rowe. 1959. Toxicological studies of o-o-Dimethyl-o-(2,4,5-trichlorophenyl)phosphothioate (Ronnel) in laboratory animals. J Agric Food Chem. 7: 689.",NOAEL,5,mg/kg-day,NA,Liver effects,,,,No,100,,,,,,,FALSE,,,Rat,Unspecified,M/F,Oral diet,,,2,Years,liver,Both,None,3589,,,,Liver effects,,,,,,Dose-response data not reported in primary source,,,,,,,,
Silvex,93721,C9H7Cl3O3,IRIS,RfD (mg/kg/day),0.008,0.94,9/7/1988,http://www.epa.gov/iris/subst/0323.htm,9/7/1988,"Mullison, W.R. 1966. Some toxicological aspects of silvex. In: Proc. 19th Ann. Meet., Southern Weed Conference, Jacksonville, FL. p. 420-435. Gehring, P.J. and J.E. Betso. 1978. Phenoxy acids: Effects and fate in mammals. In: Chlorinated Phenoxy Acids and Their Dioxins, Vol. 27, C. Ramel, Ed. Ecol. Bull., Stockholm. p. 122-133.",NOEL,0.75,mg/kg/day,NA,Histopathological changes in the liver,No,None,None,No,100,10,10,,,,,TRUE,,Kurosal SL (formulation contains the potassium salt of silvex equivalent to approximately 53% of the acid from of silvex),Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,None,1823,nonneoplastic histopathology,M,Dichotomous,Histopathological changes in the liver,,,,,,Changes included mild degenertion and necrosis of hepatocytes with slight fibroblastic proliferation.  Incidence data were not included in the primary reports.,,,,,,,,
Sodium Dodecylbenzene Sulfonate,25155300,,OPP,Chronic RfD (mg/kg/day),0.5,,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,25155-30-0",3/23/2006,"Yoneyama et al. 1976 Ann. Rep. Tokyo Metrop. Res. Lab.Public Health 27(2):105-112",NOAEL,85,mg/kg/day,NA,"decreased body weight gain, and serum/biochemical and enzymatic changes in the liver and kidney (weight of evidence from 3 studies)",No,None,None,No,,,,,,,,,,,Rat,Wistar,M/F,Oral drinking water,,,9,Months,liver,Both,None,4212,clinical chemistry,Both,,,,,,,,,,,,,,,,
Spiroxamine,118134308,,OPP,Chronic RfD (mg/kg/day),0.025,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,118134-30-8",6/18/2010,MIRD 45090214,NOAEL,2.5,mg/kg/day,NA,"hepatomegaly, cataracts, and decreased albumin in males and females, liver discoloration and decreased triglycerides in females, and increased ALT in males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,F,None,4229,gross pathology,Both,,,,,,,,,,,,,,,,
Spiroxamine,118134308,,OPP,Chronic RfD (mg/kg/day),0.025,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,118134-30-8",6/18/2010,MIRD 45090214,NOAEL,2.5,mg/kg/day,NA,"hepatomegaly, cataracts, and decreased albumin in males and females, liver discoloration and decreased triglycerides in females, and increased ALT in males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,F,None,4228,clinical chemistry,Both,,,,,,,,,,,,,,,,
Spiroxamine,118134308,,OPP,Chronic RfD (mg/kg/day),0.025,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,118134-30-8",6/18/2010,MIRD 45090214,NOAEL,2.5,mg/kg/day,NA,"hepatomegaly, cataracts, and decreased albumin in males and females, liver discoloration and decreased triglycerides in females, and increased ALT in males",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,F,None,4227,nonneoplastic histopathology,F,,,,,,,,,,,,,,,,
Stirofos (Tetrachlorovinphos),961115,C10H9Cl4O4P,IRIS,RfD (mg/kg/day),0.03,1.04,1/1/1992,http://www.epa.gov/iris/subst/0194.htm,1/1/1992,"Shell Chemical Company. 1968. MRID No. 00077819; HED Doc. No. 002607. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,3.13,mg/kg-d,NA,"Reduced body weight gain, increased liver and kidney weights, and RBC ChE inhibition",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,7,104,Weeks,liver,Both,None,2107,organ weight,Both,,,,,,,,,,,,,,,,
Styrene,100425,C8H8,IRIS,RfD (mg/kg/day),0.2,1,9/1/1990,http://www.epa.gov/iris/subst/0104.htm,9/1/1990,"Quast, J.F., C.G. Humiston, R.Y. Kalnins, et al. 1979. Results of a toxicity study of monomeric styrene administered to beagle dogs by oral intubation for 19 months. Toxicology Research Laboratory, Health and Environmental Sciences, DOW Chemical Co., Midland, MI. Final Report.",NOAEL,200,mg/kg/day,NA,Red blood cell and liver effects,No,None,None,Yes,1000,10,10,10,,,,TRUE,,,Dog,Beagle,M/F,Oral gavage,,,560,Days,liver,Both,None,2541,nonneoplastic histopathology,F,Dichotomous,"liver effects (incidence of ""moderate"" iron deposits, identified by Prussian blue staining)",,mg/kg/day,,,,Incidence data are from Table 30,,0,,,4,0,,
Styrene,100425,C8H8,IRIS,RfD (mg/kg/day),0.2,1,9/1/1990,http://www.epa.gov/iris/subst/0104.htm,9/1/1990,"Quast, J.F., C.G. Humiston, R.Y. Kalnins, et al. 1979. Results of a toxicity study of monomeric styrene administered to beagle dogs by oral intubation for 19 months. Toxicology Research Laboratory, Health and Environmental Sciences, DOW Chemical Co., Midland, MI. Final Report.",NOAEL,200,mg/kg/day,NA,Red blood cell and liver effects,No,None,None,Yes,1000,10,10,10,,,,TRUE,,,Dog,Beagle,M/F,Oral gavage,,,560,Days,liver,Both,None,265,nonneoplastic histopathology,M,Dichotomous,"liver effects (incidence of ""moderate"" iron deposits, identified by Prussian blue staining)",,mg/kg/day,,,,Incidence data are from Table 29,,0,,,4,0,,
"Sulfonylbis(4-chlorobenzene), 1,1'- ",80079,,PPRTV,RfD (mg/kg/day),0.0008,0.99,,http://hhpprtv.ornl.gov/issue_papers/Sulfonylbis4chlorobenzene11.pdf,2009,"Chhabra, R.S., R.A. Herbert, J.R. Buchner et al. 2001. Toxicology and carcinogenesis studies of p,p-dichlorodiphenyl sulfone in rats and mice. Toxicol. Sci. 60:2837.NTP (National Toxicology Program). 2001. NTP Technical Report on the Toxicology and Carcinogenesis Studies of p,p-Dichlorodiphenyl Sulfone (CAS No. 80-07-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program, Research Triangle Park, NC. September 2001. NTP TR501.",BMDL,0.79,mg/kg-day,10% ER,bile duct hyperplasia,No,None,None,Yes,1000,10,10,,,10,,TRUE,,,Rat,Fischer 344,M/F,Oral diet,,,2,Years,liver,Both,MOA Data,3354,nonneoplastic histopathology,F,Dichotomous,bile duct hyperplasia,,ppm,,mg/kg-day,,female data were used as the POD,,0,0,,50,5,,
Tebufenozide,112410238,,OPP,Chronic RfD (mg/kg/day),0.018,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,112410-23-8",8/28/2008,"MRID 42931203 (1992), 42931204 (1992)",NOAEL,1.8,mg/kg-day,NA,"growth retardation, alterations in hematology parameters, changes in organ weights, and histopathological lesions in the bone, spleen, and liver",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,4251,organ weight,Both,,,,,,,,,,,,,,,,
Tebufenozide,112410238,,OPP,Chronic RfD (mg/kg/day),0.018,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,112410-23-8",8/28/2008,"MRID 42931203 (1992), 42931204 (1992)",NOAEL,1.8,mg/kg-day,NA,"growth retardation, alterations in hematology parameters, changes in organ weights, and histopathological lesions in the bone, spleen, and liver",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,,M/F,Oral diet,,,1,Years,liver,Both,None,4252,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Tepraloxydim,149979419,,OPP,Chronic RfD (mg/kg/day),0.05,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,149979-41-9",6/7/2011,"MRID 4446720 1Mellert, W.; Deckardt, K.; Kittel, B. et al. (1997) Report Reg.No. 191819: Carcinogenicity Study in Wistar Rats: Administration in the Diet for 24 Months: Lab Project Number: 82S0268/92033: 97/10642: PCP01749. Unpublished study prepared by BASF Aktienges",NOAEL,5,mg/kg-day,,liver microscopic lesions (eosinophilic foci) in males,,,,No,100,10,10,,,,,TRUE,,,Rat,Wistar,M/F,,,,104,Weeks,liver,M,None,4262,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Terbacil,5902512,C9H13ClN2O2,IRIS,RfD (mg/kg/day),0.013,0.96,9/1/1989,http://www.epa.gov/iris/subst/0105.htm,9/1/1989,"E.I. duPont de Nemours & Company, Inc. 1967a. MRID No. 00060851. Available from EPA. Write to FOI, EPA, Washington DC. 20460.",NOEL,1.25,mg/kg/day,NA,Increase in thyroid/ body weight ratio; slight increase in liver weights; elevated alkaline phosphatase,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,2,Years,liver,Both,None,956,organ weight,Both,,,,,,,,,,,,,,,,
Terrazole,2593159,,OPP,Chronic RfD (mg/kg/day),0.016,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2593-15-9",Sep-00,"MRID 40747901: Trutter, J. (1988) Oncogenicity Study in Rats with Terrazole Technical: HLA Study No. 798-210. Unpublished study prepared by Hazleton Laboratories America, Inc. 3112 p.",NOAEL,4.8,mg/kg-day,NA,"Increased absolute and relative liver weights, renal tubule cell karyomegaly, hepatocytomegaly and spongiosis hepatis",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,,,,,,2,Years,liver,Both,None,4265,organ weight,Both,,,,,,,,,,,,,,,,
Terrazole,2593159,,OPP,Chronic RfD (mg/kg/day),0.016,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,2593-15-9",Sep-00,"MRID 40747901: Trutter, J. (1988) Oncogenicity Study in Rats with Terrazole Technical: HLA Study No. 798-210. Unpublished study prepared by Hazleton Laboratories America, Inc. 3112 p.",NOAEL,4.8,mg/kg-day,NA,"Increased absolute and relative liver weights, renal tubule cell karyomegaly, hepatocytomegaly and spongiosis hepatis",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,,,,,,2,Years,liver,Both,None,4266,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Tetraethyl Lead,78002,C8H20Pb,IRIS,RfD (mg/kg/day),0.0000001,1.2,3/1/1988,http://www.epa.gov/iris/subst/0109.htm,3/1/1988,"Schepers, G.W. 1964. Tetraethyl and tetramethyl lead. Arch. Environ. Health. 8: 277-295.",LOAEL,0.0012,mg/kg/day,NA,Histopathology of liver and thymus,Yes,None,None,No,10000,10,10,10,10,,,TRUE,,,Rat,CD,M/F,Oral gavage,,5,20,Weeks,liver,Both,None,1850,nonneoplastic histopathology,Both,Dichotomous,histopathology of liver,,,,,,Incidence data not presented in primary report.  Table 14 indicates that severity of lesions increased with increasing dose.,,,,,,,,
Thiabendazole,148798,,OPP,Chronic RfD (mg/kg/day),0.1,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,148-79-8",2-Nov,Primary source?,NOAEL,10,mg/kg-day,NA,decreased body weight gains and and histopathological changes in the liver and thyroid,No,None,None,No,100,10,10,,,,,TRUE,,,Rat,,,Oral diet,,,2,Years,liver,Both,None,4271,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Thiacloprid,111988499,,OPP,Chronic RfD (mg/kg/day),0.004,1,,"http://iaspub.epa.gov/apex/pesticides/f?p=CHEMICALSEARCH:21:0::NO:101,21:P21_NAME_VAL,P21_CODE_VAL,P21_SHOW_ALL_VAL,P21_IS_SHOW,P21_SMILES,P21_TOLERANCE,P21_IDENTICAL_STRUCTURE,P21_SUB_SUPER,P21_STEREOCHEMISTRY,P21_IDENTITY_ACTIVE,P21_SUBSUPERSTRUCT_ACTIVE,P21_MATCH_OTHER:\\,111988-49-9",11/6/2003,"MRID 44927712: Bomhard, E.; Popp, A.; Ruhl-Fehlert, C. (1998) YRC 2894: Combined Chronic Toxicity/Carcinogenicity Study in Wistar Rats Dietary Administration in Wistar Rats Over 2 Years: Lab Project Number: 27480: T7059067: 108359. Unpublished study prepared by Bayer A",NOAEL,1.2,mg/kg-day,NA,"hepatic hypertrophy and cytoplasmic change, thyroid hypertrophy, retinal degeneration.",No,None,None,No,300,10,10,,,3,,TRUE,,,Rat,Wistar,M/F,Oral diet,,,2,Years,liver,Both,None,4273,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Triallate,2303175,C10H16Cl3NOS,IRIS,RfD (mg/kg/day),0.013,0.98,1/1/1992,http://www.epa.gov/iris/subst/0195.htm,1/1/1992,"Monsanto Company. 1979. MRID No. 00029455; HED Doc. No. 005525. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1.275,mg/kg/day,NA,"Increased hemosiderin deposition, serum alkaline phosphatase, and liver weight in females",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,24,Months,liver,F,None,1274,organ weight,F,Dichotomous,,,,,,,,,,,,,,,
Triallate,2303175,C10H16Cl3NOS,IRIS,RfD (mg/kg/day),0.013,0.98,1/1/1992,http://www.epa.gov/iris/subst/0195.htm,1/1/1992,"Monsanto Company. 1979. MRID No. 00029455; HED Doc. No. 005525. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1.275,mg/kg/day,NA,"Increased hemosiderin deposition, serum alkaline phosphatase, and liver weight in females",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,24,Months,liver,F,None,1274,organ weight,F,Continuous,increased liver weight,,,,,,,,,,,,,,
Triallate,2303175,C10H16Cl3NOS,IRIS,RfD (mg/kg/day),0.013,0.98,1/1/1992,http://www.epa.gov/iris/subst/0195.htm,1/1/1992,"Monsanto Company. 1979. MRID No. 00029455; HED Doc. No. 005525. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOAEL,1.275,mg/kg/day,NA,"Increased hemosiderin deposition, serum alkaline phosphatase, and liver weight in females",No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,24,Months,liver,F,None,1931,clinical chemistry,Both,Continuous,increased serum alkaline phosphatase,,,,,,,,,,,,,,
Triasulfuron,82097505,C14H16ClN5O5S,OPP,Chronic RfD (mg/kg/day),0.01,1.2,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2012-0115-0004,2/28/2012,"Morrow, L. (1988).  Oncogenicity study in mice with CGA-131036 technical, unpublished report prepared by American biogenics Corporation, submitted to the Agency by Ciba-Geigy Corporation, report number 410-1863, dated April 9, 1988.  MRID No.  40728316, HED Doc. No. 007582",NOAEL,1.2,mg/kg/day,NA,centrilobular hepatomegaly,NA,None,None,No,100,10,10,,,,,TRUE,,,Mouse,Unspecified,M/F,Oral diet,,,chronic,Duration,liver,M,,3956,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Triasulfuron,82097505,C14H16ClN5O5S,IRIS,RfD (mg/kg/day),0.01,1.2,1/1/1991,http://www.epa.gov/iris/subst/0510.htm,1/1/1991,"Ciba-Geigy Corporation. 1988. MRID No. 40728316. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,1.2,mg/kg/day,NA,Centrilobular hepatocytomegaly in males,NA,None,None,No,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,2,Years,liver,M,None,1858,nonneoplastic histopathology,M,,,,,,,,,,,,,,,,
Trichloroacetic Acid,76039,C2HCl3O2,IRIS,RfD (mg/kg/day),0.02,0.9,9/30/2011,http://www.epa.gov/iris/subst/0655.htm,9/30/2011,"DeAngelo, AB; Daniel, FB; Wong, DM; George, MH. (2008) The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J Toxicol Environ Health A 71: 1056-1068. http://dx.doi.org/10.1080/15287390802111952.",BMDL,18,mg/kg-d,10% ER,Hepatocellular necrosis,No,None,None,Yes,1000,10,10,,,10,,TRUE,,,Mouse,B6C3F1,M,Oral drinking water,,,60,Weeks,liver,Both,MOA Evaluation,1932,nonneoplastic histopathology,Both,Continuous,Hepatocellular necrosis,,g/L TCA,Severity,mg/kg-d,,Hepatic necrosis was observed in the middle- and high-dose group at all time points and was reported to be most severe at 3045 weeks.,,0,0,,10,,0,
Trichloroacetic Acid,76039,C2HCl3O2,IRIS,RfD (mg/kg/day),0.02,0.9,9/30/2011,http://www.epa.gov/iris/subst/0655.htm,9/30/2011,"DeAngelo, AB; Daniel, FB; Wong, DM; George, MH. (2008) The induction of hepatocellular neoplasia by trichloroacetic acid administered in the drinking water of the male B6C3F1 mouse. J Toxicol Environ Health A 71: 1056-1068. http://dx.doi.org/10.1080/15287390802111952.",BMDL,18,mg/kg-d,10% ER,Hepatocellular necrosis,No,None,None,Yes,1000,10,10,,,10,,TRUE,,,Mouse,B6C3F1,M,Oral drinking water,,,60,Weeks,liver,Both,MOA Evaluation,1932,nonneoplastic histopathology,Both,Dichotomous,Hepatocellular necrosis,,g/L TCA,Incidence (%),mg/kg-d,,Hepatic necrosis was observed in the middle- and high-dose group at all time points and was reported to be most severe at 3045 weeks.,,0,0,,10,0,,
Triflumizole,68694111,,OPP,Chronic RfD (mg/kg/day),0.035,1,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2007-0312-0008,4/1/2009,MRID 00156545,LOAEL,3.5,mg/kg/day,NA,liver toxicity (eosinophilic foci in male rats and fatty vacuolation and inflammation and necrosis in female rats),NA,None,None,No,100,10,10,,,,,TRUE,,,Rat,Unspecified,M/F,Oral diet,,,chronic,Duration,liver,Both,None,4035,nonneoplastic histopathology,Both,,,,,,,,,,,,,,,,
Trifluralin,1582098,C13H16F3N3O4,IRIS,RfD (mg/kg/day),0.0075,1,7/1/1989,http://www.epa.gov/iris/subst/0268.htm,7/1/1989,"Hoechst Aktiengesellschaft. 1984a. MRID No. 00151908. Available from EPA. Write to FOI, EPA, Washington, DC 20460.",NOEL,0.75,mg/kg/day,NA,Increased liver weights; increase in methemoglobin,No,None,None,No,100,10,10,,,,,TRUE,,,Dog,Beagle,M/F,Oral diet,,,12,Months,liver,Both,None,1280,organ weight,M,,,,,,,,,,,,,,,,
Triticonazole,131983727,,OPP,Chronic RfD (mg/kg/day),0.17,1.02,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2009-0276-0009,6/10/2009,"Eddie, M. (1994) RPA400727: Oncogenicity study by dietary administration to CD-1 mice for 78 weeks.  Pharmaco-LSR Ltd., Eye, Suffolk, IP23 7PX, England.  Laboratory report no.: 93/RH446/0778, May 13, 1994, MRID 44802108. Unpublished.",NOAEL,17.4,mg/kg/day,NA,decreased body weight gain and liver toxicity,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,72,Weeks,liver,Both,None,4040,organ weight,M,Continuous,increased absolute liver weight,SD,ppm,g,mg/kg/day,,Dose response data are from Table 4 in the Data Evaluation Record.  Animal numbers at Week 79 were determined from Table 2.  Relative liver weight was also increased in the high-dose males by 26%.,,0,0,,33,,2.88,0.85
Triticonazole,131983727,,OPP,Chronic RfD (mg/kg/day),0.17,1.02,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2009-0276-0009,6/10/2009,"Eddie, M. (1994) RPA400727: Oncogenicity study by dietary administration to CD-1 mice for 78 weeks.  Pharmaco-LSR Ltd., Eye, Suffolk, IP23 7PX, England.  Laboratory report no.: 93/RH446/0778, May 13, 1994, MRID 44802108. Unpublished.",NOAEL,17.4,mg/kg/day,NA,decreased body weight gain and liver toxicity,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,72,Weeks,liver,Both,None,4041,organ weight,F,Continuous,increased absolute liver weight,SD,ppm,g,mg/kg/day,,Dose response data are from Table 4 in the Data Evaluation Record.  Animal numbers at Week 79 were determined from Table 2.  Relative liver weight was also increased in the high-dose males by 29%.,,0,0,,38,,1.9,0.33
Triticonazole,131983727,,OPP,Chronic RfD (mg/kg/day),0.17,1.02,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2009-0276-0009,6/10/2009,"Eddie, M. (1994) RPA400727: Oncogenicity study by dietary administration to CD-1 mice for 78 weeks.  Pharmaco-LSR Ltd., Eye, Suffolk, IP23 7PX, England.  Laboratory report no.: 93/RH446/0778, May 13, 1994, MRID 44802108. Unpublished.",NOAEL,17.4,mg/kg/day,NA,decreased body weight gain and liver toxicity,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,72,Weeks,liver,Both,None,4042,nonneoplastic histopathology,M,Dichotomous,hepatocytic large fatty vacuolation,,ppm,,mg/kg/day,,Dose response data are from Table 6 in the Data Evaluation Record.,,0,0,,52,1,,
Triticonazole,131983727,,OPP,Chronic RfD (mg/kg/day),0.17,1.02,,http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPP-2009-0276-0009,6/10/2009,"Eddie, M. (1994) RPA400727: Oncogenicity study by dietary administration to CD-1 mice for 78 weeks.  Pharmaco-LSR Ltd., Eye, Suffolk, IP23 7PX, England.  Laboratory report no.: 93/RH446/0778, May 13, 1994, MRID 44802108. Unpublished.",NOAEL,17.4,mg/kg/day,NA,decreased body weight gain and liver toxicity,NA,None,None,Yes,100,10,10,,,,,TRUE,,,Mouse,CD-1,M/F,Oral diet,,,72,Weeks,liver,Both,None,4043,nonneoplastic histopathology,F,Dichotomous,hepatocytic large fatty vacuolation,,ppm,,mg/kg/day,,Dose response data are from Table 6 in the Data Evaluation Record.,,0,0,,52,0,,
Vinyl chloride,75014,C2H3Cl,ATSDR,Chronic Oral MRL (mg/kg/day),0.003,,,"Air Force. 1985. One-year inhalation toxicity study of otto fuel II. Wright-Patterson Air Force Base, OH: Harry G. Armstrong Aerospace Medical Research Laboratory, Aerospace Medical Division, Air Force Systems Command. Document no. AD A163162.",6-Jul,"Til HP, Immel HR, Feron VJ. 1983. Lifespan oral carcinogenicity study of vinyl chloride in rats. Final report. Civo Institutes, TNO. Report No. V 93.285/291099.Til HP, Feron VJ, Immel HR. 1991. Lifetime (149-week) oral carcinogenicity study of vinyl chloride in rats. Food Chem Toxicol 29:713-718.",NOAEL,0.09,mg/kg/day,NA,liver cell polymorphism (moderate and severe),Yes,None,PBPK,Yes,30,3,10,,,,,,,,Rat,Wistar,M/F,Oral diet,,,149,Weeks,liver,Both,MOA Data,3636,nonneoplastic histopathology,M,Dichotomous,liver cell polymorphism (moderate and severe),,mg/kg/day,,mg/kg/day (adj evap),,"Oral intake was adjusted for evaporative loss from the diet during the daily 4-hour feeding periods.  EPA (2000) assessed the feasibility of using Benchmark Dose Modeling on incidence data for liver cell polymorphism.EPA (2000) noted that although all models provided adequate fit to the data, the liver cell polymorphism appeared to be only a high-dose phenomenon, the LED10 values ranged from 6.5 to 24.01 mg/L liver (nearly a 4-fold range), and all modeled LED10 values were higher than the NOAEL of the study. For these reasons, EPA (2000) chose not to use a benchmark LED10 value to derive the RfD for vinyl chloride. ATSDR accepted the rationale used by EPA (2000) for not using Benchmark Dose modeling results.",,0,0,,99,5,,
Vinyl chloride,75014,C2H3Cl,ATSDR,Chronic Oral MRL (mg/kg/day),0.003,,,"Air Force. 1985. One-year inhalation toxicity study of otto fuel II. Wright-Patterson Air Force Base, OH: Harry G. Armstrong Aerospace Medical Research Laboratory, Aerospace Medical Division, Air Force Systems Command. Document no. AD A163162.",6-Jul,"Til HP, Immel HR, Feron VJ. 1983. Lifespan oral carcinogenicity study of vinyl chloride in rats. Final report. Civo Institutes, TNO. Report No. V 93.285/291099.Til HP, Feron VJ, Immel HR. 1991. Lifetime (149-week) oral carcinogenicity study of vinyl chloride in rats. Food Chem Toxicol 29:713-718.",NOAEL,0.09,mg/kg/day,NA,liver cell polymorphism (moderate and severe),Yes,None,PBPK,Yes,30,3,10,,,,,,,,Rat,Wistar,M/F,Oral diet,,,149,Weeks,liver,Both,MOA Data,4427,nonneoplastic histopathology,F,Dichotomous,liver cell polymorphism (moderate and severe),,mg/kg-day,,mg/kg-day (adj evap),,"Oral intake was adjusted for evaporative loss from the diet during the daily 4-hour feeding periods.  EPA (2000) assessed the feasibility of using Benchmark Dose Modeling on incidence data for liver cell polymorphism.EPA (2000) noted that although all models provided adequate fit to the data, the liver cell polymorphism appeared to be only a high-dose phenomenon, the LED10 values ranged from 6.5 to 24.01 mg/L liver (nearly a 4-fold range), and all modeled LED10 values were higher than the NOAEL of the study. For these reasons, EPA (2000) chose not to use a benchmark LED10 value to derive the RfD for vinyl chloride. ATSDR accepted the rationale used by EPA (2000) for not using Benchmark Dose modeling results.",,0,0,,98,16,,
Vinyl chloride,75014,C2H3Cl,IRIS,RfD (mg/kg/day),0.003,,8/7/2000,http://www.epa.gov/iris/subst/1001.htm,8/7/2000,"Til, HP; Immel, HR; Feron, VJ. (1983) Lifespan oral carcinogenicity study of vinyl chloride in rats. Final report. CIVO Institutes. TNO Report No. V 83.285/291099, TSCATS Document FYI-AX-0184-0353, Fiche No. 0353. Til, HP; Feron, VJ; Immel, HR. (1991) Lifetime (149-week) oral carcinogenicity study of vinyl chloride in rats. Food Chem Toxicol 29:713-718.",NOAEL,0.09,mg/kg-d,NA,Liver cell polymorphism,NA,None,PBPK,Yes,30,3,10,,,,,,,,Rat,Wistar,M/F,Oral diet,,,150,Weeks,liver,Both,MOA Data,2132,nonneoplastic histopathology,Both,Dichotomous,Liver cell polymorphism,,mg/kg-d,number responding,,,Data presented below are for males (rows 1-4) and females (rows 5-8) with moderate to severe liver cell polymorphism.,,0,,,99,5,,
Vinyl chloride,75014,C2H3Cl,IRIS,RfD (mg/kg/day),0.003,,8/7/2000,http://www.epa.gov/iris/subst/1001.htm,8/7/2000,"Til, HP; Immel, HR; Feron, VJ. (1983) Lifespan oral carcinogenicity study of vinyl chloride in rats. Final report. CIVO Institutes. TNO Report No. V 83.285/291099, TSCATS Document FYI-AX-0184-0353, Fiche No. 0353. Til, HP; Feron, VJ; Immel, HR. (1991) Lifetime (149-week) oral carcinogenicity study of vinyl chloride in rats. Food Chem Toxicol 29:713-718.",NOAEL,0.09,mg/kg-d,NA,Liver cell polymorphism,NA,None,PBPK,Yes,30,3,10,,,,,,,,Rat,Wistar,M/F,Oral diet,,,150,Weeks,liver,Both,MOA Data,2132,nonneoplastic histopathology,Both,Dichotomous,Liver cell polymorphism,,mg/kg-d,number responding,,,Data presented below are for males (rows 1-4) and females (rows 5-8) with moderate to severe liver cell polymorphism.,,0,,,98,16,,
